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1. Cardiovascular disease 
The cardiovascular system is responsible for transporting oxygen, carbon dioxide, 
nutrients, hormones and blood cells throughout our body. The arterial system 
carries these substances to the organs, while the venous system provides 
transportation of the substances away from the organs. An obstruction of arterial 
blood flow results in tissue ischemia which can lead to tissue damage or death. 
This thesis focuses on one of the major causes of arterial obstruction: 
atherosclerosis. 
Atherosclerosis is a disease of the arterial wall. When atherosclerosis occurs in the 
carotid arteries, it can lead to stroke, while its development in the coronary 
arteries can cause myocardial infarction. Each year, cardiovascular disease causes 
3.9 million deaths in Europe which accounts for 45% of all deaths in Europe1. It is 
thus of social and economic significance to understand the pathophysiology of 
atherosclerosis. This knowledge can improve and aid in the design of new 
diagnostic and therapeutic strategies. 
A healthy artery is composed of three layers. The inner luminal layer consists of a 
thin lining of a monolayer of endothelial cells supported by the internal elastic 
lamina. This first layer is called the tunica intima. Endothelial cells are in direct 
contact with the blood stream. Endothelial cells function as a selective 
permeability barrier, controlling the passage of molecules from and into the 
circulation. The second layer is the tunica media, consisting of concentric layers of 
smooth muscle cells and elastic fibers. The fibers are grouped in lamina, which 
alternate with layers of smooth muscle cells. The media maintains vascular tone 
by constricting or dilating the vessel wall in response to changes in blood flow 
and/or pressure. The third layer, tunica adventitia, is composed of collagen fibers 
supported by the external elastic lamina. This layer provides stability by anchoring 
the blood vessels to nearby organs. The vasa vasorum (i.e. blood vessels that 
supply large arteries with blood) feeds the tunica adventitia and the tunica 
media2.  
1.1 Atherosclerosis 
Atherosclerosis is an inflammation and lipid-driven disease, which can affect all 
three layers of the arterial wall. It is the build-up of plaques, which is composed of 
lipids, inflammatory cells and fibrotic tissue in the arterial wall3,4. The endothelium 
is activated in the tunica intima, which is reflected by an increased permeability to 
the circulating lipoproteins and by the expression of adhesion molecules, which 
promote the recruitment, adhesion and transmigration of circulating monocytes 
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into the subendothelial layer. Upon infiltration, monocytes transdifferentiate into 
macrophages and transform into foam cells after internalization of lipoproteins5. 
Signaling pathways activated by these foam cells contribute to the recruitment of 
more monocytes from the circulation, lipoprotein modification and the infiltration 
and proliferation of smooth muscle cells from the tunica media4,5. The smooth 
muscle cells synthesize extracellular matrix, forming fibrotic tissue in the plaque6. 
If the inflammation is not resolved, foam cells can become apoptotic due to 
oxidative stress or nutrient deprivation. In case of impaired efferocytosis (i.e. 
phagocytosis of apoptotic cells) this results in the formation of a necrotic core. At 
this stage the internal elastic lamina often undergoes fragmentation6. Oxygen 
deprivation not only induces cell apoptosis, but also neovascularization from the 
vasa vasorum in the tunica adventitia layer into the plaque. The growth of these 
small vessels may provide another pathway for the infiltration of inflammatory 
cells4,6,7. 
During disease development, the size of the plaque increases. Initially, this does 
not affect lumen diameter or blood flow to the downstream tissues, as the vessel 
wall can remodel outward. However, as the disease progresses, the vessel wall 
can no longer fully compensate for plaque progression. The plaque will intrude 
into the lumen, whereby decreasing lumen diameter. This phenomenon is termed 
stenosis. 
1.2 Vulnerable plaque 
Traditionally, the risk of atherosclerotic disease is estimated from the percentage 
of stenosis detected by computed tomography angiography (CTA), magnetic 
resonance imaging (MRI), or Ultrasound imaging. In addition to stenosis severity, 
the imaging techniques reveal the location of atherosclerotic plaques. When the 
degree of stenosis reaches 70% in the carotid artery or 50% in the coronary 
artery, surgical intervention is deemed necessary8–10. However, plaques that are 
not (severely) flow restricting can cause a cardiovascular event. This happens 
when a plaque ruptures. Plaque rupture causes an immediate thrombotic event 
that can result in a complete obstruction of blood flow. Postmortem examinations 
of human coronary plaques showed that 60% to 70% of the cardiovascular events 
were due to plaque rupture11,12. 
Therefore, degree of stenosis alone cannot predict cardiovascular events13. Risk of 
rupture was correlated to the composition of the plaque14–16. Plaques with a high 
risk of rupture are termed vulnerable plaques12,17,18. They are characterized by a 
thin fibrotic cap overlying a large lipid-rich necrotic core, extensive inflammation, 
presence of calcification, neovascularization, and intra-plaque hemorrhage12,19. In 
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contrast, atherosclerotic plaques with abundant fibrotic tissue, and a thick fibrotic 
cap overlying a small necrotic core have a low risk of rupture and are called stable 
plaques. Although CTA was proven valuable in predicting risk of cardiac events20, 
diagnosis of mildly-stenotic, vulnerable plaques is difficult as CTA does not provide 
information on plaque composition and could leave patients at risk for future 
cardiac events. 
To develop new diagnostic tools and treatment for vulnerable plaques, we need 
to understand how plaques develop and progress into either a stable or a 
vulnerable plaque phenotype. Current knowledge about the mechanisms behind 
plaque progression and composition, and plaque vulnerability is limited. 
2. Hemodynamics and atherosclerosis 
Although risk factors for atherosclerosis, including smoking, diabetes, high blood 
pressure, hyperlipidemia, genetic susceptibility, etc., are systemic in nature, 
atherosclerosis develops at specific sites of the vasculature, i.e. near curvatures 
and bifurcations. This is due to the difference in the hemodynamic environment 
between these locations, priming the vessel wall for atherosclerotic plaque 
development21. Two hemodynamic forces are observed in the vascular system: 
wall shear stress (WSS) and wall stress. Generally, it is accepted that WSS is 
related to the initiation of plaque development, while wall stress is responsible for 
plaque rupture. 
2.1 Wall shear stress and atherosclerotic plaque initiation 
WSS is the frictional force that blood flow applies on the endothelial lining of the 
vessel wall which can vary in complexity from laminar and unidirectional in 
straight vessel segments to disturbed and oscillating near curvature and 
bifurcations. The direction of this drag force is parallel to the endothelial surface. 
A normal physiological range of WSS in the healthy arterial vascular network in 
humans is 1 Pa to 7 Pa22. 
The magnitude and direction of WSS can be sensed by mechanosensors on the 
endothelial surface which then translate the mechanical signals into biological 
responses23–25. High WSS is associated with the expression of anti-inflammatory 
transcription factors including KLF2 and Nrf2. Low WSS induces pro-inflammatory 
transcription factors i.e. NF-kB and ATF2, which are essential in the initiation of 
atherosclerosis, as they regulate expression of adhesion molecules26–29. Therefore, 
vessel areas exposed to low WSS are most susceptible to the development of 
atherosclerosis21,22,30. 
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2.2 Wall stress and plaque rupture 
Wall stress in the arterial wall is generated in response to the changes in blood 
pressure during each heartbeat. One heartbeat can be generally divided into two 
phases: a diastolic and a systolic phase. During the diastolic phase, the heart 
volume increases as blood fills up the heart chambers. At a normal physiological 
level, the blood pressure measured during the diastolic phase is about 80 mmHg, 
or 11 kPa. In the systolic phase, the heart volume decreases and the blood pumps 
out of the heart into the vascular circulation. Blood pressure rises to 
approximately 120 mmHg, or 16 kPa. As a result, the stresses that the arterial wall 
is exposed to change during each heartbeat. These pulsations of the arterial wall 
lead to the deformation of the healthy artery components, i.e. the endothelium, 
smooth muscle cells and lamina, and the plaque components including necrotic 
core, fibrous cap in the presence of an atherosclerotic plaque. 
Wall stress plays a very prominent role in vulnerable plaque rupture31–33. Plaque 
rupture occurs when the wall stress in the fibrous cap exceeds the strength of the 
fibrous cap. Even though wall stress is 1000x higher in magnitude than that of 
WSS, the biological effect of wall stress or the corresponding strain levels on 
endothelial cell biology is much smaller and therefore not investigated in this 
thesis. 
2.3 Hemodynamics and plaque progression 
In advanced atherosclerotic disease, the plaque will grow into the lumen (Fig. 1), 
thus changing lumen geometry and causing variations in WSS at different plaque 
locations34–38. Until now it is unknown how changes in WSS patterns affect the 
composition of advanced lumen intruding plaques. Analysis of human carotid and 
coronary plaques revealed that rupture was predominantly located at the 
upstream shoulder of a plaque39–41, correlating to high WSS regions42–44 and that 
high WSS correlated to weak spots in the cap45,46. Furthermore, differences in 
plaque composition at the upstream and the downstream side of the plaque were 
shown to be associated with flow directions. These differences include thinner 
fibrous cap, larger necrotic cores, relative scarcity in smooth muscle cells and 
abundant accumulation of macrophages at the upstream versus the downstream 
side of the plaque47–51, correlating rupture location to compositional 
characteristics of a vulnerable plaque. These data point towards a role for high 
WSS in plaque vulnerability. In contrast, low WSS was correlated to characteristics 
of plaque vulnerability in human and porcine coronary arteries52–60, where low 
WSS was considered to induce inﬂammation, lipid accumulation, and matrix 
degradation61. Furthermore, increasing flow over an existing plaque by surgical 
manipulation in a mouse model of atherosclerosis was shown to result in a 
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reduction in plaque size and vulnerability, indicating high WSS could stabilize 
plaques62. In summary, it is inconclusive whether low or high WSS is associated 
with plaque vulnerability. In this thesis we set out to further investigate this under 
the hypothesis that 
Changes in WSS over a developing plaque induce changes in  
plaque composition and potentially induce plaque vulnerability. 
To investigate the causal relationship between WSS and atherosclerotic plaque 
progression, it is necessary to perform a longitudinal study and obtain plaque 
compositional information. To correlate WSS to plaque composition, we make use 
of animal models. The experimental design and techniques to test our hypothesis 
is described below. 
Figure 1 Illustration of plaque development and progression (A) Inner curvature of the 
vessel wall is exposed to low WSS, which predisposed the vessel wall for atherosclerotic 
plaque initiation. The outer curvature is exposed to high WSS, which is an anti-
inflammatory factor, protecting the vessel wall against plaque development. (B) During 
the initial stage of plaque development, lumen diameter is maintained as the vessel wall 
undergoes outward remodeling. (C) Eventually, as the disease advances, plaque intrudes 
into the lumen, which affects the lumen diameter and results in changes in WSS levels 
(adapted34). 
3. Research Approach and techniques 
3.1 Animal model to study WSS and atherosclerosis 
Several animal models for atherosclerosis research exist. All models require 
modulation of the animal’s lipid profile (genetically and/or diet-induced) and 
generally certain form of surgical manipulation (injury or alteration in WSS) to 
accelerate the formation of plaques. The most commonly-used model in 
atherosclerotic research is the mouse, other often-used models include pig and 
Plaque 
progression 
Plaque 
initiation 
Outward 
remodeling 
(A) (B) (C) 
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rabbit63. A more detailed introduction on available animal models to study WSS 
and atherosclerosis is described in Chapter 2. 
Pigs share great similarities with humans regarding physiology, lipid profile and 
atherosclerotic plaque formation. Most importantly, plaque composition is 
comparable to that of human plaques, although plaque rupture is rare. However, 
the disadvantages of using pig model for atherosclerosis research include high 
costs and the long duration to develop atherosclerosis. In rabbits, atherosclerosis 
does not occur spontaneously but can be induced by high fat diet feeding in 
combination with endothelial injury63–65. Even though the lipid metabolism of 
rabbits shares more similarities with humans than that of mice, rabbit 
atherosclerotic plaques are not as complex as those of humans and take several 
months to form63,66. The possibilities to create genetic mutations in mice, fast 
disease progression, and low costs to maintain make it an attractive model to 
study atherosclerosis. Mice with a wild type genetic background develop 
atherosclerosis only after a long duration of high fat feeding67. With the possibility 
to genetically manipulate genes involved in lipid metabolism, atherosclerosis can 
be induced by different stimuli in shorter time periods. Also, several surgical 
techniques are readily available for WSS manipulation in vivo and inducing 
atherosclerosis, including the AV-fistula model, vascular grafts, ligation models 
and perivascular device models68.  
In 2006 the cast model was created69. The surgical technique placed a perivascular 
device called cast, consisting of two halves with a tapered lumen, around the 
common carotid artery of mice. Cast placement induces low WSS proximal to the 
cast, an increasing WSS gradient in the cast area, and low, oscillatory WSS distal to 
the cast (Fig. 2B). The model not only enables the study of the effect of different 
WSS environments in the same arterial segment, but also accelerates plaque 
development in mice genetically predisposed to atherosclerosis development. In 
Apolipoprotein E (ApoE) knockout mice, within weeks of cast placement, plaques 
proximal and distal to the cast are formed. Strikingly, the two plaques differs in 
composition: the proximal plaque is rich in lipid content, equal or higher 
macrophage content, and lower collagen and smooth muscle cell levels compared 
to the distal plaque69–75. The proximal plaque is therefore considered more 
vulnerable than the distal plaque (Fig. 2C). In this thesis, we set out to study the 
changes in WSS during the progression of this proximal, more vulnerable plaque 
and the correlation between WSS and plaque composition.  
3.2 WSS: Computational fluid dynamics (CFD) 
WSS in an arterial segment is a parameter that cannot be measured directly in 
vivo. It can be calculated by multiplying the viscosity of the blood by wall shear 
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rate, which is the spatial gradient of blood velocities at the wall in the radial 
direction66. These parameters of fluid flow can be obtained by solving flow 
equations using computational fluid dynamics (CFD). CFD allows one to determine 
the velocity and pressure distribution at any location within an arterial segment, 
and from the velocity distribution we can derive the shear rate and therefor WSS. 
Figure 2 Tapering cast placed around the common carotid artery induced atherosclerotic 
plaque development in ApoE-/- mice. (A) Healthy common carotid artery with arrow 
indicating the direction of the blood flow. (B) A tapering cast is placed around the 
common carotid artery of the mouse, reducing WSS upstream to the cast, 
increasing WSS inside the cast, and inducing oscillatory WSS distal to the cast. (C) 
As a result, plaques develop in the upstream and downstream region of the cast. 
To perform CFD simulation, knowledge of arterial geometry and blood flow are 
required. Micro contrast-enhanced Computed Tomography (micro-CT) and 
Doppler Ultrasound imaging were used in this thesis to obtain such information 
with great resolution. Next, several assumptions need to be made when using CFD 
including the viscosity of the blood, rigidity of the wall etc. These assumptions 
simplify the calculation of flow equations in CFD and therefore reduce complexity 
of the solution procedure. The assumptions can also influence the choice of 
imaging techniques and subsequent image processing pipeline. 
From a computational perspective, the most important assumption is the rigid 
wall assumption. This assumption implies that the impact of the blood pressure-
induced movement of the arterial wall minimally influences the blood flow 
patterns. By neglecting the pulsation of the vessel wall, the calculations can be 
solved on stationary arterial geometry, which is a huge advantage from a 
computational perspective. A recent study by de Wilde et al. demonstrated that 
this assumption holds true for the flow in the carotid artery of mice76. Since the 
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atherosclerotic plaque developed in the cast mouse model is located in the 
common carotid artery69,73, we therefore neglected the pulsation of the vessel 
wall in our CFD simulation. This also brought a huge advantage to the micro-CT 
imaging protocol. It is thus possible to opt for a non-cardiac-gated imaging to 
minimize imaging duration and reduce radiation dosage when capturing the 
geometry of the mouse carotid artery. 
The high resolution arterial geometry data then needs to be converted into a 
finite element mesh for the CFD solution procedure. This process involves 
subdividing the volume of the arterial lumen into small elements. This spatial 
discretization step is a very important step, and in many cases also the most time-
consuming step in any CFD procedure. The finite element mesh must be of such 
quality that the final solution of the flow equations does not depend on the 
number or the distribution of the elements. Then, and only then, the solution is 
called mesh-independent. A mesh-independency study should therefore be 
performed for each ‘typical’ geometry, which in our case is the carotid artery of a 
mouse with a cast. 
The second important assumption is related to the material model used for the 
blood. Blood is a non-Newtonian fluid, which is mainly expressed by the fact that 
the viscosity of blood decreases as the shear rate it is imposed to increases. This 
so-called shear thinning behavior is especially important at lower shear rates, and 
was shown to be important for velocity and WSS distribution in large arteries in 
the human circulation77. The average shear rates in mice however is at least one 
order of magnitude higher than the shear rates in human66, and the effect of the 
shear thinning behavior of blood can therefore be neglected in mice. Other non-
Newtonian effects, including viscoelasticity, are generally regarded as secondary 
to the shear thinning behavior and can therefore be neglected as well. 
In rigid arterial geometry without bifurcations, boundary conditions at three 
interfaces are generally prescribed: the inlet, the wall and the outlet. A general 
assumption for the velocity at the wall is made: the so-called ‘no-slip’ condition. 
This condition prescribes that all the velocity components at the wall are equal to 
zero. Outlet boundary condition is assumed to be stress-free. This assumption can 
be made when only a single outlet is present in the arterial segment during CFD 
simulation. In this thesis, we only studied WSS distribution in the main branch of 
the carotid artery where plaque growth was induced by the cast surgery. CFD 
simulation was thus performed on the main branch of the carotid segment before 
the vessel bifurcates into the internal and the external carotid arteries. Therefore, 
a stress-free outlet can be assumed. The inlet boundary condition required mouse 
specific input: the amount of blood that goes through an artery can vary from one 
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mice to another and is influenced by the size of the artery. The measured velocity 
distribution can either be used for CFD simulation directly, or be converted to an 
idealized flow profile by assuming e.g. a parabolic velocity distribution at the inlet. 
Depending on the research question of interest, the inlet flow can be time-
averaged, giving rise to the time-averaged WSS (TAWSS) over the entire cardiac 
cycle. With time-dependent inlet flow, time-dependent WSS parameters can be 
quantified, i.e. oscillatory shear index (OSI), transverse WSS (transWSS), relative 
residence time (RRT), etc., at any defined time step during one cardiac cycle. 
However, time-dependent CFD simulation is more complex and time consuming. 
In previous studies, it was demonstrated that time-dependent WSS-derived 
parameters are generally less relevant due to the geometry and flow conditions in 
proximal segment in the cast mouse model78, unlike in other vascular 
territories79,80. A time-averaged inlet profile is thus more favored in the work of 
this thesis. 
3.3 Vessel geometry: contrast-enhanced computed tomography 
To study the correlation between WSS and plaque progression, it is necessary to 
perform multiple image acquisitions during disease progression. Besides, as WSS 
is extremely sensitive to small deviations in the lumen81, accurate, robust and 
reproducible assessment of artery geometry is of eminent importance. Micro-CT 
is a non-invasive, X-ray imaging technique that can capture the 3D vessel 
geometry without sacrificing the animal. This allows the possibility to capture 
changes in vessel geometry over time and calculate WSS at multiple time points 
during plaque progression. 
However, it was reported previously that frequent exposure to radiation imaging 
can increase the incidence of cardiovascular diseases in oncology patients82,83. 
Radiation at high dose can induce inflammation as indicated by animal studies84,85. 
Therefore, it is necessary to use a modality that can perform the imaging in a 
short amount of time with low radiation dosage for the experimental animals. At 
the same time, such a technique should offer high resolution to capture the 
lumen geometry of the murine carotid with a diameter of approximately 500 
µm86. 
A micro-CT scanner (Quantum FX, PerkinElmer) especially designed for imaging 
small animals was used in this thesis which allowed us to obtain murine vascular 
geometry in high resolution. During the 5-minute scan, the mouse is anesthetized 
and immobilized on the imaging bed, an X-ray tube rotates 360 degrees around 
the animal, acquiring a high resolution (40 µm) image, while exposing the animal 
to a minimal radiation dose (1.7 Gy). Due to the low attenuation nature of the soft 
tissue i.e. vessel wall, plaque, the use of contrast agent is required to visualize the 
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lumen when performing micro-CT imaging. Several contrast agents are 
commercially available for small animals. Selection of the contrast agent is based 
on its biocompatibility and the signal intensity that it can provide (discussed in 
Chapter 3). 
3.4 Blood velocity: Doppler Ultrasound 
Blood velocity can be measured non-invasively in vivo using Doppler Ultrasound 
(Vevo 2100, VisualSonics) which is a non-ionizing imaging modality. The velocity 
waveform is captured in the pulse-wave mode. However, blood velocity is a 
parameter that is dependent on the local geometry of the blood vessel and 
cannot be used directly as the input boundary condition for the CFD simulation. 
Therefore, it is necessary to obtain the vessel diameter at the location of the 
measurement in the motion mode. One can thus convert the measured blood 
velocity (m/s) to blood flow (m3/s) with the knowledge of vessel diameter at the 
location of measurement. This maintains the consistency across different 
measurements during plaque progression, and corrects for the different 
measurement locations at each time for CFD simulation. 
3.5 Correlate WSS to plaque composition 
Once WSS distribution in an arterial segment was established, this biomechanical 
parameter needs to be correlated to the plaque composition. Therefore, we need 
to match the geometrical data used for CFD simulation to the plaque 
compositional information. The latter cannot be obtained with current available in 
vivo imaging modalities. To visualize plaque composition and quantify plaque 
area, macrophage area, necrotic core area etc., we used general histology staining 
and immunohistochemical staining. Serial plaque sections were stained for plaque 
components including macrophages, endothelial cells and collagen. These 
sections were then spatially registered to the 3D WSS map, and correlations 
between WSS and plaque compositions can then be investigated (details 
described in Chapter 4). However, since histology analyses only provide 
compositional information on a 2D level, consequently, plaque components with a 
3D nature, i.e. cap thickness, necrotic core volume or distribution will be lost. 
Therefore, in Chapter 7 we explored the use of an ultrahigh resolution X-ray 
based imaging modality to visualize and quantify plaque compositional 
information on a 3D level. 
4. Aim and scope 
The aim of this thesis was to study the evolution of WSS during plaque 
progression and determine its correlation to plaque composition. Understanding 
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the relation between WSS and plaque composition will enhance our knowledge 
on the mechanisms that lead to vulnerable plaque rupture and potentially aid in 
the design of new diagnostic and therapeutic strategies.  
To be able to investigate quantitative correlations between WSS and plaque 
composition of a developing plaque, a bioengineering approach with a 
multidisciplinary team is required. In Chapter 2, we reviewed the use of different 
animal models to study the relationship between WSS and atherosclerosis. 
Throughout the thesis we make use of the cast model in ApoE-/- mice, as cast 
placement quickly results in the formation of a vulnerable plaque. To obtain a 3D 
WSS map we established an image segmentation protocol and WSS simulation 
pipeline, presented in Chapter 3, using small animal imaging modality and 
contrast agent suitable for longitudinal imaging studies. With this protocol we 
determined the temporal and spatial changes in WSS over the growing plaque in 
our mice with cast-induced vulnerable plaque in Chapter 4, and correlated WSS to 
plaque composition. We found that WSS decreased during plaque progression. To 
determine the effect of increasing WSS on plaque composition, we investigated 
the effect of the heart rate lowering drug Ivabradine on WSS, as it was suggested 
that Ivabradine can increase WSS. Chapter 5 and 6 describe the effect of 
Ivabradine on hemodynamics in vivo, with a focus on its effect on endothelial 
inflammation during the onset of atherosclerosis in Chapter 5 and on plaque 
composition in advanced atherosclerosis in Chapter 6. Quantitative analysis of key 
features of plaque vulnerability, including cap thickness and necrotic core size and 
morphology, are however hindered by the 2D approach of histological processing. 
In Chapter 7, a new imaging modality to capture 3D plaque composition is 
presented. We developed a new analysis pipeline to visualize and quantify 3D 
plaque composition in ultrahigh resolution. Finally, the implications of the findings 
of this thesis and future prospects are discussed in Chapter 8. 
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Figure 3 Overview of thesis outline  
 
   
   
  
 
 
 
 
 
 
 
 
 
Chapter 2 
 
Animal models of surgically manipulated flow velocities 
to study shear stress-induced atherosclerosis 
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Abstract 
Atherosclerosis is a chronic inflammatory disease of the arterial tree that develops 
at predisposed sites, coinciding with locations that are exposed to low or 
oscillating shear stress. Manipulating flow velocity, and concomitantly shear 
stress, has proven adequate to promote endothelial activation and subsequent 
plaque formation in animals. In this article, we will give an overview of the animal 
models that have been designed to study the causal relationship between shear 
stress and atherosclerosis by surgically manipulating blood flow velocity profiles. 
These surgically manipulated models include arteriovenous fistulas, vascular 
grafts, arterial ligation, and perivascular devices. We review these models of 
manipulated blood flow velocity from an engineering and biological perspective, 
focusing on the shear stress profiles they induce and the vascular pathology that 
is observed. 
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1. Introduction 
Atherosclerotic plaque development occurs preferentially at geometrically 
predisposed areas, like the inner curvature of the aortic arch and at arterial 
branch points. This site specific development occurs despite the fact that the 
entire vasculature is exposed to systemic risk factors like hypertension and 
hypercholesterolemia55,87. The specific plaque localization is caused by the local 
differences in blood flow velocities, and thus the shear stress, to which the vessel 
wall is exposed to. Besides blood flow-induced shear stress, the vessel wall is also 
exposed to wall strain. Shear stress is the frictional force generated by the blood 
flow on the vessel wall, parallel to the endothelium, while wall strain is generated 
by the blood pressure, perpendicular to the endothelium. Both forces play a role 
in either plaque initiation and/or development, but shear stress was most often 
correlated to atherogenesis22,87,88. This review focuses on the animal models in 
which the blood flow velocities, and thereby shear stress, have been manipulated 
in order to study its causal relation with atherosclerosis. 
The SI-unit of shear stress is Pascal (Pa), which is equal to N/m2 or 10 dynes/cm2. 
Shear stress at the vascular wall, wall shear stress (WSS), can be calculated by 
combining data on flow velocity, blood viscosity and vessel geometry using 
advanced modeling techniques and is usually averaged over the cardiac cycle. The 
most commonly used mathematical technique to calculate shear stress is 
computational fluid dynamics (CFD). Different blood flow velocity patterns in the 
vasculature give rise to diverse average WSS levels (Box 1) varying over the whole 
vasculature and between species. These WSS levels can range from 3-14 Pa in 
mice, 1-16 Pa in rabbits and 1-2 Pa in humans89. 
The correlation between atherosclerotic plaque localization and different blood 
flow velocity patterns is caused by the response of endothelial cells (ECs) to 
alterations in shear stress. ECs react via mechano-transduction by changing gene 
regulation and, subsequently, cell phenotype. The process of mechano-sensing 
and -transduction has been extensively studied and reviewed90–93. It includes 
mechanical deformation and activation of cytoskeletal elements, primary cilia, the 
glycocalyx, the VE-cadherin/PECAM-1/VEGFR2 complex, integrins, ion channels, 
and G-protein coupled receptors90–93. The mechanical signal is subsequently 
converted into a biochemical signal. When exposed to a high unidirectional 
laminar shear stress, ECs are quiescent and align into the direction of the blood 
flow22,94. They express an anti-inflammatory and anti-oxidant gene profile 
controlled by a concerted action of the shear stress-responsive transcription 
factors of which Krüppel-like factor 2 (KLF2) and nuclear factor (erythroid-derived 
2) -like 2 (Nrf2) are the most important29,95–99. An important function of KLF2 is 
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regulating vascular tone via regulation of endothelin-1 (ET-1), a 
vasoconstrictor99,100, and endothelial nitric oxide synthase (eNOS), producing the 
vasodilator nitric oxide (NO). 
At regions of low or oscillatory shear stress, the endothelium is activated and 
shows a pro-inflammatory transcription profile. This pro-inflammatory profile is 
mainly regulated by activation of NF-ƙB and its transcriptional targets, resulting in 
expression of adhesion molecules, a decrease in NO, and a higher permeability to 
plasma macromolecules, which results in a dysfunctional endothelium that is 
prone to atherosclerotic plaque initiation93,101,102.  
The different cellular adhesion molecules expressed by the dysfunctional 
endothelium facilitate adhesion and migration of monocytes and 
lymphocytes103,104 into the sub-endothelial layer. There, monocytes differentiate 
into macrophages, which will take up oxidized low density lipoprotein (oxLDL) and 
transform into foam cells105. These foam cells produce high levels of pro-
inflammatory cytokines, chemokines, and growth factors, which attract more 
inflammatory cells and induce smooth muscle cell (SMC) proliferation and 
migration into the intima. This results in plaque growth. Initially, plaque growth 
will not affect lumen diameter due to compensatory outward remodeling106. 
Shear stress remains low and will therefore continue to activate pro-inflammatory 
pathways, including pathways related to extracellular matrix degradation 
(reviewed by Wentzel et al.54). This process in turn promotes further 
compensatory outward remodeling37,52,53,106. When outward remodeling is not 
sufficient anymore to avoid lumen protrusion of the growing plaque, the shear 
stress levels at the plaque will change45. 
During atherosclerosis development, plaques can develop into a stable plaque or 
a vulnerable plaque. While most atherosclerotic plaques are stable, some develop 
into a vulnerable or rupture prone plaque12. The American Heart Association 
(AHA) classification12,107 describes the characteristics of the different stages of 
human atherosclerotic plaques. The vulnerable or rupture-prone plaques (AHA 
class IV, V and VI) often show an eccentric phenotype and are defined by a large, 
lipid-rich necrotic core, a thin fibrous cap infiltrated by inflammatory cells, and 
outward vascular remodeling18. Other common characteristics of human plaque 
vulnerability are intraplaque hemorrhage, neovascularization, and 
calcification12,107–112. 
Atherosclerotic plaque formation in humans is slow and spans over a period of 
decades. Furthermore, harvesting plaque tissue from humans is not straight 
forward, and thus molecular mechanisms involved in the generation and 
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destabilization of plaques can be difficult to investigate. Therefore, several animal 
models for atherosclerotic plaque development including mouse, rat, rabbit, pig 
and primate are used. To initiate the atherosclerotic process in these animal 
models, risk factors like a high cholesterol level and inflammation are genetically 
or experimentally induced. Shear stress can be surgically manipulated in these 
animal models in order to study the causal relationship between shear stress and 
atherosclerosis initiation and progression. This surgical manipulation can also be 
used to accelerate the atherosclerotic process. Here we review these surgically 
manipulated flow models from an engineering and biological perspective. 
 
Figure 1 Schematic depiction of the different laminar flow and shear stress profiles. 
2. Flow velocity manipulated models  
2.1 Arteriovenous fistula models 
The arteriovenous (AV) fistula model is one of the first animal models that used 
surgery to manipulate the flow velocities in order to study the correlation 
between shear stress and atherosclerosis113. For the creation of an AV-fistula, an 
artery is connected directly, end-to-side, to a neighboring vein, thereby bypassing 
the distal arterial and venous vascular beds (Fig. 2A). The AV-fistula is originally 
developed as a form of permanent vascular access for hemodialysis patients by 
inducing venous maturation. However, the development of venous neointimal 
hyperplasia often led to fistula failure. This observation triggered a series of 
studies with this model on vascular remodeling and maturation of the venous 
segment, and a few studies on plaque development.  
Flow measurements and shear stress calculations in mice demonstrated that 
creation of an AV fistula resulted in elevated blood flow levels, and concomitantly 
shear stress, in the arterial segment. 
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The venous segment showed endothelial dysfunction, which was indicated by an 
upregulation of shear stress responsive pro-inflammatory genes and proteins. 
Furthermore, significant lumen narrowing occurred as a result of intimal 
hyperplasia with infiltrating macrophages and SMCs114,115. Flow velocities and 
shear stress changes in the venous segment were not reported. The 
hemodynamics at the site where the artery connects to the vein is so complex, it 
is not possible to predict what happens at that site without local measurements. 
Similar results for blood flow and shear stress levels were obtained in in a dog and 
rabbit model, where flow velocities and shear stress in the arterial segment were 
also elevated, which led to vasodilation and eventually outward remodeling as a 
compensatory process to control the shear stress levels113,116. Furthermore, the 
group of Zarins116 showed in rabbits that temporal reduction of shear stress in the 
arterial segment by short term closure of the fistula triggered the formation of 
neointimal hyperplasia with SMC infiltration in this segment. In rabbits, arterial 
segments that remained exposed to high shear stress showed no intimal 
hyperplasia117–120. In summary, the AV fistula model demonstrated a correlation 
between elevated shear stress and arterial remodeling in multiple animal 
models121–125. 
2.2 Vascular grafts  
Bypass graft surgery with venous grafts is often used to treat atherosclerotic 
occlusive disease in patients. However, graft failure due to intimal hyperplasia and 
plaque formation often occurs. Animal models of vascular grafts were created to 
study the pathophysiology of atherosclerosis in coronary artery bypass grafts. 
These models involve surgical removal of a vessel segment, either artery or vein, 
which is then transplanted into, for instance, the carotid or coronary artery126,127 
(Fig. 2B). 
In mice, the vein graft resulted in early intimal cell-loss and vessel wall 
degeneration, which was followed by immune cell infiltration, intimal hyperplasia, 
matrix protein accumulation and an increase in SMC numbers126. In 
hypercholesterolemic pigs, vein grafts implanted in carotid arteries were 
obstructed by atherosclerotic plaques with lipid-rich necrotic cores and immune 
cell infiltration128. EC dysfunction and plaque formation were probably triggered 
by a combination of several factors. These factors include the surgically-induced 
vessel damage, hypoxia, and presumably hemodynamic factors. As no 
hemodynamic measurements were performed in this model, it is speculated that 
the introduction of a larger diameter vein in a smaller diameter artery resulted in 
a lower flow velocity in the graft, and thus lower shear stress, than in the native 
artery. 
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Figure 2 A schematic overview of all the flow alteration models described in this review 
and the measured or speculated shear stress levels. A) shows the AV-fistula model where 
an artery is attached to a vein (adapted from Castier et al.114). *At the site where the 
artery connects to the vein it is not possible to postulate what happens to the shear stress 
levels as the hemodynamics at this site are too complex. B) shows the vascular graft model 
in which a vessel segment is transplanted onto an artery (adapted from Zou et al.126). C-I) 
shows the ligation models. C) the complete ligation model in which the right common 
carotid artery (RCA) is completely tied off with cessation of flow as a result. The flow 
velocities and shear stress levels proximal to the ligation would be extremely low due to 
still existing variations of blood pressure and compliance of the artery. D-G) shows the 
partial ligation models (adapted from Nam et al.129). D) the internal carotid artery (ICA) 
and external carotid artery (ECA) are completely tied off. E) the ECA, ICA and the occipital 
artery (OA) are completely tied off leaving blood flow only through the superior thyroid 
artery (STA). F) in the tandem stenosis model, the RCA has two partially constrictive 
ligations placed in succession between the right subclavian artery (RSA) and the 
bifurcation. G) the RCA is partially tied off. H-I) show the aortic constriction models 
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(adapted from Tropea et al.130). H) shows the partial ligation of the descending aorta. 
*Shear stress levels proximal to the ligation would be low, but depends on cardiac 
compensation. I) shows the partial ligation between the brachiocephalic artery (RCCA) and 
the left common carotid artery (LCCA) and the resulting shear stress levels. J-L) show the 
perivascular devices with a constrictive cast in J, a tapered cast in K and a dotted cast in L 
(adapted from von der Thüssen et al.131, Cheng et al.132 and Kivelä et al.133). *The shear 
stress levels in J would depend on the degree of constriction.  
 
Box 1 Blood flow velocity patterns and shear stress 
Flow velocity patterns and the concomitant shear stress profiles, depend on the velocity 
profile itself, blood viscosity, lumen diameter and vessel geometry. A simplified schematic 
depiction of the different laminar flow and shear stress profiles is shown in fig 1. The 
different flow routes a blood particle can follow are depicted by the brown streamlines. 
Blood flow is laminar in most cases, which means the blood flows in parallel layers, 
without intersecting. WSS is represented by the slope of the parabolic velocity profile 
depicted in black (Fig. 1A). In case of a stenosis, caused by for example a plaque, flow 
remains laminar but can separate distal from the stenosis, forming recirculating flow 
layers near the wall, resulting in low and/or retrograde shear stress at the wall (Fig. 1B). At 
a curvature, secondary flow can occur, meaning that flow is moving perpendicular to the 
flow direction (Fig. 1C transverse section). This is still considered laminar flow as parallel 
flow layers are present. The peak velocity shifts to the outer curvature of the vessel, 
resulting in a higher shear stress at the outer curvature compared to the inner curvature 
(Fig. 1C). At bifurcations, secondary flow is present similar to flow patterns seen at 
curvatures, resulting in particle movement parallel and perpendicular to the vessel wall 
(Fig. 1D). This is not to be confused with the term turbulent flow. With turbulent flow, 
particles do not flow in parallel layers but intersect, and show unpredictable multi-
directional, multi-velocity streamlines. Turbulent flow is uncommon but can occur 
occasionally in the human descending aorta, behind the aortic valve leaflets during peak 
systole, in large arteries distal to a very severe stenosis and in aneurysms134–136. Figure 1 
summarizes the different flow velocity patterns at one point in time. However, due to 
cardiac contractions, flow in the arterial system is pulsatile and therefore flow velocities, 
and the time averaged wall shear stress may differ in magnitude and direction. 
 
 
2.3 Ligation models 
Another animal model used to study the role of shear stress in atherogenesis is 
the ligation model. The first ligation model described was developed by Wexler 
and Saroff137 in the early 70’s and was used to induce brain ischemia in rats by 
completely ligating the carotid artery, causing cessation of blood flow. When a 
correlation between reduced blood flow and intimal hyperplasia became 
evident138–140, Kumar and Lindner141 used the ligation model to study 
atherosclerosis in carotid arteries of mice. Others have since altered the model of 
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Kumar and Lindner to study atherosclerosis, by ligating different arteries e.g., the 
external or internal carotid artery, by varying the location of the ligature on the 
same artery, and by varying the degree of stenosis and the number of ligations. 
These different ligation models were used to address different research questions 
and are discussed below.  
• Complete ligation of the carotid artery 
The Kumar and Lindner141 model described a complete ligation of the common 
carotid artery in mice, resulting in complete cessation of blood flow distal to the 
ligation (Fig. 2C). Because the artery was still subject to arterial blood pressure, 
pressure pulsation proximal to the ligation and extremely low and oscillatory 
shear stress were assumed, although, flow measurements were never 
performed141. Plaque development and thrombus formation occurred just 
proximal to the ligation141. A great number of studies in mice using the complete 
ligation of the carotid artery based their technique on the Kumar and Lindner 
model. This model was applied to accelerate plaque formation and to study 
molecular mechanisms involving endothelial activation, leukocyte recruitment 
and neointimal hyperplasia142,143. This model has also been used to study new 
imaging techniques and new drug treatments in mice144–146. 
Application of the complete ligation model in hyperlipidemic mice induced rapid 
formation of lipid rich plaques with high macrophage content proximal to the 
ligation147–150. Furthermore, when these mice were treated with angiotensin II, a 
vulnerable plaque phenotype developed151. 
Plaque rupture was induced in mice by combining the complete ligation, which led 
to plaque formation, with subsequent placement of a non-constrictive cast 
around the area of the common carotid where plaque developed. Lipid rich 
plaques developed just proximal of the ligation and subsequently, after cast 
placement, plaque rupture, intraplaque hemorrhage and thrombus formation 
occurred 152,153. As no hemodynamic studies were performed in this model we 
speculate that completely ligating the artery causes a cessation of blood flow and 
probably results in very low shear stress, as mentioned above. Placement of a 
non-constrictive cast around an already developed plaque will probably not 
change the local shear stress unless very large changes in the vessel trajectory are 
introduced. Even in that case, shear stress will not be large enough to induce 
rupture itself. Since it is not expected that the presumably local decrease in 
plaque distensibility caused plaque rupture, the most plausible explanation for 
plaque rupture after cast placement is the additional local inflammation 
presumably causing plaque weakening154. 
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Table 1: Animal models of different surgically manipulated flow velocities. 
Model flow 
manipulation 
Flow velocity and 
shear stress profiles 
Reported vessel 
pathology 
Animal 
species 
Remarks 
AV-fistula • High flow velocity, 
high WSS 
• Endothelial 
activation115 
• Neointimal 
hyperplasia113,116–
119,121–125  
• Mice 
• Mice, rat, 
rabbit, pig, 
primate, 
dog 
• Atherosclerotic 
plaque development 
only specific for AV-
fistula 
Vascular 
graft 
• Low flow velocity 
assumed 
• Neointimal 
hyperplasia126,127    
• Plaque; lipid rich, 
necrotic core128     
• Mice 
 
• Pig 
• Atherosclerotic 
plaque development 
only specific for 
vascular graft 
• Vascular grafts are 
exposed to non-
physiological high 
pressure, and thus 
additional exposure to 
high strain 
     
Ligation     
Complete 
CCA 
• No flow 
(extremely low and 
oscillatory WSS 
assumed) 
• Endothelial 
activation142 
• Neointimal 
hyperplasia 143 
• Plaque; lipid rich, 
high macrophage 
content, intraplaque 
hemorrhage141,147–151 
• Mice • Atherosclerosis 
development due to 
complete cessation of 
blood flow, non-
physiological flow 
condition 
CCA & cast • Low flow velocity 
and oscillatory WSS 
assumed 
• Plaque; intra plaque 
hemorrhage, plaque 
rupture, lumen 
thrombus152,153 
• Mice • Development of 
plaque rupture 
 
Partial     
ICA & ECA • Low flow velocity, 
oscillatory WSS 
• Endothelial 
activation155 
• Neointimal 
hyperplasia156–158 
• Mice • No surgery induced 
vessel damage at site of 
plaque development 
ICA, ECA & 
OA 
• Low flow velocity, 
oscillatory WSS 
• Plaque; lipid rich, 
neovascularization, 
cholesterol 
clefts129,159–162 
• Mice • No surgery induced 
vessel damage at site of 
plaque development 
• Hemodynamics 
studied by CFD 
• Large diffuse plaques 
CCA & renal 
artery 
• Low flow velocity, 
oscillatory WSS 
• Plaque; necrotic 
core, plaque rupture, 
lumen thrombus163 
• Mice • Development plaque 
rupture 
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Table 1 (continued): Animal models of different surgically manipulated flow velocities 
Model flow 
manipulation 
Flow velocity and 
shear stress profiles 
Reported vessel 
pathology 
Animal 
species 
Remarks 
Tandem CCA • Low flow velocity, 
oscillatory WSS 
• Plaque; disruption 
fibrous cap, 
intraplaque 
hemorrhage, lumen 
thrombus164 
• Mice • Large area of artery 
containing plaque 
CCA 
 
• Low flow velocity, 
oscillatory WSS 
• Plaque; necrosis 
core, calcification, 
intraplaque 
hemorrhage165–168 
• Pig • Development plaque 
rupture 
Aortic 
constriction 
• RCCA: increased 
flow velocity & WSS 
• LCCA: decreased 
flow velocity & WSS 
• Aorta: low WSS 
• Endothelial 
activation169–171  
• Neointimal 
hyperplasia 130,172,173   
• Mice, 
primate 
• Primate, 
rabbit 
• No surgery induced 
vessel damage at site of 
plaque development 
• Large area with 
plaques 
     
Perivascular device    
Constrictive 
cast CCA 
• Low flow velocity, 
oscillatory WSS 
• Plaque; low lipid, 
high SMC, high 
collagen content, high 
macrophage content, 
thrombus formation, 
plaque rupture 174–181• 
Thrombusformation182    
• Mice 
 
 
• Pigs 
• Large variation in 
plaque phenotype in 
the same model 
• Local effect of cast on 
wall strain and wall 
motion due to 
pulsation 
Tapered cast 
CCA 
• Low, high, low & 
oscillatory flow 
velocity and WSS 
 
• Plaque; high lipid 
content, higher 
macrophage content, 
lower collagen and 
SMC content 
70,71,73,75,132,183–185 
• Micro-
calcifications185 
• Mice 
 
• Creates two types of 
shear stress profiles 
and subsequently both 
"stable" and "unstable" 
plaque in one artery 
segment. 
• Effect of cast locally 
on wall strain and wall 
motion due to 
pulsation 
Dotted cast 
CCA 
• Low, high, low & 
oscillatory flow 
velocity and WSS 
• Plaque; low 
numbers of 
macrophage and high 
SMC content133 
• Rabbit • Development 
eccentric plaques 
• Local effect of cast on 
wall strain and motion 
     
Aortic 
regurgitation 
• Low flow velocity, 
oscillatory WSS 
• Plaque 
development, but 
composition not 
reported186,187 
• Mice • No surgery induced 
vessel damage at site of 
plaque development 
• Hemodynamics 
extensively studied 
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• Partial ligation of the carotid artery 
Cessation of blood flow induced by complete ligation generates a non-
physiological flow condition and, therefore, does not reflect the in vivo situation. 
A more physiologically relevant model would generate a reduction in flow. 
Accordingly, a partial ligation model was developed to study the effect of altered 
and reduced blood flow velocities and shear stress on atherogenesis. This flow 
reduction can be achieved via different methods. Ligation of one or more of the 
arteries distal to the bifurcation of the common carotid artery, resulting in 
reduced blood flow through the common carotid artery129,188–190 (Fig. 2D-E). 
Another approach involves ligation using a spacer, in the form of a needle or a 
rod, to reduce lumen diameter of the common carotid artery or aorta, and 
thereby decreasing blood flow through this artery164,165 (Fig. 2F-I).  
diameter was measured using a ruler under a dissecting microscope188,189.This 
model has also been used in rats and mice to study the effect of shear stress on 
endothelial activation and neointimal hyperplasia155–158. Recently, Nam et al.129 
modified the above described ligation model by additionally ligating the occipital 
artery (OA) in mice, leaving blood flow through the superior thyroid artery only 
(Fig. 2E). In this model, the effect on shear stress was extensively studied by 
performing CFD calculations using the geometry of the ligated carotid artery, 
which was determined by high-resolution ultrasound. The results showed a 
reduction in flow velocity during systole and reversal of flow direction during 
diastole. These changes in flow velocities resulted in low and oscillatory shear 
stress129. Large complex lipid rich plaques developed along the whole ligated 
artery proximal to the ligation sites, containing cholesterol clefts and intraplaque 
neovessels. This model has been used to study novel mechano-sensitive genes, 
and plaque formation in mice159–162. 
Plaque rupture has not been reported in the above described partial ligation 
models and extra stimuli are needed to induce rupture. For instance, ligating the 
renal artery in addition to ligating the common carotid artery, in mice, increased 
the systolic blood pressure but lowered blood flow velocities in the carotid artery. 
Vulnerable plaques developed proximal to the ligation in the carotid artery. These 
plaques were characterized by a necrotic core, intraplaque hemorrhage and 
plaque rupture with lumen thrombus163. 
Recently, Chen et al.164 developed a new partial ligation model to generate 
rupture prone vulnerable plaques in mice without an extra stimulus. A surgical 
procedure was developed, placing two partial ligations around the right carotid 
artery using a spacer to create a tandem stenosis (Fig. 3F). Based on idealized 
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computer-generated vessel geometry models and CFD calculations, they 
predicted that this approach would generate both low shear stress and high wall 
strain, thereby increasing the probability for plaque rupture. The in vivo flow 
measurements using ultrasound showed a 65% flow reduction. An unstable 
plaque developed between the proximal ligation and the origin of the right carotid 
artery from the brachiocephalic trunk. Rupture of the fibrous cap was described, 
along with intra plaque hemorrhage, intraluminal thrombosis and the presence of 
neo vascularization. Stable plaques developed between the two ligations, and 
between the second ligation and the bifurcation164.  
Several groups attempted to create a model of surgically-induced plaque 
instability in pigs. As pigs have a physiology similar to humans, pig models develop 
plaques which have human-like characteristics191,192. Ishii et al.165 partially ligated 
one of the common carotid arteries by using a spacer to create a stenosis (Fig. 
2G). Advanced plaques characterized by calcification, intraplaque hemorrhage and 
necrosis were located proximal to the ligation 165–168. Hemodynamic 
measurements have yet to be performed in this model, but flow velocities are 
expected to be reduced upstream of the stenosis (Box 1). 
• Aortic constriction  
Aortic constriction creates a pressure drop along the aorta which results in 
hypertension proximal to the constriction. To study hypertension-related 
atherogenesis or vascular remodeling in the aorta and carotid arteries, several 
models of aortic constriction were developed170,171. One model alters blood flow 
by creating a stenosis in the aorta by tightening a synthetic band around the 
descending aorta midway between the origin of the left subclavian artery and the 
diaphragm (Fig. 2H). In rabbit and primate models, an increase in blood pressure 
in the aorta proximal to the band was measured while distal to the band blood 
pressure remained at baseline level130,172,173,193,194. Plaques developed at both sides 
of the constriction with differences in composition. Distal of the constriction, 
lumen stenosis and plaque area were less significant than lumen stenosis and 
plaque area proximal of the constriction172,173. In the proximal plaque, foam cells 
were more abundant, and an increased expression of VCAM-1 and elevated levels 
of macrophage infiltration were observed130,173. Based on the measured pressure 
gradient, one could expect reduced flow velocities in this aortic constriction 
model (Box 1), but without flow measurements it is unknown what the amount of 
cardiac compensation is. 
In a different aortic constriction model, in mice, the aorta was partially ligated 
between the origins of the brachiocephalic artery and left carotid artery using a 
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suture171 (Fig. 2I). Flow velocity measurements at different time points in both 
right and left carotid arteries were performed using ultrasound showing an 
increase in blood flow and WSS in the right carotid artery and a decrease in the 
left carotid artery. This corresponded with vascular remodeling and increased 
media thickening in the right carotid artery while no change in vessel morphology 
was observed in the left carotid artery. 
In the 80’s, researchers ligated the left external carotid artery of rabbits to study 
the vascular response to altered blood flow in the common carotid artery195. 
Later, in the 90’s, a model was developed in rats where both the right internal and 
the right external carotid artery were ligated, leaving blood flow through the 
ascending pharyngeal and the superior thyroid artery188,189 (Fig. 2D). Changes in 
shear stress were estimated using velocity measurements obtained with a transit-
time flowmeter and vessel  
2.4 Perivascular devices  
Another model to study the influence of specific flow velocity and shear stress 
patterns on the development of atherosclerosis uses perivascular devices (Fig. 2J-
K). These perivascular devices were mainly applied in mice. However, some 
studies used pig and rabbit models of atherosclerosis, which enabled the use of 
specific (intravascular) imaging techniques also used in the clinic.  
Different perivascular constrictive devices were developed including a 
constrictive131 and a tapered cast132. Recently, a dotted cast was also constructed 
and tested in rabbits133.These perivascular devices alter blood flow velocity 
profiles and concomitantly shear stress in distinct regions of the artery, enabling 
analysis of the effect of specific shear stress profiles on atherogenesis.  
• Constrictive cast model 
The first cast model that focused on shear stress as a trigger for the development 
of atherosclerosis was developed by Von der Thüsen et al.131, who designed a 
mildly constrictive cast inducing approximately a 30% luminal stenosis in a mouse 
common carotid artery (Fig. 2J). Ultrasound blood flow and lumen diameter 
measurements were performed in mice directly after cast implantation. These 
measurements showed a decreased blood velocity and subsequently decreased 
shear stress levels in the proximal region of the cast compared to the baseline 
situation196. The alterations in shear stress lead to rapid formation of site-
controlled atherosclerosis131.  
C h a p t e r  2  | P a g e  31 
 
The effect of changes in shear stress on the development of an atherosclerotic 
plaque in the proximal region of the constrictive cast was analyzed in multiple 
mouse studies174–178. The general phenotype of the plaques, induced by the use of 
a constrictive cast, was relatively stable. Most studies showed plaques with low 
lipid, high SMC and high collagen content. However, levels of, for example, 
collagen and SMCs, varied between the studies. This was presumably due to the 
large variation in secondary study parameters like age, sex and diet. Strikingly, 
most studies also observed high macrophage content, which is often associated 
with plaque vulnerability. Interestingly, LDLR-/- mice developed smaller plaques197 
with more stable plaque characteristics in the proximal region180 compared to the 
plaques in ApoE-/-mice after cast placement.  
In this cast model, plaque rupture is seldom observed in mice and can only be 
induced by adding an extra stimulus, like triggering of the immune system179 or 
inducing apoptosis180,181. 
The first application of a cast in mini pigs was by the group of Falk182. An 
important advantage of this pig model is the more human-like plaques that these 
pigs develop and the spontaneous plaque rupture that can occur after cast 
placement, without the need of an extra stimulus. However, a disadvantage of the 
pig model is the lengthy duration of plaque development. In this model shear 
stress was assessed by MRI and CFD at the end of the experiment, when plaques 
had already developed. At this time of plaque development, shear stress in the 
cast region was elevated, while distal to the cast shear stress was oscillatory and 
lower than the area proximal to the cast, where it remained at baseline level. 
Plaque development varied extensively between animals, ranging from no plaque 
development at all, to thrombus formation and occlusion, mainly in the distal 
area. It is unclear why cast experiments in mice have been more consistent while 
the same technique induces such a wide range of plaque phenotypes in pigs. 
• Tapered cast model  
Decreased shear stress, as induced by the constrictive cast, is an important trigger 
for atherosclerotic plaque formation. Besides low shear stress, also oscillatory 
shear stress patterns were indicated as a factor involved in plaque initiation and 
progression198. To compare the effect of low shear stress versus low, oscillatory 
shear stress on atherogenesis, Cheng et al.132 developed a tapered cast (Fig. 2K). 
Shear stress-induced by the tapered cast in the mouse carotid artery was 
calculated using CFD and the vessel geometry of the manipulated artery was 
obtained from histological images to create a 3D model of the vessel132. The 
tapered cast model induced low shear stress proximal to the cast, like the 
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constrictive cast model. However, due to its tapered geometry, a shear stress 
gradient is present in the cast area, and flow separation causing low, oscillatory 
shear stress was observed distal to the cast. This cast model enabled the study of 
the causative role of both shear stress patterns on plaque development in one 
vessel segment at the moment of placement, avoiding inter-animal and inter-
vessel variations. This is in contrast to the constrictive cast in pigs described 
above, where shear stress was reported to be low and oscillatory after plaque 
development. In the tapered cast model, corresponding with the shear stress 
profiles, plaques developed both proximal and distal to the cast. Plaques in the 
proximal region had a higher lipid content, equal or higher macrophage content 
and lower collagen and smooth muscle cell levels compared to plaques that 
developed in the distal region69–71,73,75,183,184,199. Other characteristics of human 
plaque vulnerability, like the presence of micro-calcifications and iron and zinc 
deposits in the intimal layer were also observed in low shear stress region of 
mouse carotid arteries185. These plaque characteristics are rarely observed in 
other models applied in mice. 
In conclusion, the different flow velocity patterns in this model induced the 
development of both stable and unstable atherosclerotic plaques.  
• Dotted cast 
Beside the commonly applied cast models described above, Kivelä et al.133 
recently developed a ‘dotted cast’ with two non-symmetrically placed cushions 
inside (Fig. 2L). This cast was developed to mimic eccentric plaque formation seen 
in the human situation, instead of the concentric plaque formation usually seen in 
other cast models. Implantation of the cast around one of the carotid and femoral 
arteries in New Zealand White rabbits reduced flow velocities, which were 
measured by ultrasound. Inside the dotted cast, high levels of shear stress can be 
expected on the apex of the cushions. Flow velocities returned to initial velocity 
levels after eccentric plaques developed. These plaques exhibited low numbers of 
macrophages and high smooth muscle cell levels, indicative for a stable plaque 
phenotype, although the lipid levels were not analyzed.  
2.5 Aortic Regurgitation 
Hemodynamics was extensively studied in a model of diastolic retrograde flow in 
the aorta of mice. In this model, the aortic valve leaflets of mice were punctured 
to study the pathogenesis of atherosclerosis186,187. The model significantly alters 
blood flow patterns throughout the aorta, inducing extensive atherosclerotic 
plaque formation along the descending thoracic and abdominal aorta. Shear 
stress simulations, using CFD based on an ideal geometry, were performed and 
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extensive analysis was done. Shear stress levels were reduced by 50% at a distinct 
pattern along the aortic arch, and plaque formation co-localized with these sites 
of low shear stress186. Although plaque formation was observed, further plaque 
characterization was not described (Table 1). 
3. Discussion 
In this review we gave an overview of animal models in which blood flow 
velocities were surgically altered in specific areas of the vasculature which can be 
used to study the causative role of shear stress in atherosclerotic plaque 
formation. In these studies, different terminology for flow velocity and shear 
stress patterns is used, leading to confusion. Therefore, we defined the 
biomechanically correct terminology in box1/figure1, which depicts the most 
common flow phenomena that occur in the vasculature. 
Many studies used the described models to accelerate or to control the induction 
of atherogenesis but did not focus on shear stress level that was generated. 
Consequently, solid analysis of the surgically-induced alterations in 
hemodynamics was not performed in all individual studies. When studying the 
relation between shear stress and atherosclerosis, a proper calculation of shear 
stress is required. This is not an easy task and requires input from imaging and 
physiological parameters. Furthermore, help from CFD experts is recommended, 
as inexperienced users can easily make mistakes when using the existing 
commercially available CFD tools200. It is important to realize that small 
differences in vessel geometry or flow velocity can have a big effect on the 
outcome of shear stress calculations, and therefore, can vary considerably 
between individual animals. Extrapolating data from previous studies is therefore 
less useful. It is recommended to perform CFD calculations for each individual 
animal. Because absolute values of shear stress differ between animals and 
change over time, it is better to portray relative differences in shear stress levels 
locally, e.g. proximal, inside, or distal to a cast. Another important point is the 
often disregarded contribution of other biomechanical forces to plaque 
development that might be affected by surgical manipulation. The effect of e.g. 
ligation or cast placement on wall strain is often ignored. The reported effects 
might not be fully attributed to shear stress.  
All the models we described have advantages and limitations. Choosing which 
model to use depends on the research question at hand. Each model generates 
different flow velocity and shear stress profiles, at different locations, and even 
develops different plaque phenotypes. Table 1 summarizes the surgical models 
described in this review; the altered flow velocity and shear stress profiles they 
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create; the resulting plaque phenotypes, and the animal species in which these 
models were used.  
Some models, like the AV-fistula model and the vascular graft model, were initially 
developed for another purpose than to study the role of shear stress in 
atherogenesis. They can be used to study the role of shear stress in atherogenesis, 
but keep in mind that they are far from mimicking a physiological setting in which 
atherosclerosis develops, as these models incorporate a piece of vein. The surgery 
involved in these models is extensive and has an unknown effect on flow 
velocities and shear stress, especially for the venous part, which was presumable 
exposed to a completely different shear stress before transplantation.  
Ligation models are ideal to study the role of shear stress in atherogenesis due to 
the reduction in flow velocity and shear stress. The complete ligation model, 
however, creates a non-physiological condition as blood flow is completely 
stopped. The partial ligation models offer a more physiological flow condition by 
reducing blood flow velocities and shear stress. Ligating an artery induces vessel 
damage, which could contribute to plaque development. The models in which the 
ICA, ECA, or OA are ligated and plaque development is studied in the CCA, far 
away from the suture, instead of close to the ligation, avoid this effect. 
The perivascular device models enable the comparison of the effect of different 
flow velocity and shear stress profiles on the same vessel segment. The tapered 
cast model even allows for the study of three different shear stress patterns and 
subsequently two different plaque phenotypes. Disadvantages of the cast models 
are the extensive area of vessel damage along the length of the cast and the 
inhibition of pulse pressure-induced arterial strain and outward remodeling due 
to the rigid cast.  
The last model to consider is the aortic regurgitation model. An advantage of the 
model is that surgery-induced vessel damage in the aortic arch does not affect 
atherogenesis at the site of plaque development. The model can be used to study 
the relation between shear stress and atherogenesis, but requires further studies 
on the final plaque composition.  
4. Conclusion 
The use of animal models where blood flow velocities and shear stress are 
surgically manipulated enables us to study the mechanics and molecular pathways 
of atherogenesis in a complex in vivo setting. Not only does it provide us with 
novel insights into the pathogenesis of atherosclerosis, it also enables us to test 
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new imaging techniques and drug treatments, which could later be used in the 
clinic.   
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Abstract 
Wall shear stress (WSS) is involved in the pathophysiology of atherosclerosis. The 
correlation between WSS and atherosclerosis can be investigated over time using 
a WSS-manipulated atherosclerotic mouse model. To determine WSS in vivo, 
detailed 3D geometry of the vessel network is required. However, a protocol to 
reconstruct 3D murine vasculature using this animal model is lacking. In this 
project, we evaluated the adequacy of eXIA 160, a small animal contrast agent, for 
assessing murine vascular network on micro-CT. Also, a protocol was established 
for vessel geometry segmentation and WSS analysis. 
A tapering cast was placed around the right common carotid artery (RCCA) of 
ApoE-/- mice (n=8). Contrast-enhanced micro-CT was performed using eXIA 160. 
An innovative local threshold-based segmentation procedure was implemented to 
reconstruct 3D geometry of the RCCA. The reconstructed RCCA was compared to 
the vessel geometry using a global threshold-based segmentation method. 
Computational fluid dynamics was applied to compute the velocity field and WSS 
distribution along the RCCA. 
eXIA 160-enhanced micro-CT allowed clear visualization and assessment of the 
RCCA in all eight animals. No adverse biological effects were observed from the 
use of eXIA 160. Segmentation using local threshold values generated more 
accurate RCCA geometry than the global threshold-based approach. Mouse-
specific velocity data and the RCCA geometry generated 3D WSS maps with high 
resolution, enabling quantitative analysis of WSS. In all animals, we observed low 
WSS upstream of the cast. Downstream of the cast, asymmetric WSS patterns 
were revealed with variation in size and location between animals. 
eXIA 160 provided good contrast to reconstruct 3D vessel geometry and 
determine WSS patterns in the RCCA of the atherosclerotic mouse model. We 
established a novel local threshold-based segmentation protocol for RCCA 
reconstruction and WSS computation. The observed differences between animals 
indicate the necessity to use mouse-specific data for WSS analysis. For our future 
work, our protocol makes it possible to study in vivo WSS longitudinally over a 
growing plaque. 
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1. Introduction 
Atherosclerosis is an inflammatory disease characterized by the accumulation of 
lipids, fibrous tissue and inflammatory cells3,6. Atherosclerotic plaques are 
predisposed to develop at the inner curvatures and branches of the arterial 
system, a process which is known to be driven by the local wall shear stress (WSS) 
environment21,34. WSS is the frictional force that blood flow exerts on the 
endothelium of the vessel wall. The endothelial cells respond to various WSS 
patterns differently by inducing either an anti-inflammatory or a pro-
inflammatory profile22. The pro-inflammatory status of the endothelial cells thus 
primes the vessel wall for atherosclerotic development21. As the disease progress, 
the plaque intrudes into the lumen, thereby altering the local WSS distribution. It 
has been hypothesized that WSS is also involved in plaque progression34,35,201 yet 
there is no in vivo animal experimental evidence. In order to study the effect of 
different WSS patterns on plaque progression in vivo, a WSS-induced 
atherosclerotic mouse model has been developed69. In this model, a tapering cast 
is placed around the animal’s right common carotid artery (RCCA), inducing 
distinct WSS patterns in this vessel. As a result, atherosclerotic plaques developed 
both upstream and downstream to the cast69,132.  
The most commonly used method to determine WSS on the vessel wall is 
computational fluid dynamics (CFD). CFD is a well-established computational tool 
that computes the velocity and pressure of the blood in a vessel. WSS is 
subsequently derived from the velocity field. Previous studies have used CFD to 
illustrate the WSS patterns in the murine vasculature86,186,202–204. In order to 
accurately calculate WSS, reliable three-dimensional (3D) geometry of the blood 
vessel is required. The use of contrast agents in micro-CT imaging allows blood 
vessels as small as 100 µm to be visualized205,206, which makes it possible to obtain 
an accurate 3D vessel geometry for CFD-based WSS analysis in mice.  
Several commercially available contrast agents for use in small animals have been 
tested for evaluating vascular structures in healthy and atherosclerotic mice. 
Monitoring of atherosclerosis progression ideally requires longitudinal studies. 
Such studies require multiple micro-CT imaging and contrast injections over time. 
Therefore, it is necessary to use a contrast agent that provides good signal 
enhancement, at the same time, is biocompatible with the murine system. We 
compared different small animal contrast agents based on their signal 
enhancement and potential adverse effects.  
Fenestra VC (MediLumine) was the first iodine-based contrast agent developed 
for murine vascular imaging. It has a low iodine concentration (50 mg/ml) and 
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thus low blood-pool enhancement207. AuroVist 15 nm (Nanoprobes) is a gold 
nanoparticle that gives excellent signal enhancement. However, this contrast 
agent leaves dark staining at the injection spot, making it extremely difficult to 
distinguish the vein for repeated administration205. Also, histology analysis has 
showed that AuroVist 15 nm is taken up by plaques208, which might interfere with 
repeated measurements. These properties limit the use of AuroVist 15 nm for 
studying atherosclerosis progression regardless of the strong signal it provides. 
Exitron nano 12000 (Miltenyi Biotec) is a barium-based nanoparticle with polymer 
coating206. Its high equivalent iodine concentration (300 mg/ml) permits excellent 
contrast209. However, Exitron nano 12000 is cleared via macrophages209,210 and 
accumulates in liver and spleen and is still present after months, allowing possible 
imaging even 185 days after a single contrast injection211. This would potentially 
complicate longitudinal vessel imaging. Since macrophages are involved in the 
pathogenesis of atherosclerosis3, Exitron nano 12000 might accumulate in plaques 
and give false signals during subsequent lumen measurements, leading to an 
overestimation of lumen surface and subsequently an underestimation of WSS. 
Moreover, repeated injections have been shown to have toxic effects212. This 
leaves our choice to the recently developed eXIA 160 and eXIA 160XL (Binitio 
Biomedical), which are aqueous colloidal polydisperse contrast materials. Both 
contrast agents have a high iodine concentration (160 mg/ml), allowing for good 
signal enhancement. eXIA 160XL remains in the vascular circulation longer than 
eXIA 160 does213,214. Because current imaging protocols allow fast image 
acquisition215, prolonged vascular circulation of eXIA 160XL is not necessary. A 
second property of eXIA 160XL that makes it less suitable for longitudinal studies 
than eXIA 160 is that data on survival rates after the use of eXIA 160XL are 
inconclusive, since separate studies have reported 50%205 or 100%214 of survival 
rates. On the contrary, several studies have suggested that biocompatibility of 
eXIA 160 with the murine system is excellent, as the contrast agent was 
eliminated from the blood, liver and spleen within 24 hours207,213. Given the high 
contrast intensity of eXIA 160 and its biocompatibility, eXIA 160 is the only 
contrast agent promising for the purpose of longitudinal studies. 
The aim of this study was to determine whether eXIA 160 is a suitable contrast 
agent for reconstructing reliable 3D geometry for CFD analyses in the WSS-
manipulated atherosclerotic mouse model. As the vessel narrows and become 
severely stenotic due to atherosclerotic plaque progression, it is challenging to 
capture vessel geometry using this specific animal model. Contrast-enhanced 
micro-CT was performed on atherosclerotic mice using eXIA 160 and contrast 
enhancement in the RCCA and the surrounding soft tissue by eXIA 160 was 
subsequently analyzed. At the same time, we investigated a semi-automatic 
segmentation procedure to reconstruct 3D murine vessel geometry. We 
C h a p t e r  3  | P a g e  41 
 
established a standardized protocol for local threshold-based segmentation and 
we compared this protocol with a global threshold segmentation method. Finally, 
transient CFD analyses using mice-specific flow data were performed to illustrate 
how the segmentation methods influence the computed WSS distribution. 
2. Methods 
2.1 Animal preparation 
Female ApoE-/- mice on C57BL/6J background (n=8) were purchased from Charles 
River (Maastricht, The Netherlands) and were fed normal chow diet up to 13 
weeks of age. An atherogenic Western diet (nr 4021.06, Arie Blok, Woerden, The 
Netherlands) was then introduced and provided ad libitum. At 15 weeks of age, 
cast surgery was performed on the animals under isoflurane-induced anesthesia. 
A tapering cast was placed around the right common carotid artery (RCCA) of the 
animal as described previously69,73. The cast has a tapering lumen (diameter from 
400 µm to 200 µm over 1.5 mm) which changed the blood flow along the RCCA, 
intended to induce a decreased shear stress region upstream of the cast and an 
oscillatory shear stress area downstream of the cast. All the animal experiments 
were approved and conducted according to guidelines by the ethical committee 
of Erasmus MC Rotterdam.  
2.2 Doppler Ultrasound 
Five weeks after cast placement, mice were prepared for Doppler ultrasound 
imaging. Blood flow through the RCCA was imaged with a high-frequency 
ultrasound scanner (Vevo 2100, VisualSonics Inc., Toronto, Ontario, Canada) using 
a 40-MHz transducer. Doppler velocity measurements were recorded in the RCCA 
upstream of the cast. Five consecutive cycles were recorded, and averaged to 
obtain the transient flow wave form for the CFD simulations.  
2.3 Contrast Agents and Micro-CT Imaging 
Directly after Doppler ultrasound, mice were prepared for micro-CT imaging. Both 
imaging were performed during the same anesthesia session. A commercially 
available contrast agent developed for murine studies, namely eXIA 160 (Binitio 
Biomedical) was tested. We injected as much contrast as allowed in our animals 
because we intended for the highest possible amount of contrast circulating in the 
murine system for image segmentation. The maximum injection volume was 150 
µl according to the local animal welfare regulations. In order to correct the 
contrast concentration in each animal, we used the maximum weight observed 
from the 8 animals, which was 25g. This leaded to an injection dose of 150 µl/25 
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grams of body weight. The contrast agent was slowly injected intravenously via 
the lateral caudal vein. Micro-CT imaging was performed using an ultra-fast micro-
CT scanner (Quantum FX, PerkinElmer). The micro-CT acquisition parameters were 
90 kvp, 160 µA with field of view 20 mm and 360° rotation in 1 step. The 
acquisition time was 4.5 minutes. Images in Hounsfield unit (HU) were 
reconstructed in cubic voxels of 40 µm, generating a matrix of 512 x 512 x 512 
voxels. The bones and vascular network were visualized using the volume 
renderer available from MeVisLab (MeVisLab 2.2.1, MeVis Medical Solutions AG). 
2.4 Image Segmentation 
Image segmentation of the RCCA was performed on two software platforms: 
MeVisLab 2.2.1 and Matlab (Matlab 2011b, MathWorks, Inc.). The region of 
interest spanned from the separation of the RCCA from the brachiocephalic artery 
to the bifurcation of the internal and external carotid artery. Initial segmentation 
was performed in MeVisLab using two in-house developed modules216,217. First, 
center points of the RCCA were manually identified to create the centerline of the 
RCCA. 2D planes that cut through the long axis of the RCCA were defined by two 
adjacent points on the centerline. The centerline was then straightened and the 
2D planes were projected. The border of the RCCA along the long axis was then 
placed manually at three equally spaced rotations of the projected plane: 0°, 60° 
and 120°. The information of the vessel border was reconstructed by the module 
using spline interpolation to create an initial set of contours for RCCA geometry 
and subsequently exported into Matlab 2011b to analyze contrast related 
parameters. 
The lumen region was defined by shrinking the initial contours with 20% of their 
radius. Similarly, the initial contour radius was expanded with 20% and 40%, 
creating an area outside the lumen delineated by the two layers. This second 
region represents the surrounding background. For areas outside the cast region, 
soft tissue (muscle, fat tissue, etc.) was present in the background region. For 
areas within the cast, the cast region itself was defined as the background (Fig. 1). 
We determined the 20% shrinkage and 20% and 40% expansion based on the 
smallest diameter in the cast region. The diameter of the distal cast is 200 µm. 
The resolution of the micro-CT is 40 µm. Therefore, there are 5 pixels at the 
narrowest part of the vessel. While 20% of 5 pixels equals to 1 pixel, by 
expanding/shrinking 20% of the original contour, we included/excluded at least 1 
pixel in the background/lumen regions. The voxels within the lumen region and 
the background region were then identified. The average HU values of these 
voxels inside lumen and background regions were calculated. To determine the 
final contours, threshold-based segmentation was performed. A straightforward 
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method was used to determine the threshold, which was defined as the midway 
value between the HU values of the lumen region and the surrounding 
background218. The threshold was calculated for each contour along the entire 
RCCA, generating an array of local threshold values specific to each contour. 
 
Figure 1 Illustration of image segmentation. Red straight line indicates the original contour 
placed in MeVisLab; Lumen area is represented by the red shaded area by shrinking 20% 
of the original contour area; Background area is defined as the area between the 20% and 
40% expanded original contour, shown as the green shaded area. 
2.5 Computational Fluid Dynamics 
The RCCA lumen surface was further processed using the Vascular Modelling Tool 
Kit (VMTK 1.2, OROBIX). A volume preserving smoothing algorithm was applied. 
Same smoothing parameters were used for geometry reconstructed from local 
and global threshold method. Flow extensions 5 times the radius of the inlet or 
outlet were added at both ends of the vessel. Flow extensions ensure that the 
flow entering and leaving the vessel is fully developed, facilitating adequate flow 
development for later simulation. 
Guided by the local threshold information generated with MATLAB, the CT images 
were converted into a set of white/black binary images. The initial contours were 
manually modified based on the binary images in MeVisLab. This generated the 
final set of contours which were used to create the RCCA lumen surface for 
further analysis. Vessel diameter along the RCCA was calculated. Vessel wall 
thickness within the cast region was defined as half of the difference between 
RCCA vessel diameter and cast dimension. In addition, a global threshold value 
was also calculated by averaging the local threshold values along the RCCA. A 
global threshold guided RCCA lumen surface was created, as commonly used in 
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vascular segmentation219,220. The complete image segmentation process time was 
approximately 60 minutes per vessel. 
The surface was then imported into ICEM (ICEM-CFD 14.5, Ansys, Inc.) to generate 
a volume mesh with tetrahedral cells. Prism layers with quadrilateral and 
hexahedral cells were created at the wall. Element size was locally determined 
based on vessel diameter and curvature, giving rise to smaller elements in 
narrowed vessels or higher curvature. Parameters including maximum element 
size and number of prism layers were optimized to obtain a mesh-independent 
solution. The final mesh contained 0.6 million elements for the geometry based 
on the local threshold method and 1.9 million elements for the geometry based 
on the global threshold method. 
The Navier-Stokes equations were solved by computational fluid dynamics (CFD) 
using Fluent (Fluent 14.5, Ansys, Inc.). Blood was modeled to be incompressible 
and the vessel wall rigid. As inlet boundary condition, a time-dependent velocity 
profile was imposed, which was derived from Doppler velocity measured 
upstream of the cast. No-slip boundary conditions were applied at the wall, and 
zero pressure was used as the outlet boundary condition. Blood was modeled as a 
Newtonian fluid with a viscosity of 3.5x10-3 kg m-1 s-1 and a density of 1060 kg/m3. 
The Reynolds number was calculated as Re = 7. The Newtonian assumption is 
justified since the characteristic shear rates in the carotid artery of mice are high77 
and transient flow simulations were performed using standard numerical 
techniques. The results were analyzed using CFD-Post (CFD-Post 14.5, Ansys, Inc.) 
and Matlab 2011b. The time-averaged WSS (TAWSS) and the oscillatory shear 
index (OSI)221 were computed.  
2.6 Statistics 
Data are presented as mean ± SD and analyzed in Matlab. Differences between 
the two segmentation methods were evaluated using a two-sample t-test. 
3. Results 
3.1 Contrast Enhancement 
A 3D volume rendering of the contrast enhancement in the lumen is shown in 
Figure 2. eXIA 160 allowed visualization of the major vascular structure. The 
internal jugular veins (Fig. 2, Label 1) were clearly visible as they travel parallel 
along the vertebrae, at both sides of the neck. The common carotid arteries are 
located closely to the vertebrae (Fig. 2, Label 2). The narrowing of the RCCA 
caused by the tapering cast is clearly visible (Fig. 2, zoomed-in box).  
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3.2 Contrast intensity along the RCCA 
Figure 3 shows the contrast intensity of the lumen region and the background 
region from one of the eight mice. eXIA 160 provided good contrast intensity with 
a clear signal enhancement in the blood (Fig. 3B, red line with square marker) to 
differentiate from the surrounding background region (Fig. 3B, green line with 
circle marker). For this specific animal, contrast intensity was 330 HU in the lumen 
region and 41 HU in the background region. The difference between the two 
regions was 289 HU. 
The contrast-related parameters of all the animals are summarized in Table 1. The 
average contrast intensity was 339 HU in the lumen region and 53 HU in the 
background region for all the eight animals. We did not observe significant 
difference of the contrast intensity between the lumen region upstream and 
downstream of the cast. The average difference between the lumen region and 
the background region was 285 HU, enabling visualization of the vessel lumen. 
 
Figure 2 3D volume rendering of the bone structures and vascular network in the neck 
region for eXIA 160. Major vasculature including internal jugular vein (①) and the carotid 
arteries (②) were visualized (scale bar 1 mm). The box shows the zoomed-in area of the 
narrowing RCCA caused by the tapering cast (scale bar 400 µm). 
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Table 1 Contrast-related parameters (in Hounsfield Units) of eXIA 160 along RCCA 
 Non-cast Region Cast Region 
Mouse 
Number 
Lumen Background 
Contrast 
Difference 
Lumen Background 
Contrast 
Difference 
1 428±58 95±36 323±61 325±90 -47±51 372±124 
2 372±35 76±42 296±47 299±47 -93±47 392±87 
3 286±41 32±54 254±45 199±54 -169±33 368±65 
4 328±49 67±40 261±41 247±62 -93±33 340±71 
5 330±38 41±31 289±34 241±53 -135±45 376±85 
6 281±33 41±29 240±39 191±71 -96±56 287±111 
7 306±33 42±35 264±45 255±67 -46±39 301±98 
8 383±65 31±36 352±67 299±90 -100±49 399±128 
Average 339±51 53±23 285±38 257±48 -97±41 354±41 
In all the animals, the contrast intensity of the lumen region dropped within the 
cast region (339±51 HU vs. 257±48 HU). Similarly, a decrease in the contrast 
intensity of the background region was observed. The average contrast difference 
between the lumen region and the background region increased slightly (285±38 
HU vs. 354±41 HU). Contrast-related parameters are summarized in Table 1. 
Local threshold values were calculated (Fig. 3B, blue line with cross marker) by 
averaging the contrast intensity between the lumen region and the background 
region. Signal fluctuation was observed along the entire RCCA in both lumen and 
background region. The fluctuation was also seen along the local threshold values 
in all animals. 
3.3 Threshold-based Segmentation 
Two sets of RCCA geometry were reconstructed using local threshold 
segmentation (Fig. 4A) and global threshold segmentation (Fig. 4B). The local 
threshold method generated smoother vessel surface than the geometry 
reconstructed using global threshold values. The effect of the two threshold 
methods on vessel geometry within the cast region was evaluated. The cast is 
clearly visible as a dark region surrounding the RCCA on the micro-CT image (Fig. 
3A). Its diameter ranges from 400 µm to 200 µm, serving as a landmark for 
comparison. The result revealed good agreement between the cast dimension 
and the vessel geometry obtained from the local threshold segmentation (Fig. 5A, 
straight line). On average, the vessel dimension in the lumen region was 9.6% ± 
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4.5% smaller than that of the cast. However, the vessel geometry reconstructed 
from the global threshold segmentation underestimated 27.6% ± 11.6% of the 
lumen dimension (Fig. 5A, dashed line). As a result, the vessel was greatly 
narrowed in the distal cast region when using the global threshold segmentation. 
Vessel wall thickness reconstructed from local threshold segmentation was 
13.5±4.0 µm (Fig. 5B, black straight line), while global threshold methods resulted 
in a much larger dimension of 38.4±7.9 µm (Fig. 5B, black dash line). The 
difference between the two methods was significant (p < 0.05). For the local 
threshold method, we observed thinner vessel wall thickness compared to that of 
healthy tissue (16.6±1.3 µm, Lacolley et al222). It is likely due to the reduced cyclic 
loading due to the placement of cast around RCCA. 
For the same vessel, we performed segmentation procedures for two times. 
Vessel diameter of the two reconstructed geometry were calculated and 
compared (data not shown). There were less than 5% differences between the 
two segmented vessels, indicating that the vessel reconstruction was not 
influenced by the segmentation method. 
Figure 3 (A) Illustration of the RCCA with cast on micro-CT using eXIA 160. (B) 
Contrast intensity along the RCCA using eXIA 160. Lumen region is shown in red 
line with square markers; Blue line with cross markers represents the local 
threshold; Black dashed line indicates global threshold value; Background region is 
marked as green line with circles; Standard deviation is indicated by shadow 
areas. 
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Figure 4 3D reconstruction of RCCA by eXIA 160 enhanced micro-CT using (A) the local 
threshold and (B) the global threshold segmentation. The narrowing of the lumen caused 
by the cast was clearly captured. 
3.4 Hemodynamics in shear-manipulated RCCA 
Figure 6 shows the velocity field of the blood along the RCCA at the time-averaged 
velocity in the diastolic phase. Average flow rate and WSS at the inlet of RCCA 
were summarized in Table 2. Figure 7A (left panel) illustrated the streamlines in 
the vessel geometry reconstructed from the local threshold method. Upstream of 
the cast region, parallel streamlines with relatively low velocity was observed, 
while the flow velocity increased within the cast region. Due to the narrowing of 
the tapering cast, a slightly asymmetric jet was formed downstream of the cast. 
Flow reversal downstream of the cast was observed for a short period during peak 
systole. TAWSS (Fig. 7A, middle panel) was low at the upstream side of the RCCA, 
with an average value of 6.0 ± 1.8 Pa. Increased TAWSS was seen proximal to the 
cast region. A maximum TAWSS of approximately 180 Pa was observed inside the 
cast region where the lumen narrowed. Due to the off-axis jet, asymmetric TAWSS 
was observed immediately downstream of the cast. Since we did not observe flow 
reversal upstream of the cast, OSI (Fig. 7A, right panel) was zero, and only the 
small region downstream of the cast that was exposed to low TAWSS showed 
elevated OSI levels. 
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Figure 5 (A) Comparison of RCCA vessel dimensions obtained from two segmentation 
methods with known cast geometry. Vessel surface reconstructed from the local threshold 
segmentation (straight line) showed good agreement between the vessel geometry and 
the cast dimension. Vessel surface reconstructed from the global threshold segmentation 
(dashed line) significantly underestimated the cast dimensions. (B) RCCA vessel wall 
thickness within the cast region obtained from the local threshold segmentation (straight 
line) corresponded to that of the normal vessel wall thickness. Vessel surface 
reconstructed from the global threshold segmentation (dashed line) significantly 
overestimated the vessel wall thickness. 
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Table 2 Average flow rate and wall shear stress at inlet of RCCA 
Mouse Number Mean flow rate (mm3/s) Wall shear stress (Pa) 
1 25.8±0.2 5.0±0.6 
2 15.5±0.1 2.5±0.5 
3 N/A N/A 
4 13.7±0.2 1.8±0.2 
5 9.4±0.2 1.6±0.2 
6 20.2±0.2 3.3±0.2 
7 39.0±0.4 6.4±0.1 
8 14.8±0.2 2.2±0.1 
Average 19.8±9.9 3.3±1.8 
 
 
Figure 6 Time-dependent velocity profile at proximal RCCA. Black dash lines indicate wave 
forms measured by Doppler Ultrasound; Red line represents the averaged velocity 
calculated over 4 cardiac cycles while blue line indicates the filtered wave form used as 
inlet boundary condition. 
C h a p t e r  3  | P a g e  51 
 
 
Figure 7 (A) Hemodynamic analysis of shear-manipulated RCCA using vessel geometry 
created from the local threshold method. Streamline (left panel) representing velocity 
field along the RCCA; TAWSS (middle panel) and OSI distribution (right panel) along the 
RCCA. (B) Hemodynamic analysis of shear-manipulated RCCA using vessel geometry 
created from the global threshold method. Streamline (left panel) representing velocity 
field along the RCCA; TAWSS (middle panel) and OSI distribution (right panel) along the 
RCCA. The range of the colormap is between 0-20 Pa. 
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In the upstream region, little differences between the local and global threshold 
method were observed, although stripes of low WSS bands were observed, due to 
the uneven lumen surface created from the global threshold method (Fig. 7B, 
middle panel). The global threshold method mainly underestimated the cast 
dimension (Fig. 5), thus leading to a stronger jet downstream of the cast. This 
gave rise to flow reversals, even at the time-averaged velocity during the diastolic 
phase. Furthermore, the jet was asymmetrical, leading to regions with relatively 
high TAWSS downstream of the cast (Fig. 7B, middle panel). The downstream 
regions exposed to elevated OSI (Fig. 7B, right panel) were much larger when 
compared to the results based on the local threshold method.  
4. Discussion 
To monitor changes of WSS over time, knowledge about the vessel geometry at 
various time points during disease progression is required. The 3D vessel 
geometry can be acquired by the micro-CT modality by using a contrast agent that 
provides good contrast enhancement in blood. In our present work, we 
demonstrated that eXIA 160 provides clear contrast enhancement in the RCCA, 
thereby facilitating vessel segmentation. Although the amount of the contrast 
agent administrated was adjusted according to body weight, the contrast intensity 
in the lumen region varied among animals. We also observed differences in soft 
tissue contrast intensity among all animals, which was probably caused by the 
individual differences among the animals. Furthermore, contrast intensity within 
the cast region also differed among animals. Therefore, it is necessary to analyze 
contrast enhancement of each animal individually. Moreover, we established a 
local threshold-based segmentation protocol to reconstruct 3D vessel geometry 
for calculating WSS. This protocol is especially relevant for WSS analysis in a single 
mouse over time. Finally, the fact that we observed asymmetric WSS distribution 
downstream of the cast region suggests that it is preferable to analyze WSS data 
for each mouse separately. 
Global thresholding is a simple segmentation method in vascular image processing 
for separating blood vessels from the surrounding soft tissue202,219,220. However, 
determining vessel geometry using the global threshold method could introduce 
errors, since the signal variation along the RCCA might then be overlooked. Two of 
our findings demonstrate that it is indeed better to calculate the threshold value 
specific to its location along the RCCA. First of all, as the vessel narrowed within 
the cast region, we observed decreasing contrast intensity in the lumen. This was 
likely due to the decreasing blood volume within the cast region, thus reducing 
the amount of contrast agent present in the blood223. Consequently, 
segmentation using global threshold method could underestimate a severely 
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narrowed vessel due to the growth of an atherosclerotic plaque. Secondly, in all 
the animals, the signal fluctuated along both the lumen region and the 
background region. This generated a set of fluctuating threshold values that were 
specific to their location along the RCCA. While this fluctuation artefact was 
overlooked by segmentation using global threshold method, local threshold 
segmentation took it into account, thus generating more reliable vessel geometry. 
Our result was in line with the findings of Vandeghinste et al86 in murine aorta 
without cast. Since the dimension of the cast geometry is known, it was used to 
validate the results of the two segmentation methods. The vessel surface 
generated from the global threshold values significantly underestimated the 
lumen diameter within the cast region when compared to the vessel geometry 
reconstructed using the local threshold method. Also, in areas outside the cast 
region, global threshold had lower values than the local threshold method. A 
lower threshold means that the background region which has lower intensity 
values could be defined as the vessel region. As a result, this could potentially 
overestimate the vessel dimensions outside the cast. Therefore, local threshold-
based segmentation is a better approach for reconstructing accurate 3D vessel 
geometry.  
Our findings for overall WSS distribution are in good agreement with those of the 
others: WSS was low upstream of the cast region, with an average value of 
approximately 6 Pa. Other studies using the same WSS-manipulated mouse 
model204,224 reported a WSS of approximately 10 Pa upstream of the cast. The 
value that we observed for peak WSS was approximately two-fold lower than 
values observed by Mohri et al204. The average WSS value downstream of the cast 
region was also low. No flow recirculation was found using the vessel surface 
created from the local threshold method. However, due to the slight curvature of 
the vessel, we found that the vessel wall downstream of the cast was exposed to 
an asymmetric WSS pattern. A similar observation was reported by Willett et al203. 
Mohri et al noted that the recirculation zone covered only a quarter of the wall 
circumference downstream204. In the study performed by Thim et al225, in which a 
non-tapering cast was placed around the carotid artery of minipig, an 
asymmetrical flow pattern was also evident downstream of the cast as a result of 
vessel curvature. Once again, this underlines the necessity – when calculating CFD 
– of performing animal-specific WSS analysis rather than using mouse-averaged 
vessels or idealized geometries. This concept has also been suggested by van 
Doormaal et al226.  
A final consideration in terms of our preference for local threshold-based 
segmentation when reconstructing accurate 3D vessel geometry is that we 
observed different WSS patterns downstream of the cast region when global 
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threshold method was used to obtain vessel geometry. As the cast dimension was 
significantly underestimated, a jet was formed downstream of the cast which led 
to an unrealistic high WSS distribution in this area. This result illustrates that WSS 
is highly sensitive to small changes in vessel geometry and thus to the 
segmentation protocol used for 3D reconstruction. Accurate WSS computation is 
not only important for the TAWSS but especially for OSI, therefore requires local 
threshold segmentation. 
5. Study Limitations 
One of the limitations of our study is that the accuracy of the two threshold 
methods was only validated within the cast region. For the region outside the 
cast, we did consider various ways to evaluate the difference between the two 
segmentation methods. Two approaches potentially qualify for this: high 
resolution ultrasound and vascular corrosion casting. However, both techniques 
do not have sufficient resolution to differentiate true dimensions from errors. The 
difference between the two segmentation methods is small (about 20-30 µm). 
This small difference can have substantial effects on the WSS computations. 
However, the spatial resolution of ultrasound is 30 µm, larger than the differences 
between the two segmentation methods. The use of vascular corrosion casting is 
another way to obtain vessel dimension. However vessels acquired from this 
method are known to shrink (16-20%) resulting in an underestimated vessel size86. 
The resolution and errors of the two mentioned alternatives are larger than the 
differences between the two segmentation methods and therefore cannot be 
used for validation and drawing robust conclusions. In our study, we only 
investigated a simple threshold-based segmentation method to reconstruct 3D 
vessel geometry. The method showed reliable results. We didn’t explore the 
possibility of using a commercial software package or other more advanced 
segmentation methods. Whether these methods would give rise to more accurate 
vessel geometry needs further investigation. Another limitation pertains to the 
computational methods that were applied to determine the OSI. Recent work has 
indicated the importance of the buffering capacity of the carotid bifurcation on 
the computed OSI level, and they concluded that for accurate OSI computations 
fluid-structure interaction (FSI) simulations were required76. Whether FSI 
simulations would also influence the OSI values immediately upstream of the cast 
needs to be investigated.  
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6. Conclusion 
eXIA 160 provided good blood-pool contrast using a WSS-manipulated 
atherosclerotic mouse model when performing longitudinal studies. We 
established a robust segmentation protocol in which local threshold values were 
applied to generate 3D vessel geometry. The approach eliminated artefact and 
thus reconstructed reliable vessel geometry for WSS calculation. Finally, we 
showed that it is crucial to use mouse-specific geometry data when computing 
WSS. 
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Abstract 
Wall shear stress (WSS) is involved in atherosclerotic plaque initiation, yet its role 
in plaque progression remains unclear. We aimed to study (i) the temporal and 
spatial changes in WSS over a growing plaque and (ii) the correlation between 
WSS and plaque composition, using animal-specific data in an atherosclerotic 
mouse model. Tapered casts were placed around the right common carotid 
arteries (RCCA) of ApoE-/- mice. At 5, 7 and 9 weeks after cast placement, RCCA 
geometry was reconstructed using contrast-enhanced micro-CT. Lumen narrowing 
was observed in all mice, indicating the progression of a lumen intruding plaque. 
Next, we determined the flow rate in the RCCA of each mouse using Doppler 
Ultrasound and computed WSS at all time points. Over time, as the plaque 
developed and further intruded into the lumen, absolute WSS significantly 
decreased. Finally at week 9, plaque composition was histologically characterized. 
The proximal part of the plaque was small and eccentric, exposed to relatively 
lower WSS. Close to the cast a larger and concentric plaque was present, exposed 
to relatively higher WSS. Lower WSS was significantly correlated to the 
accumulation of macrophages in the eccentric plaque. When pooling data of all 
animals, correlation between WSS and plaque composition was weak and no 
longer statistically significant. In conclusion, our data showed that in our mouse 
model absolute WSS strikingly decreased during disease progression, which was 
significantly correlated to plaque area and macrophage content. Besides, our 
study demonstrates the necessity to analyze individual animals and plaques when 
studying correlations between WSS and plaque composition. 
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1. Introduction 
Wall shear stress (WSS) is the frictional force induced by blood flow acting on the 
endothelial lining of the vessel surface. WSS regulates the inflammatory status of 
the endothelium and thus determines the location of plaque development22,24,25. 
The progression of a plaque is a dynamic process, during which vessel geometry 
undergoes remodeling and narrowing, leading to substantial changes in the local 
WSS environment over time34,35,37,38. As the disease advances, plaques grow and 
they differ in composition, showing either a stable or vulnerable phenotype. 
Vulnerable plaques are characterized by the presence of a large necrotic core with 
a thin overlying fibrous cap and abundant infiltration of inflammatory cells227. 
Vulnerable plaques are prone to rupture and can cause subsequent 
thromboembolic events107. A substantial role for WSS in the initiation of 
atherosclerosis is established, however, whether WSS plays a role in plaque 
growth and/or progression remains under debate. 
Evidence towards a role for WSS in plaque growth and progression does exist but 
is ambiguous. Clinical studies revealed that in carotid and coronary arteries, 
plaque rupture was predominantly located at the upstream shoulder of a 
plaque41,47,228,229. Plaque composition was heterogeneous along the direction of 
blood flow: thinner fibrous caps, larger necrotic cores and accumulation of 
macrophages were observed at the upstream shoulder of a plaque, correlating a 
vulnerable plaque phenotype to the location of rupture47–51. Several studies 
proposed that these regions were exposed to increased WSS, suggesting that high 
WSS may promote plaque vulnerability42–44,230. In contrast, low WSS was 
correlated to characteristics of plaque vulnerability in human and porcine 
coronary arteries52–60. Nevertheless, no direct association between evolution of 
WSS and plaque composition was established. We set out to study the dynamic 
process of disease progression and the concomitant spatial and temporal changes 
in lumen geometry and WSS using an atherosclerotic mouse model. In addition, 
we analyzed the association between WSS and plaque composition.  
We use an atherosclerotic animal model in which we can manipulate WSS in vivo 
and induce atherosclerotic plaque development69,78,115,129,141,164,225. We previously 
summarized the use of surgically manipulated flow models68 and found that WSS 
distribution was studied only in some of these models and usually not taking full 
3D vessel geometry into account129,164,231, while calculation of WSS critically 
depends on detailed vessel geometry and blood flow velocity232. In a previous 
cross-sectional study, using a tapered cast model69, Pedrigi et al78 discovered that 
certain WSS metrics co-localized to the presence of a plaque with increased Oil 
Red O-lipid-staining. However, quantitative analysis of plaque composition was 
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not performed in this study and thus spatial correlations between WSS metrics 
and plaque composition could not be studied. The WSS metrics were investigated 
only at one time point while temporal data were lacking. Due to the dynamic 
nature of plaque progression, monitoring WSS in vivo over time is a prerequisite. 
To the best of our knowledge, no studies have monitored temporal and spatial 
changes of WSS or correlated these to plaque composition in individual animals. 
We investigated the evolution of geometry, flow and WSS during plaque 
progression and the correlation between WSS and plaque composition in 
individual animals by analyzing WSS in vivo at various time points during plaque 
progression. First, we obtained mouse-specific geometrical and flow data to 
compute WSS distribution at 5, 7 and 9 weeks after cast placement. This enabled 
us to monitor changes in WSS over the very same plaque during its growth and 
progression into an advanced plaque. At 9 weeks after cast placement, vessel 
samples were harvested and plaque composition was histologically characterized. 
Finally, regression analysis was performed to determine correlations between 
plaque composition and WSS.  
2. Methods 
2.1 Animals and cast placement 
Female ApoE-/- mice on C57BL/6J background (n = 9) were purchased from Charles 
River (Maastricht, The Netherlands). At 13 weeks of age, normal chow diet was 
replaced with an atherogenic Western diet and provided ad libitum (Arie Blok, The 
Netherlands). Cast surgery was performed two weeks later on the animals under 
isoflurane-induced anesthesia as described previously63,69,73. The average weight 
of the mice was 21.9 grams. A tapering cast was placed around the right common 
carotid artery (RCCA), leading to changes in local WSS environment and 
subsequent plaque development. All animal experiments were performed 
conform to the guidelines from Directive 2010/63/EU of the European Parliament 
on the protection of animals used for scientific purposes and approved by ethical 
committee of Erasmus MC Rotterdam. 
2.2 Contrast-enhanced micro-CT imaging and RCCA lumen 
reconstruction 
To compute WSS in RCCA, we used time point and mouse-specific vessel 
geometries as the input, which was captured by contrast-enhanced micro-CT 
imaging (Quantum FX) with isotropic resolution of 40 µm. Images in Hounsfield 
unit (HU) were reconstructed. RCCA geometry of each animal at week 5, 7 and 9 
was analyzed using in-house developed modules in MeVisLab (MeVisLab 2.2.1) 
and Matlab (Matlab 2012). The segmentation protocol was previously 
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established232. RCCA lumen surface was reconstructed from its origin at the 
bifurcation of the brachiocephalic artery, to its bifurcation into the internal and 
external carotid artery. Mice were anesthetized with isoflurane with scanning 
parameters of 90kvp, 160µA, field of view 20mm (Fig. 1). The radiation dose of 
each micro-CT scan was approximately 1.7 Gy. Mice underwent 3 scans in total, 
with 2 week time intervals. To determine a possible effect of radiation on 
atherosclerosis progression, we included a control group (n = 5) that was not 
imaged and analyzed plaque composition 9 weeks after cast placement. No 
significant differences in plaque area or macrophage content were found (data 
not shown). Contrast agent eXIA 160 was used with an injection dose of 150 µl/25 
grams of body weight. One mouse had paralyzed hind limbs after the 1st imaging 
and was euthanized. One mouse was found dead before the 3rd imaging at week 
9. These two mice were excluded from subsequent analyses. Note that micro-CT is 
unable to capture outward remodeling of the vessel wall but allows visualization 
of lumen surface.  
 
Figure 1 Experimental scheme. At t = -2 weeks, ApoE-/- mice were fed a high fat diet; Cast 
operation was performed on the right common carotid artery (RCCA) at t=0 week to 
induce plaque growth (Note that at t = 0, mice were 15 weeks of age); At t = 5, 7, 9 weeks 
during plaque progression, 3D RCCA vessel geometry was reconstructed using contrast-
enhanced micro-CT imaging. Blood flow velocity through the RCCA was measured by 
Doppler Ultrasound; Both micro-CT and ultrasound were carried out in each individual 
mouse; 3D WSS maps at 3 time points of the same animal were thus generated using 
these imaging data; After the last imaging moment at t = 9 weeks, animals were 
euthanized, RCCA was excised for histological analyses. 
2.3 Doppler Ultrasound imaging 
Ultrasound imaging was performed using Vevo 2100 (VisualSonics) with a 40-MHz 
transducer. Blood velocity wave form was measured upstream of the RCCA under 
pulse-wave mode at 5 different time points: before and immediately after cast 
surgery, at 5, 7 and 9 weeks after cast surgery (Fig. 1). RCCA diameter was 
measured under M-mode at the same location of the pulse-wave measurement, 
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thus allowing conversion of blood velocity (mm/s) to flow (mm3/s) assuming a 
parabolic velocity profile. 
2.4 Mesh and CFD simulations 
RCCA lumen surface was smoothed using Vascular Modelling Tool Kit (VMTK 1.2). 
The superfluous ends at the proximal and distal side of the vessel surface were 
clipped and flow extensions were added. A volume mesh with prism layers was 
then generated using ICEM (ICEM-CFD 14.5, Ansys). Parameters including number 
of mesh elements, maximum element size, use of curvature/proximity based 
refinement, numbers and thickness of prism layers were optimized to obtain a 
mesh-independent solution resulting in approximately 640,000 elements. Surface 
area of the RCCA inlet was derived, enabling the calculation of location-specific 
blood flow velocity as boundary condition. 
Several assumptions were made when solving the Navier-Stokes equations. First, 
the endothelial cells are exposed to time varying WSS levels. It is well established 
that the response of these cells is triggered by the time-averaged WSS that they 
are exposed to233. To obtain the time-averaged WSS, we can use steady flow 
simulations, using the average flow through the vessel as input81. In previous 
studies, it was demonstrated that other time dependent WSS derived parameters 
such as Oscillatory Shear Index (OSI) are not relevant due the geometry and flow 
conditions in this model78,232, unlike in other vascular territories79,80. Furthermore, 
we assumed the WSS values are not influenced by the distensibility of the vessel 
wall. For blood flow in carotid arteries in mice, it was previously shown that 
distensibility is only important in the carotid bifurcation, and has a negligible 
effect in the common carotid artery234. Finally, blood was modeled as a 
Newtonian fluid, a valid assumption given the high shear rates in the carotid 
arteries of mice77. Therefore, we confined ourselves to steady flow simulation.  
The resulting Navier-Stokes equations were solved by computational fluid 
dynamics (CFD) using Fluent (Fluent 14.5, Ansys). Blood was modeled to be 
incompressible. A constant viscosity of 3.5 × 10-3 kg/m/s and a density of 1060 
kg/m3 were used234,235. Vessel wall was assumed to be rigid. A parabolic velocity 
profile was imposed as inlet boundary condition. Average blood flow velocity of 
the RCCA was derived from Doppler velocity measurements. For outlet boundary 
condition, zero pressure was used. WSS was then derived from the computed 
velocity field. Finally, post-processing and analysis were performed using CFD-Post 
(CFD-Post 14.5, Ansys) and Matlab.  
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2.5 Histological staining and analysis 
After final imaging at week 9 (Fig. 1), mice were euthanized by isoflurane 
overdose. The vascular system was then flushed with PBS through the left 
ventricle. Subsequently, 4% paraformaldehyde (PFA) in 0.15 mM PBS was used for 
pressure fixation at 100 mmHg236. Tissue around the RCCA was carefully cleaned, 
exposing the vasculature. The RCCA, cast, proximal brachiocephalic bifurcation 
and aortic arch could be clearly seen (Fig. 2B). Photos of RCCA were taken with a 1 
mm grid strip. The cast was then carefully removed from the vessel. Proximally, 
the RCCA was excised 3 mm distal to the aortic arch and distally after the carotid 
bifurcation. RCCA was then immersed in 4% PFA for 24h at room temperature. 
Tissue samples were then processed and embedded in paraffin for histological 
analysis. We focused on the plaque upstream of the cast because its composition 
was relevant to our aim of study. We didn’t investigate the region within the cast 
because this region was exposed to increased WSS, and thus no plaque formation 
was observed. For the region downstream of the constriction, the cast was 
generally located close to the bifurcation. We can therefore expect a strong 
interplay between the presence of the jet downstream of the cast and the flow 
features associated with the division of the flow in the carotid bifurcation. These 
features will be greatly influenced by the flow division over the internal and 
external carotid artery. This ratio will change during the progression of the 
disease234. Since we did not measure flow in the internal or external carotid artery 
due to restricted time allocated for flow measurements, we cannot establish flow 
division and thus cannot evaluate WSS patterns downstream of the cast reliably. 
Therefore, we decided to exclude the plaque formed downstream in our analysis. 
Serial sections of the plaque upstream to the cast were collected. On average 
each plaque contains 21 serial sections (5 µm, at 50 µm interval), the two sections 
adjacent to the cast were excluded from the analysis to avoid possible 
confounding effects from the presence of the cast. Sections were stained for 
general plaque morphology (H&E), macrophages (CD68, Bio-Rad), endothelium 
(CD31, Dianova), and collagen (Resorcin-Fuchsine). Atherosclerotic plaque area, 
media area, and relative macrophage area were quantified (BioPix iQ3.2). Necrotic 
core was defined as a-cellular, a-nuclear areas, free of H&E staining237. 
2.6 Registration of histological staining to 3D WSS maps 
For each animal, histological sections of the RCCA (Fig. 2A) were spatially 
registered to 3D WSS maps at various time points (Fig. 2C) via the in vivo RCCA 
overview (Fig. 2B). We correlated plaque composition to WSS at different time 
points because although the effect of WSS on the endothelium is instant, the 
subsequent changes in plaque composition are not. Thus it is necessary to register 
WSS maps at week 5, 7, and 9 to plaque composition observed at the latest time 
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point. To do the registration, we calculated RCCA vessel shrinkage from the in vivo 
situation to histology. Two landmarks are needed for this purpose. Since vessel 
segments with and without plaques were likely to exhibit different elasticity and 
therefore shrinkage, selection of landmarks should preferably be the beginning 
and the end of a plaque. The proximal edge of the plaque was clearly visible both 
on the RCCA overview (Fig. 2B, arrow) and histological sections (Fig. 2A, 2nd 
section on the left). We thus selected it as the first landmark. The end of the 
plaque coincided with the proximal edge of the cast, which can be identified on 
histology. However, due to the scar tissue surrounding the cast, the distal edge of 
the plaque was not clearly visible on the RCCA overview. The black suture around 
the cast, however, can be easily spotted (Fig. 2B, arrowhead). Since the distance 
to the proximal edge of the cast was known (0.5 mm), we could pinpoint it as our 
second landmark. The average longitudinal shrinkage was 51%±20%, comparable 
to that reported previously78. On the 3D WSS maps, location of the cast was 
identified from the micro-CT images. Using the individual shrinkage factor 
obtained for each mouse, histological sections were then spatially registered to 
the 3D WSS maps at week 5, 7 and 9 (Fig. 2C). We investigated the association 
between plaque composition and WSS profiles at 3 time points as the duration 
between changes in WSS and the actual effect of that particular WSS on plaques 
composition is unknown. 
According to the histological sections, proximal RCCA was divided into 2 
segments: the healthy segment and the diseased segment. The corresponding 
segments were also identified on the 3D RCCA geometry reconstructed from the 
micro-CT images at week 9. Since histology was only available at week 9 and 
micro-CT imaging can only capture lumen geometry but not plaque composition, 
it was not possible to pinpoint the border between the healthy and diseased 
segment on the 3D RCCA geometry at week 5 and 7. We used the histology data 
obtained at week 9 to identify the healthy and diseased segments for these two 
time points. Lumen area in the proximal RCCA was derived from the 3D RCCA 
geometry assuming circular cross-section238. Degree of stenosis was calculated as 
the percentage ratio between the minimum lumen area in the diseased segment 
and the average lumen area of the healthy segment. When analyzing histological 
data, the diseased segment was further divided into two segments. Proximally, 
the plaque was composed of sections with eccentric plaque growth, in which 
plaque did not cover the entire circumferential direction. Close to the cast, the 
plaque covered the entire circumferential direction and was thus concentric (Fig. 
2A). 
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Figure 2 Spatial matching of histological sections to 3D WSS map of an individual RCCA. (A) 
Representative H&E stained sections of the RCCA proximal to the cast, showing the 
healthy part, eccentric plaque part and the concentric plaque part. (B) Overview of the 
RCCA in situ before excision with 1 mm-spacing grid paper (Arrowhead: black suture 
around the cast; Arrow: proximal side of the plaque; Asterisk: plaques located at the inner 
curve of the aortic arch and brachiocephalic artery). (C) 3D WSS map. 
2.7 Statistics 
Data are presented as mean ± SD and analyzed in Matlab and RStudio. Differences 
between samples were evaluated using a paired, two-tailed, Student’s t-test or 
repeated measures ANOVA. A Tukey's honestly significant difference (HSD) post-
hoc test was performed after the ANOVA test. Correlations between histological 
quantifications and WSS data were performed by linear regression. A value of 
p<0.05 was considered significant. 
3. Results 
3.1 In vivo micro-CT reveals various plaque progression profiles 
among animals 
3D RCCA vessel geometries were reconstructed from contrast-enhanced micro-CT 
at 5, 7 and 9 weeks after cast placement. Various plaque progression profiles 
were evident among animals. Changes in lumen diameter were most evident 
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between either 7 and 9 weeks, or 5 and 7 weeks. In a representative animal 
(mouse number 1 shown in Fig. 3-6), lumen narrowing was observed gradually 
over time (Fig. 3A, pink line, 3B). Degree of stenosis increased steadily from 55% 
at week 5 to 63% at week 7 and 80.0% at week 9 (Fig. 3A, pink line).  
 
Figure 3 (A) Degree of stenosis of RCCA at 5, 7 and 9 weeks after cast placement: Average 
of 7 animals (black line, *p<0.05, repeated measures ANOVA); Mouse 1 (pink line); 
Shadow area indicates data range of 7 animals. Notably, animals exhibited various plaque 
progression profiles. (B) 3D reconstruction of RCCA at 5, 7 and 9 weeks after cast 
placement of Mouse 1. Direction of blood flow is indicated by the arrow in the upper left 
corner. Location of the cast is illustrated. Upstream to the cast, the RCCA is divided into a 
healthy segment and a diseased segment based on the week 9 histology data. Lumen 
narrowing can be observed over time, suggesting the development and progression of a 
lumen intruding plaque.  
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In all animals (n = 7), at week 5, lumen narrowing can be clearly seen in the 
diseased segment upstream of the cast (Suppl Fig. 1), suggesting presence of a 
lumen intruding plaque. Degree of stenosis averaged among 7 animals was 
41±11% at week 5, 57±8% at week 7 (p<0.05 vs. week 5) and 62±16% at week 9 
(p<0.05 vs. week 5) (Fig. 3A, black line). 
3.2 Blood flow in RCCA decreased over time 
Blood velocity was measured upstream of the RCCA before and immediately after 
cast surgery, and at 5, 7 and 9 weeks after cast placement. Blood flow in the RCCA 
was then converted using the measured parameters. In our representative animal, 
blood flow reduced from 47.3 mm3/s to 19.4 mm3/s after cast placement and 
furthered decreased during plaque progression, from 14.8 mm3/s at week 5 to 
11.4 mm3/s at week 7 and 2.0 mm3/s at week 9 (Fig. 4, pink line). 
All mice except for one (Mouse number 3) showed a general decrease in blood 
flow over time. Blood flow in the RCCA averaged from all 7 animals decreased 
immediately after cast placement from 38.4±9.0 mm3/s to 28.0±5.5 mm3/s (Fig. 4, 
black line). At week 5 and 7, blood flow further reduced to 19.8±9.2 mm3/s and 
16.4±6.0 mm3/s (p<0.05 vs. before cast placement). Finally, at 9 weeks, blood flow 
was 9.9±11.3 mm3/s, significantly lower than that before and after cast placement 
(p<0.05). 
 
Figure 4 Blood flow along RCCA over time: Average of 7 animals showed a general 
decrease in blood flow over time (black line, * indicates p<0.05, repeated measures 
ANOVA); Mouse 1 (pink line); Shadow area indicates data range of all animals. 
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Figure 5 Illustration and quantification of WSS in a RCCA. (A) 3D WSS distribution in the 
RCCA of representative mouse 1 at 5, 7 and 9 weeks after cast placement. 
Circumferentially-averaged WSS along the RCCA is shown (B). Proximally the RCCA was 
divided into a healthy and diseased segment, indicated by the vertical dashed line, based 
on the week 9 histology data. WSS distribution was heterogeneous over the diseased 
segment. (C) Averaged WSS in both segments significantly decreased over time and was 
relatively higher in the diseased segment (Student’s t-test, *p<0.05). 
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3.3 WSS profiles as determined by animal-specific geometry and flow 
data 
The spatial and temporal 3D WSS distribution based on the mouse-specific 
geometry and flow data was computed at 5, 7 and 9 weeks after cast placement 
with CFD. Figure 5 illustrates the evolution of the 3D WSS distribution of our 
representative animal. Before cast placement, average WSS was 14.4±9.4 Pa 
decreasing to 12.9±4.4 Pa after cast placement. At week 5, WSS was low upstream 
of the cast with an average value of 4.1±2.2 Pa (Fig. 5A, upper panel). At week 7 
and 9, as blood flow in the RCCA gradually reduced, WSS decreased in the RCCA 
(Fig. 5A, middle and lower panel). WSS distribution in the RCCA upstream to the 
cast was further analyzed in the healthy and diseased segment. At week 5, the 
two segments were exposed to WSS of 2.2±0.1 Pa and 5.0±2.2 Pa respectively 
(Fig. 5C, green bars). Furthermore, WSS distribution was heterogeneous over the 
diseased segment (Fig. 5B, green line). Over time, as lumen area remained 
constant along the healthy segment, the decrease in blood flow lead to lower WSS 
in this region (Fig. 5B, blue and red lines), with 1.3±0.1 Pa at week 7 and 0.3±0.0 
Pa at week 9 (p<0.05, Fig. 5C, blue bars). For the diseased segment, the lumen 
area narrowed gradually over time. Combined with the reduction in blood flow 
over time, WSS in this segment decreased significantly to 3.4±1.7 Pa at week 7 
and 1.7±1.0 Pa at week 9 (p<0.05, Fig. 5C, red bars).  
Since various geometry features and blood flow patterns were observed among 
the 7 mice, different WSS profiles were evident. A general reduction in WSS over 
time was seen in 5 animals. Mouse number 2 showed an increase in WSS from 5 
to 7 weeks, with a subsequent dramatic decrease from 7 to 9 weeks. Mouse 
number 3 was the only one showing a WSS increase over time, while in all other 
mice WSS was minimal in both the healthy and diseased segment at week 9. 
Furthermore, in all mice, the healthy segment was exposed to significantly lower 
levels of WSS when compared to the diseased segment at all time points.  
3.4 Plaque morphology and composition varied within a single plaque 
Histological analysis revealed the presence of one continuous plaque in the RCCA 
upstream to the cast 9 weeks after cast placement. However, differences in 
morphology and composition were found within this continuous plaque 
depending on the axial location. Histological sections of our representative animal 
are shown in Figure 6. A smaller and eccentric plaque was observed proximally 
(Fig. 6, left section). Closer to the cast, the plaque was concentric and larger (Fig. 
6, right section). Plaque area of the eccentric part was 0.04 mm2 compared to that 
of the concentric plaque 0.15 mm2. Relative macrophage area in the eccentric 
plaque was 24.6%, while in the concentric plaque a relative macrophage area of 
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13.9% was observed. In the eccentric plaque, relative necrotic core area was 2.7%, 
while it was 15.0% in the concentric plaque (data not shown). 
The eccentric-concentric plaque morphology was present in all animals. Plaque 
area was significantly smaller in the eccentric plaque compared to that of the 
concentric plaque (0.03±0.01 mm2 vs. 0.12±0.02 mm2, p<0.05) (Fig. 6A).  
 
Figure 6 Characterization of plaque composition. Representative histological staining of 
the eccentric and concentric segment of representative mouse 1 and quantification of all 
mice is shown. (a) Plaque area (mm2) was delineated by CD31 endothelial staining; (b) 
Relative macrophage area (%) was determined using CD68 staining; (c) relative necrotic 
core area (%) was delineated by H&E nuclei staining (Arrows: necrotic cores); Plaque area 
was significantly larger in the concentric segment, while macrophage area was larger in 
the eccentric segment (Student’s t-test, n = 7, *p<0.05). Bar is 100 µm. 
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Macrophages were more concentrated in the eccentric plaque compared to that 
of the concentric plaque (Fig. 6B). On average, relative macrophage area in the 
eccentric plaque was 28.3±6.9%, while in the concentric plaque a relative 
macrophage area of 13.4±3.5% was observed (p<0.05). In the eccentric plaque, 
relative necrotic core area appears to be somewhat smaller than that of the 
concentric plaque (Fig. 6C, 15.2±8.2% vs. 21.1±7.7%). However, the difference 
between the eccentric and concentric plaque regarding relative necrotic core area 
was not statistically significant. 
 
Figure 7 Correlation between WSS at all time points and plaque composition. Yellow: 
positive correlation, p<0.05; Blue: positive correlation, p>0.05; Light Yellow: negative 
correlation, p<0.05; Light Blue: negative correlation, p>0.05.  
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3.5 Correlation between WSS and plaque composition 
Plaque area, macrophage content, and necrotic core area at week 9 was linked to 
WSS profiles at week 5, 7 and 9 (Fig. 7). In our representative animal, plaque area 
was positively associated with WSS and significant at all time points (p<0.05). 
Accumulation of macrophages was negatively correlated to WSS and significant at 
both week 5 and 7 (p<0.05), indicating that lower WSS suggested a pro-
inflammatory profile in plaques. A positive correlation between relative necrotic 
core area and WSS level was positive at all 3 time points, however only significant 
at week 5 and 7. Figure 7 summarizes the correlation between WSS and plaque 
area, macrophage content, and necrotic core area of all 7 animals at 3 time 
points. Thus for each plaque parameter, there were 7x3=21 observations. In 6 out 
of 7 animals at all time points, a positive and statistically significant correlation 
between WSS and plaque area was seen in 17 out of 21 observations. Inverse 
correlation between WSS and macrophages was observed in 6 out of 7 animals 
where 12/21 observations were statistically significant, and 6/21 showed a non-
significant negative correlation. The correlations between WSS and relative 
necrotic core size showed less significance. For relative necrotic core size, 6/21 
correlations were positive and statistically significant. The correlation between 
plaque composition and WSS profiles were analyzed in each individual animal. 
When histological data from all the animals was pooled together, as is usually the 
followed approach in these types of studies, a positive but very weak correlation 
between WSS and plaque area was seen, which was not statistically significant at 
any time point (the correlation coefficient at week 5 was 0.08, 0.1 at week 7 and 
0.04 at week 9, p>0.05), contrary to the result obtained from the individual animal 
analysis. Pooling data results in different and not necessarily correct correlation 
patterns. 
4. Discussion 
Our study described the temporal and spatial changes in vessel geometry, blood 
flow and concomitant WSS over an advanced murine plaque and its correlation to 
plaque area and macrophage content. First, we demonstrated that it was possible 
to follow changes in lumen area over time using contrast-enhanced micro-CT. 
Lumen narrowing was observed in all animals upstream to the cast, implying the 
formation of a lumen intruding plaque. The minimum degree of stenosis varied 
among animals at each time point, leading to different progression profiles 
overtime. These differences in disease progression rate were not related to the 
initial degree of stenosis at week 5 or plaque size observed at week 9. 
Immediately after cast placement, flow reduction of 23.3±19.8% was observed in 
the RCCA, comparable with previously reported values69,78. During plaque 
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progression, as stenotic degree increased over time, blood flow in the RCCA 
decreased gradually from week 5 to 9. Flow decrease was also observed in 
animals with constant degree of stenosis over time. Therefore, the observed flow 
decrease was not only due to the increasing stenotic degree of the lumen 
intruding plaque, but also likely to be due to increasing resistance of the distal 
vascular bed beyond the carotid bifurcation. In general, blood flow decreased 
during plaque progression in all mice, except one. Our results strongly suggested 
that there were temporal and animal-specific variations in vessel geometry and 
blood flow and therefore one should not use generic values when computing WSS 
distribution as suggested previously226.  
Variations in the local geometrical and blood flow data at the time of investigation 
lead to a complex spatial and temporal distribution of WSS in vivo among animals. 
As blood flow reduced and vessel diameter remained constant, RCCA was exposed 
to dramatically decreasing levels of absolute WSS over time. However, over all, 
WSS decreased over time and was minimal at week 9 in all animals but one. 
Generally it is believed that WSS over a lumen intruding plaque would increase 
over time due to the increased degree of stenosis. Our findings showed that this is 
not the case in this animal model, contrary to the general consensus239. 
Nevertheless, if we look at the spatial distribution of WSS in the upstream RCCA, 
relative WSS showed a gradual increase from the healthy segment to the 
eccentric and then concentric plaque segment, which is in line with the general 
consensus. Although relative WSS distribution followed the expected spatial 
pattern, one should keep in mind that it was on a background with dramatically 
decreased absolute WSS levels. This implies that previous studies which 
correlated high WSS to plaque pathogenesis using this mouse model should 
potentially be reinterpreted. This underlines again the importance of computing 
WSS on subject-specific flow and geometries. 
To analyze correlations between WSS and plaque components, we analyzed 
plaque composition after the final imaging moment. To visualize the spatial 
heterogeneity of plaque composition, we performed consistent sampling of the 
plaque, similar to the study reported before240. This analysis revealed the 
presence of one continuous plaque. Its composition varied in the axial direction 
(Fig. 8). In all animals, proximally, the plaque was small and eccentric, and 
abundant in macrophages. The macrophage concentration was comparable to 
that reported by Cheng et al69. We observed that the plaque segment located 
closer to the cast was big and concentric. CT data demonstrated that vessel lumen 
narrowing was first observed close to the upstream part of the cast, suggesting 
that the plaque revealed here was present for a longer time and thus its 
composition was more advanced, while the proximal part of the plaque is 
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“younger” and less advanced. The spatial heterogeneity of the plaque implied that 
sampling location should be taken into account when analyzing plaque 
composition in any animal model for atherosclerosis or human atherosclerotic 
sample49. Results might be different if one only selects histological sections from 
either eccentric or concentric diseased segments.  
Using mouse-specific absolute WSS at a given time point and using the histological 
data, we demonstrated a strong inverse relationship between macrophages and 
WSS. Macrophages accumulated in the proximal eccentric plaques where WSS 
was lowest, confirming the pro-inflammatory effect of low WSS reported 
before21,22,48. In this mouse model, the continuous exposure to reducing levels of 
WSS in the proximal eccentric plaque correlated to inflammation and thus plaque 
growth. However, regardless of the homogeneous distribution of WSS in the 
upstream RCCA, the proximal segment of the plaque had an eccentric 
composition. In addition, although the upstream part of the RCCA was 
homogeneously exposed to extremely low WSS, plaque was only present close to 
the cast. These evidences suggested that low WSS alone is not incentive enough 
to induce plaque initiation. We think that the plaque initially grew from the region 
close to the cast, and there might be factors (damage from the cast surgery, 
distribution of inflammatory cells or layout of fibrotic tissues) from the existing 
plaque that induced a non-homogeneous growth pattern in the proximal 
direction. In addition, we showed that 6 out of 7 mice had a positive and 
significant correlation between WSS and plaque area. The one animal that 
showed contrasting correlations (mouse number 6 in Fig. 7) presented with such 
extensive plaque progression that the stenosis created by the plaque was more 
severe than the stenosis induced by cast placement (Suppl Fig. 1). 
In our study, we observed large variations in both WSS distribution and plaque 
composition among animals. Correlation between WSS distribution and plaque 
composition reduced when data were pooled. This implies that one can miss out 
on important correlations if the often-applied approach of pooling WSS and 
histological data is used. Similarly, De Wilde38 showed that pooling data lead to 
misinterpretation of correlation between WSS metrics and plaque composition. 
Therefore, when analyzing functional parameters from one to another, using 
subject-specific WSS and histological data is necessary.  
5. Study Limitations 
A limitation of this study was that we were not able to perform rotational 
matching between the 3D WSS maps to the lumen surface obtained from 
histology. Subdividing the 3D WSS maps into cross-sections and matching it to the 
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corresponding orientation of the histological sections would potentially increase 
information density. In our study, the upstream RCCA was relatively a straight 
segment where WSS distributed homogeneously along the lumen circumference. 
We thus expected little effect of performing rotational matching. In addition, we 
focused on computing WSS and did not compute wall stress which is expected to 
play a role, especially close to the cast63, which is why we did not include the 
sections close to the cast in our histological analysis. A limitation of our model is 
that mice do not present with vulnerable plaques in accordance with the 
definition of a human vulnerable plaque and that is mouse plaques are not 
rupture-prone63. The differences between mice –and animal models in general- 
and humans were reviewed by us and others63,201,241. The implication of these 
differences is that translation of the findings based on these animal data to 
patient studies should therefore be done cautiously. A relevant example of the 
difference between mice and humans pertains to cap thickness, a strong indicator 
of plaque vulnerability in human plaques, which is ill-defined in mice due to the 
presence of multiple necrotic cores, located deep in the plaque. We therefore 
decided not to put forward cap thickness analyses in this manuscript. 
 
Figure 8 Schematic overview plaque morphology. Proximally, the plaque was smaller and 
eccentric with abundant accumulation of macrophages. Closer to the cast, the plaque was 
larger and concentric. 
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6. Conclusion 
We quantified the temporal and spatial evolution of WSS in an atherosclerotic 
mouse model and we studied the correlation between the animal-specific WSS 
data and plaque composition in the same animal. Strikingly, due to the temporal 
changes in geometry and flow, WSS decreased over time during disease 
progression, contrary to the general belief. In the majority of the mice, lower WSS 
was associated with elevated levels of inflammation, which mainly localized 
proximally where the plaque was small and eccentric. Closer to the cast where a 
larger concentric plaque was observed, higher WSS was associated with increased 
plaque area. In addition, our study clearly demonstrated the necessity to analyze 
individual animals and plaques when studying correlations between WSS and 
plaque composition. 
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Supplement Figure 1 WSS distribution in all mice. 3D WSS distribution in the RCCAs at 
5, 7 and 9 weeks after cast placement. Circumferentially-averaged WSS along the 
RCCA is shown. Each color bar shows animal-specific absolute WSS levels.  
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Abstract 
Blood flow generates wall shear stress (WSS) which alters endothelial cell (EC) 
function. Low WSS promotes vascular inflammation and atherosclerosis whereas 
high uniform WSS is protective. Ivabradine decreases heart rate leading to altered 
haemodynamics. Besides its cardio-protective effects, Ivabradine protects arteries 
from inflammation and atherosclerosis via unknown mechanisms. We 
hypothesised that Ivabradine protects arteries by increasing WSS to reduce 
vascular inflammation. Hypercholesterolaemic mice were treated with Ivabradine 
for seven weeks in drinking water or remained untreated as a control. En face 
immunostaining demonstrated that treatment with Ivabradine reduced the 
expression of pro-inflammatory VCAM-1 (p<0.01) and enhanced the expression of 
anti-inflammatory eNOS (p<0.01) at the inner curvature of the aorta. We 
concluded that Ivabradine alters EC physiology indirectly via modulation of flow 
because treatment with Ivabradine had no effect in ligated carotid arteries in vivo, 
and did not influence the basal or TNFα-induced expression of inflammatory 
(VCAM-1, MCP-1) or protective (eNOS, HMOX1, KLF2, KLF4) genes in cultured EC. 
We therefore considered whether Ivabradine can alter WSS which is a regulator of 
EC inflammatory activation. Computational fluid dynamics demonstrated that 
Ivabradine treatment reduced heart rate by 20 % and enhanced WSS in the aorta. 
In conclusion, Ivabradine treatment altered haemodynamics in the murine aorta 
by increasing the magnitude of shear stress. This was accompanied by induction 
of eNOS and suppression of VCAM-1, whereas Ivabradine did not alter EC that 
could not respond to flow. Thus Ivabradine protects arteries by altering local 
mechanical conditions to trigger an anti-inflammatory response.  
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1. Introduction 
Heart rate is an important risk factor and therapeutic target in cardiovascular 
disease242–247. Elevated heart rate was associated with poor cardiovascular 
outcome in patients with heart failure or acute myocardial infarction242,243. 
Correspondingly, interventions that lowered resting heart rate led to protection 
from experimental atherogenesis246,247 and reduced infarct size and mortality 
rates in patients with acute myocardial infarction244. A beneficial effect of heart 
rate reduction on coronary artery disease (CAD) was also demonstrated in clinical 
trials using Ivabradine. This compound decreases heart rate by inhibiting the If 
current in the sinus node, without affecting blood pressure or systolic ventricular 
function. 
Ivabradine treatment improved prognosis in patients with chronic heart failure248 
and had anti-ischaemic effects in patients with stable angina249. Moreover, 
Ivabradine was associated with a reduction in coronary endpoints in CAD patients 
with left ventricular dysfunction and heart rate ≥ 70 bpm250. Despite this, a recent 
study found that Ivabradine did not have beneficial effects in patients with stable 
CAD but without heart failure251, suggesting that its vasculoprotective effects may 
be restricted to patients with heart failure. The mechanism for the protective 
effects of Ivabradine has been studied using animal models252–255. The 
administration of Ivabradine reduced experimental atherosclerosis in 
hyperlipidaemic murine254 and rabbit models255. However, molecular targets of 
Ivabradine have not been identified in vascular cells and the atheroprotective 
effects of Ivabradine are not due to a lipid-lowering effect of Ivabradine, since the 
drug had no effects on cholesterol levels252–254. Taken together, these experiments 
suggest that a direct effect of Ivabradine on vessels is unlikely, and suggest that 
reduction of heart rate may be a primary mechanism of action of the drug. 
Arteries are exposed to mechanical forces including mechanical wall stress 
(tangential, longitudinal or circumferential) and blood flow induced wall shear 
stress (WSS) that play important roles in vascular homeostasis and disease. 
Indeed, although atherosclerosis is associated with systemic risk factors, such as 
hypercholesterolemia, it develops preferentially at branches and bends of the 
arterial tree that are exposed to complex patterns of blood flow256. Computational 
fluid dynamic (CFD) studies have demonstrated that the magnitude of WSS (time-
averaged WSS (TAWSS) over the cardiac cycle) is lower at atherosclerosis-prone 
sites exposed to complex flow compared to regions that are protected51,202. Low 
WSS promotes atherosclerosis by inducing endothelial expression of inflammatory 
molecules (e. g. VCAM-1) that promote lesions28,257,258, whereas high 
unidirectional WSS induces anti-inflammatory genes such as endothelial nitric 
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oxide synthetase (eNOS)132. Although Ivabradine is known to increase stroke 
volume and coronary perfusion259, its effects on WSS have not been studied. Here 
we tested the hypothesis that Ivabradine protects arteries by enhancing WSS 
which reduces inflammatory activation of arterial EC. 
2. Methods 
2.1 Animals, surgery, Ivabradine treatment and diet 
All experiments conform to the guidelines laid out in the UK Animals Scientific 
Procedures Act (1986) and to the guidelines from Directive 2010/63/EU of the 
European Parliament on the protection of animals used for scientific purposes, 
and were performed under a project license from the UK Home Office. LDLR-/- 
(low density lipoprotein receptor–deficient) mice on a C57BL/6 genetic 
background were obtained commercially from Jackson laboratories and then bred 
in-house. All mice used in this study were male. Mice were housed under specific-
pathogen free conditions. Where indicated, mice of eight weeks of age were 
anaesthetized using a mixture of ketamine, xylazine and atropine prior to surgical 
exposure of the carotid arteries. The right carotid artery was ligated using cotton 
thread immediately proximal to the carotid bifurcation. Mice were allowed to 
recover for one week prior to experimentation. Some animals were treated with 
Ivabradine either by i. v. injection (5 mg/kg) or in drinking water ad libitum (162 
mg/l for 1 or 7 weeks). Alternatively, mice remained untreated as a control. 
Where indicated, normal chow diet was replaced at 10 weeks of age with Diet W; 
a cholate-free high-fat Western-type diet (Arie Blok Diet W, 4021.06; Woerden, 
Netherlands) for six weeks. The Diet W (high-fat diet) consisted of (w/w) Cocoa 
butter (15 %), cholesterol (0.25 %), sucrose (40.5 %), cornstarch (10 %), corn oil 
(1 %), cellulose (5.95 %), casein (20 %), 50 % choline chloride (2 %), methionine 
(0.2 %) and mineral mixture (5.1 %), total fat content (16 %). 
2.2 En face staining 
Animals were killed using pentobarbital (800 mg/kg by intraperitoneal injection). 
Endothelial expression of VCAM-1 or eNOS was determined by en face staining of 
the murine aorta as described28,258. Briefly, aortae were perfusion fixed and 
isolated prior to permeabilisation using 0.5 % Triton X-100 (Sigma-Aldrich, St. 
Louis, MO, USA), and blocking with 20 % goat serum for 2 hours (h) at room 
temperature. After washing with phosphate-buffered saline (PBS), the tissue was 
incubated with anti-VCAM-1 (EPR505; Novus Biologicals UK, Abingdon, UK) or 
anti-eNOS (BD Biosciences, San Jose, CA, USA) primary antibodies overnight at 
4 °C. The tissue was then washed with PBS and incubated with goat anti-rabbit IgG 
antibody conjugated to AlexaFluor-568 (A11036; Invitrogen, Carlsbad, CA, USA) 
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for 2–3 h at room temperature followed by incubation with AlexFlour-488 labelled 
anti-CD31 antibody (102514; BioLegend, San Diego, CA, USA) for 72–120 h at 4 °C. 
The tissue was incubated with TOPRO-3 to counterstain nuclei. To control for 
specific binding, tissues were incubated with irrelevant rabbit IgG antibodies and 
appropriate fluorescent secondary antibodies, or were incubated with secondary 
antibodies alone. The ascending aorta and arch were mounted and images of the 
EC monolayer were obtained using an inverted laser-scanning confocal 
microscopy (LSM 510 Meta inverted; Zeiss, Oberkochen, Germany). Protected 
(outer curvature) and susceptible (inner curvature) regions of the aortic arch were 
located using anatomical landmarks as described258. The mean expression levels 
of VCAM-1 and eNOS were determined by pooling mean fluorescence values from 
multiple cells (> 50 cells per field of view). 
2.3 EC culture and exposure to shear stress 
Human umbilical vein EC (HUVEC) were isolated using collagenase digestion and 
cultured. EC at passage 3–5 were cultured until confluent in six-well plates and 
exposed to flow using an orbital shaking platform (PSU-10i; Grant Instruments, 
Cambridge, UK) housed inside a cell culture incubator260. The radius of orbit of the 
orbital shaker was 10 mm and the rotation rate was set to 210 rpm. This system 
generated low shear stress (approximately 5 dyn/cm2) with rapid variations in 
direction in the centre and high shear stress (approximately 15 dyn/cm2) with 
relatively uniform direction at the periphery260. 
2.4 Comparative real-time PCR 
The levels of transcripts were assessed using quantitative real time PCR (qRT-PCR) 
as described28,260 using gene-specific primers (Suppl. Table 1, available online at 
www.thrombosis-online.com). Relative gene expression was calculated by 
comparing the number of thermal cycles that were necessary to generate 
threshold amounts of product. Fold changes were calculated using the ∆∆Ct 
method. 
2.5 Vascular geometry and heart rate measurements 
Heart rate and blood pressure were measured in conscious, restrained LDLR-/- 
mice using a commercial automated system Visitech Systems (Apex, NC, USA). In 
order to familiarise mice to this procedure, daily measurements were carried out 
for two weeks prior to experimentation. Mean blood pressure and heart rate 
values were generated by pooling data from 20 measurements. 
CT angiography was carried out as described (Inveon, Siemens, Malvern, PA, 
USA)261. Electrocardiogram gating was used to minimise movement artefacts 
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caused by the movement of the heart and of the vessel during the cardiac cycle. 
Thus all images were acquired at the same time point of the cycle, the end of 
diastole, to avoid scanning during the dilation of the aorta during systole. 
Transthoracic echocardiography was carried out using a commercial system (Vevo 
770® with a RMV707B scan head, Visual Sonics, Toronto, ON, Canada) as 
described262. Briefly mice were anaesthetised with isoflurane via oxygen before 
being placed supine on a heated platform and covered to minimise heat loss. 
Maintenance Isoflurane (0.5–1.5 %) with oxygen was delivered via a nose cone. 
Following depilation, Doppler pulse wave velocities were captured from peak flow 
in the ascending aorta. Data were averaged from 3–5 measurements per mouse. 
2.6 Computational fluid dynamics (CFD) 
The triangulated lumen surface was imported into ANSYS ICEMCFD to generate a 
high quality hybrid tetrahedral mesh with prismatic boundary layer. The use of a 
prismatic layer of four cells allows for accurate representation of the WSS using a 
low overall cell count. Preliminary grid sensitivity studies using grid sizes from 
80,000 to 500,000 cells showed that the results for WSS were grid insensitive 
within 2 % for a grid size of approximately 200,000 cells while allowing for low 
simulation times of approximately 8 h on two cores of a 2.5GHz Intel i7 processor. 
The unsteady Navier-Stokes equations were solved numerically using the finite 
volume method (FVM) in ANSYS FLUENT 14.5. The vessel geometry was assumed 
to be rigid. Blood was modelled as a Newtonian fluid with a dynamic viscosity of μ 
= 0.004 Pa s (4 cP) and a density of ρ = 1235 kg/m3. Using a typical maximum flow 
speed at the aortic root V = 1m/s and the hydraulic diameter of D = 1.58 mm, the 
maximum Reynolds number is 
𝑅𝑒 =  
𝜌𝑉𝐷
𝜇
 =  488 
The flow was therefore modelled as laminar. The aortic root cross section was 
extruded by 10 diameters to allow for development of the flow and prescription 
of a Dirichlet inlet boundary condition for the normal velocity as a plug profile at 
the extruded section. The time dependent mean velocity was digitised from the 
US Doppler images, and a 3rd order Bezier approximation263 was used to generate 
a second-order-smooth mean velocity curve.  
At the exit of the aorta descendens and the branches a Neumann outlet boundary 
condition was used with a flow split of 70%, 16%, 8% and 6% for aorta 
descendens, innominate, common carotid and subclavian, respectively.  
Numerical solutions were obtained using cell based higher with second order 
pressure, quadratic upwind momentum and second order implicit time 
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discretisation. Time step size was chosen as 1/400th or 1/600th of the cycle time 
for the control and Ivabradine cases, respectively, maximum Courant numbers 
were below 8. In addition to the solution vector, three dimensional WSS data for 
the aorta and the defined ROI at the outer and inner curvature were area-
averaged during run time. From the time-dependent WSS, the time-averaged WSS 
at the wall was calculated: 
?̅? =  
1
𝑁
∑ 𝜏𝑛
𝑁
 
2.7 Statistics 
Differences between samples were analysed using an unpaired or paired 
Student’s t-test, one-way ANOVA with Bonferroni’s adjustment, or two-way 
ANOVA with Sidak’s multiple comparison test. 
3. Results 
3.1 Ivabradine reduced inflammation of arterial EC 
We hypothesised that Ivabradine protects rodent arteries by reducing 
inflammatory activation of EC. This was assessed using LDLR-/- mice exposed to a 
high-fat diet for six weeks, a regime that is known to generate 
hypercholesterolaemia and inflammatory activation of aortic EC264. In the first 
instance, we investigated whether oral Ivabradine can reduce heart rate in LDLR-/- 
mice. Male LDLR-/- mice were exposed to Ivabradine in drinking water for seven 
weeks or were exposed to untreated water as a control (Fig. 1A). The average 
consumption of water in Ivabradine treated and control groups was similar (4.85 
vs 5.27 ml/day/animal, respectively) and it was calculated that treated animals 
consumed an average of 27 mg/kg Ivabradine daily. Pressure cuff measurements 
revealed that treatment with Ivabradine reduced heart rate by approximately 
20 % but did not influence systolic or diastolic blood pressure (Fig. 1B). Thus 
although Ivabradine was administered to LDLR-/- mice at doses significantly 
greater than those used clinically (0.25–0.33 mg/kg/day) it caused a reduction in 
heart rate that was proportional to that observed in Ivabradine-treated 
patients248–250. 
We examined whether reduced heart rate in Ivabradine-treated mice was 
associated with an altered inflammatory profile using en face staining to quantify 
endothelial expression of molecules with inflammatory (VCAM-1) or anti-
inflammatory (eNOS) function. In untreated mice, VCAM-1 expression in EC was 
significantly higher at the inner compared to the outer curvature (Fig. 2, left 
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panels), whereas eNOS expression was comparable at the inner and outer 
curvature (Fig. 3, left panels). Treatment with Ivabradine significantly reduced 
VCAM-1 expression and simultaneously increased eNOS expression at both the 
inner and outer curvatures demonstrating that Ivabradine reduced inflammation 
in aortic EC (Fig. 2 and Fig. 3, compare left and right panels). Thus we conclude 
that Ivabradine exerts anti-inflammatory effects in the murine aorta by inducing 
eNOS and by suppressing VCAM-1. 
 
Figure 1 Ivabradine treatment reduced heart rate in a murine model. LDLR-/- mice aged 
nine weeks were treated using Ivabradine (in drinking water) or remained untreated as a 
control (n = 5 per group). After one week, both groups of mice were exposed to a high-fat 
diet in the presence of absence of Ivabradine treatment. Following six weeks, heart rate 
and blood pressure measurements were made and EC expression of specific proteins was 
determined by en face staining. (A) An overview of the experimental approach is shown. 
(B) Mean heart rates (upper panel), systolic (centre panel) and diastolic blood pressures 
(lower panel) ± standard deviations are shown. Differences between means were analysed 
using an unpaired Student’s t-test. n.s., non-significant. 
3.2 Ivabradine did not have direct pharmacological effects on EC 
We wished to know whether Ivabradine reduces vascular inflammation directly by 
pharmacological modification of EC or whether it acts indirectly by altering heart 
rate and hemodynamics. To address this, we exposed cultured HUVEC to 
Ivabradine and determined the expression of inflammatory and anti-inflammatory 
genes. HUVEC were cultured under shear stress for 72 h using an orbiting 6-well 
plate system that generates low mean shear stress at the centre, and high mean 
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shear stress at the periphery. They were simultaneously exposed to Ivabradine at 
concentrations that mimic those detected in plasma in Ivabradine-treated 
individuals (25–50 ng/ml)265. Some cultures were subsequently treated with the 
proinflammatory cytokine TNFα to determine the effect of Ivabradine on 
inflammatory responsiveness. qRT-PCR revealed that the expression of the 
inflammatory effector molecules VCAM-1 and MCP-1 was enhanced in EC exposed 
to low compared to high WSS, and that anti-inflammatory eNOS, HMOX1, KLF2 
and KLF4 displayed the opposite pattern (Fig. 4, compare treatments 1 and 7). The 
application of TNFα enhanced the expression of VCAM-1, MCP-1 and HMOX-1 but 
reduced the expression of KLF2, KLF4 (under low WSS only) and eNOS (under high 
WSS only) (Fig. 4, compare treatments 1, 4 and 7, 10). Notably, treatment of EC 
with Ivabradine had no effect on the expression of VCAM-1, MCP-1, KLF2, KLF4, 
HMOX-1 or eNOS under high WSS (compare treatments 1, 2, 3) or low WSS 
(compare 7, 8, 9), and did not alter their modulation by TNFα (compare 4, 5, 6 and 
10, 11, 12). Thus we conclude that Ivabradine does not alter EC inflammatory or 
protective responses directly. 
The potential ability of Ivabradine to alter EC directly was also studied by ligating 
carotid arteries in LDLR-/- mice so that EC were exposed to static conditions. After 
carotid artery ligation, mice were exposed to Ivabradine for seven weeks (in 
drinking water as above) or to untreated water as a control. En face staining 
revealed that eNOS expression was negligible in ligated arteries of control or 
Ivabradine-treated animals (Suppl. Figure 1). This observation is consistent with 
previous reports that eNOS is shear-sensitive132 and indicates that Ivabradine does 
not induce eNOS expression in EC directly via a pharmacological effect. In 
summary, Ivabradine had anti-inflammatory effects in the aorta which is exposed 
to flow but did not influence EC in cultured EC or cuffed arteries exposed to static 
conditions. Thus we conclude that Ivabradine does not alter EC activation directly. 
Instead, our data are consistent with the hypothesis that Ivabradine reduces 
inflammation of arteries by altering haemodynamics. 
3.3 Heart rate reduction by Ivabradine increased average wall shear 
stress 
Next, we tested the hypothesis that Ivabradine protects atheroprone sites by 
increasing the magnitude of WSS. This was studied by CFD, which relies on 
accurate measurement of vascular geometries and blood flow velocities. WSS is 
sensitive to changes in vascular diameter since it is inversely proportional to the 
vessel radius cubed. Because of this we examined whether treatment of mice with 
Ivabradine altered the geometry of the aorta. MRI revealed that exposure of mice 
to Ivabradine for seven weeks (in drinking water as above) did not influence the 
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Figure 2 Ivabradine reduced endothelial expression of VCAM-1 in the murine aorta. LDLR-/- 
mice aged nine weeks were treated using Ivabradine (in drinking water) or remained 
untreated as a control (n = 5 per group). After one week, both groups of mice were 
exposed to a high-fat diet in the presence or absence of Ivabradine treatment. Following 
six weeks, VCAM-1 expression levels in EC were assessed by en face staining of the inner 
and outer curvatures (red). EC were identified by co-staining with anti-CD31 antibodies 
conjugated to FITC (green). Cell nuclei were identified using TOPRO-3 (purple). 
Representative images and quantitation of VCAM-1 expression (mean ± SEM) are shown. 
Scale bar, 20 μm. Differences between means were analyzed using a two-way ANOVA. 
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Figure 3 Ivabradine induced endothelial expression of eNOS in the murine aorta. LDLR-/- 
mice aged nine weeks were treated using Ivabradine (in drinking water) or remained 
untreated as a control prior to exposure to high-fat diet for six weeks (n = 7 control group, 
n = 8 Ivabradine group). eNOS expression levels in EC were assessed by en face staining of 
the inner and outer curvatures (red). EC were identified by co-staining with anti-CD31 
antibodies conjugated to Alexa Fluor® 488 (green). Cell nuclei were identified using 
TOPRO-3 (purple). Representative images and quantitation of eNOS expression (mean ± 
SEM) are shown. Scale bar, 20 μm. Differences between means were analyzed using a 
two-way ANOVA. 
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diameter of the aortic arch (1.7 ± 0.04 mm vs 1.76 ± 0.06 mm, respectively, p > 
0.1; measured between the brachiocephalic and left common carotid artery). We 
next assessed the effects of Ivabradine on blood flow velocities which were 
measured by transthoracic echocardiography. Since mice were anesthetised for  
Figure 4 Ivabradine did not regulate inflammatory or protective gene expression in 
cultured endothelial cells. HUVEC were exposed to low or high WSS for 72 h in the 
presence of varying concentrations of Ivabradine (or in the absence of Ivabradine 
as a control). Some cultures were subsequently exposed to TNF (10 ng/ml) from 
68–72 h. The expression levels of specific transcripts were measured by qRT-PCR. 
Data were pooled from three independent experiments and mean values ± 
standard errors are shown. Differences between means were tested using a two-
way ANOVA. Only significant differences are indicated. 
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this procedure, Ivabradine was administered by intravenous injection to ensure 
high precision in dose and timing. We wished to achieve a heart rate reduction of 
approximately 20% since this is similar to the reduction observed in mice used for 
assessment of inflammation (Fig. 1B). Using varying doses of Ivabradine (0.5, 5 or 
15 mg/kg) we observed that Ivabradine reduced heart rate in a dose-dependent 
manner (Fig. 5A). Subsequent studies of the effects of Ivabradine on blood flow 
were carried out using 5 mg/kg Ivabradine because this dose achieved an 
approximate 20% reduction in heart rate (Fig. 5A). We observed that Ivabradine 
treatment significantly altered blood flow velocity in the ascending aorta by 
enhancing both the peak velocity and the average velocity over the cardiac cycle 
(Fig. 5B). Unsteady CFD simulations were then performed using time-varying 
waveforms from Ivabradine-treated versus control animals as inlet boundary 
conditions and a single representative geometry. The kinetic changes in WSS 
magnitude were determined over the cardiac cycle for anatomically-distinct 
portions of the aortic arch. At the inner curvature WSS displayed a transient peak 
followed by a rapid decline in magnitude (Fig. 5C). By contrast, WSS magnitude 
declined less rapidly following systole in the outer curvature and was therefore 
higher in the outer compared to the inner curvature for most of the cardiac cycle 
(Fig. 5C). Consistent with this, mapping of time-averaged WSS onto the geometry 
of the aortic arch revealed higher values at the outer compared to the inner 
curvature (Fig. 6, left panels) as described202,266,267. Treatment with Ivabradine 
generated a prolonged higher flow rate in the aorta after systole leading to a 
prolonged higher level WSS (Fig. 5C) and thus an enhanced time-averaged WSS at 
both the inner and outer curvatures (Fig. 6, compare left and right panels). These 
data linking reduced EC inflammatory activation with enhancement in time-
averaged WSS in response to Ivabradine are consistent with the hypothesis that 
Ivabradine reduces inflammation in the aortic arch by enhancing the magnitude of 
WSS. 
4. Discussion 
Ivabradine treatment has been used successfully to treat coronary artery 
disease249,250 and can also reduce atherosclerosis in experimental models252–254. In 
particular, Ivabradine prevented renal and cerebral endothelial dysfunction in a 
mouse transgenic model of mild dyslipidaemia252 and prevented atherosclerotic 
lesion formation254 and improved erectile function253 in hypercholesterolaemic 
ApoE-/- mice. The underlying mechanism has remained elusive because 
Ivabradine-targets have not been identified in vascular cells and Ivabradine did 
not influence plasma lipid levels252,254. Given that Ivabradine alters heart rate, 
stroke volume and coronary perfusion259, we tested the hypothesis that  
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Figure 5 Ivabradine altered haemodynamics in the murine aorta. (A) LDLR-/- mice aged nine 
weeks were sedated using isofluorane prior to assessment of baseline heart rates by 
transthoracic echocardiography (untreated). Mice were treated with 0.5, 5 or 15 mg/kg 
Ivabradine (i. v.), and heart rates were measured 15 min later. Data were pooled from five 
mice and mean values ± standard deviations are presented. (B, C) LDLR-/- mice aged nine 
weeks were sedated using isofluorane. Mice were then treated with Ivabradine (5 mg/kg; 
i. v.) and repeat measurements of aortic blood flow were made 15 min later (Ivabradine). 
(B) Ultrasound data (left panels) were used to generate velocity waveforms (right panels). 
(C) The velocity distributions were used as boundary conditions for CFD assessment of the 
aorta. WSS was calculated over the cardiac cycle at outer and inner curvatures of the aorta 
in basal (control) and Ivabradine treated conditions. Data shown are representative of 
those generated from five independent experiments.  
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Figure 6 Ivabradine enhanced wall shear stress in the murine aorta. LDLR-/- mice aged nine 
weeks (n = 5) were sedated prior to the assessment of blood flow velocities in the aorta 
either prior to (control) or following administration of Ivabradine (5 mg/kg; i. v.). The 
velocity distributions were used as boundary conditions for CFD assessment of the aorta. 
Time-averaged WSS were calculated and mapped onto the aortic geometry. 
Representative data from five independent experiments are shown in two orientations 
(inner curvature, upper panels; greater curvature, lower panels). Note that the 
brachiocephalic and left common carotid arteries are hidden in the upper panels due to 
the orientation of the vessel. 
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Ivabradine may exert protective effects of arteries indirectly by altering 
hemodynamics which has been tightly linked to cardiovascular disease51,202,256. 
Our study demonstrated that Ivabradine significantly altered flow in the murine 
aorta leading to enhanced WSS magnitude at both atheroprone and 
atheroprotected sites. Ivabradine induced protection from inflammation in the 
aorta (exposed to flow) but did not alter the inflammatory state of EC in 
conditions where flow was unaltered (either in vitro or in vivo), providing strong 
evidence that Ivabradine functions indirectly via alteration of vascular mechanics. 
This is consistent with in vitro studies showing that VCAM-1 expression correlates 
inversely with shear stress magnitude268. 
Although it is well established that flow influences vascular function and disease, 
the relative contributions of WSS and mechanical wall stress remain uncertain. 
This is exemplified by Bolduc et al.269 who compared the effects of heart rate 
reduction with Ivabradine or metoprolol (β blocker) on arterial physiology and 
plaque development in hypercholesterolaemic mice. Although metoprolol and 
Ivabradine had similar effects on heart rate reduction, the influence of these 
compounds on vascular physiology varied according to anatomical location. In 
cerebral arteries and the aorta, Ivabradine restored function and reduced plaque 
more effectively than metoprolol indicating that its protective effects include 
factors other than heart rate reduction per se. We propose that Ivabradine 
confers additional vasculoprotective effects by enhancing stroke volume leading 
to elevated WSS. On the other hand, Bolduc et al.269 found that Ivabradine and 
metoprolol reduced carotid artery stiffness to a similar degree and suggested that 
this was due to reduced mechanical wall stress as a result of lowered heart rate. 
Collectively, these and our own observations suggest that Ivabradine can 
modulate vascular function by altering mechanical stress as well as WSS and that 
the relative importance of these factors may vary according to anatomical site. 
The effects of Ivabradine on cardiovascular hemodynamics and physiology 
partially mimic protection afforded by physical exercise which can also lower 
resting pulse rate and enhance stroke volume259. In clinical studies, exercise at 
140–180 % above resting heart rate enhanced peak blood flow velocity and 
increased WSS in the aorta270,271. Bolduc et al.269 compared the effects of 
Ivabradine and physical exercise in hypercholesterolaemic mice and found that 
while increased exercise and Ivabradine both normalized cerebral artery function, 
only Ivabradine reduced carotid artery stiffness. Further studies are required to 
determine whether the differential effects of these interventions on carotid and 
cerebral artery physiology are due to divergent effects on WSS and vascular 
mechanical stress. 
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The numerical model used is consistent with models used in previous 
studies202,266,267. Since WSS is inversely proportional to the cubed radius of the 
vessel, vascular remodeling in response to Ivabradine could have major effects on 
WSS. However, while Ivabradine treatment significantly enhanced arterial blood 
flow velocity it did not modify the geometry of the aorta. Because of these 
considerations we compared fluid dynamics of Ivabradine-treated and control 
mice using distinct inlet velocities (boundary conditions) applied to a single 
representative geometry. An important simplification of the numerical model was 
the use of a rigid geometry. 
In a detailed study of the murine aorta, Trachet et al.272 demonstrated that the 
inclusion of distensibility resulted in more realistic flow velocity waveforms using 
fluid structure interactions (FSI) compared to CFD using a rigid geometry. 
However, CFD and FSI gave similar predictions of WSS at proximal sites near the 
model inlet272. Because of this, we reason that the use of a rigid model in our 
simulations is justifiable because modelling is restricted to the aortic arch which is 
proximal to the flow inlet. Moreover, vascular distensibility may have relatively 
minor effects on WSS simulations in rodent vasculature since de Wilde 
demonstrated that CFD and FSI simulations were almost identical in murine 
carotid arteries66. Nevertheless, the use of a rigid geometry is a simplifying 
assumption that inevitably leads to a degree of error and prospective FSI studies 
should now be carried out to validate our observations using CFD. A second 
simplication concerns the physical properties of blood. Since blood is a highly 
concentrated suspension of red blood cells, it will exhibit non-Newtonian 
behaviour. However, since the level of shear rates in the murine aorta are 
relatively high, the assumption of Newtonian behavior of blood is considered to 
be valid. 
Our observation that Ivabradine reduces arterial expression of VCAM-1 is 
consistent with its ability to protect against atherogenesis252–254. The mechanism 
may involve eNOS, which was induced by Ivabradine in our study and is known to 
inhibit inflammation via NO-dependent nitrosylation of pro-inflammatory 
signaling intermediaries and transcription factors132,191. Notably, previous studies 
revealed that high WSS enhanced the expression of eNOS and reduced VCAM-
128,257,258. Thus we hypothesize that Ivabradine suppresses EC expression of VCAM-
1 via WSS-dependent induction of eNOS. However, it is also plausible that the 
enhancement of WSS and/or modulation of vascular mechanical stress in 
response to Ivabradine reduces inflammation via other mechanosensitive anti-
inflammatory molecules including KLF2, Nrf2 and MKP-196,273. 
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5. Conclusion 
In summary, we have identified a pharmacological approach using Ivabradine to 
elevate WSS in the arterial tree. Altered WSS in response to Ivabradine was 
accompanied by induction of a mechanosensitive protective gene (eNOS) and 
suppression of inflammatory VCAM-1. These observations demonstrate that 
Ivabradine protects arteries by altering local mechanical conditions including 
increased WSS magnitude which triggers an anti-inflammatory response. In 
addition to providing an explanation for the protective effects of Ivabradine, our 
study has broader significance by suggesting that interventions that alter blood 
flow (e. g. heart rate reduction by Ivabradine or exercise) protect the vasculature, 
in part, by modulating local WSS. 
 
 
 
 
 
 
 
 
Suppl. Table 1: Sequences of PCR primers. 
Gene Forward primer Reverse primer 
KLF4 GAACCCACACAGGTGAGAAA CCCGTGTGTTTACGGTAGTG 
HPRT TTGGTCAGGCAGTATAATCC TTGGTCAGGCAGTATAATCC 
MCP1 GCAGAAGTGGGTTCAGGATT GCAGAAGTGGGTTCAGGATT 
VCAM1 CATTGACTTGCAGCACCACA CATTGACTTGCAGCACCACA 
KLF2 ATCACAAGCCTCGATCCTCT ATCACAAGCCTCGATCCTCT 
eNOS TGAAGCACCTGGAGAATGAG TGAAGCACCTGGAGAATGAG 
HMOX1 CCAGTGCCACCAAGTTCAAG CCAGTGCCACCAAGTTCAAG 
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Suppl. Figure 1: Ivabradine did not alter endothelial expression of eNOS in ligated carotid 
arteries. Ligation of the right carotid artery was carried out in LDLR-/- mice aged 8 weeks. 
At 9 weeks, mice were treated using Ivabradine (in drinking water) or remained untreated 
as a control (n=6 per group). At 10 weeks of age, mice were exposed to high fat diet for 6 
weeks. eNOS expression levels in EC were assessed by en face staining of ligated carotid 
arteries (lower panels). Non-ligated arteries were used as a control for staining (upper 
panel). EC were identified by co-staining with anti-CD31 antibodies conjugated to Alexa 
Fluor® 488 (green). Cell nuclei were identified using TOPRO-3 (purple). The study revealed 
that eNOS expression was negligible in ligated arteries and was not induced by Ivabradine. 
Representative images are shown. Scale bar, 20 μm. 
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Abstract 
The heart rate lowering drug Ivabradine was shown to improve cardiac outcome 
in patients with previous heart failure. However, in patients without heart failure, 
no beneficial effect of Ivabradine was observed. Animal studies suggested a 
preventive effect of Ivabradine on atherosclerosis which was due to an increase in 
wall shear stress (WSS), the blood flow-induced frictional force exerted on the 
endothelium, triggering anti-inflammatory responses. However, data on the effect 
of Ivabradine on WSS is sparse. We aim to study the effect of Ivabradine on i) the 
3D WSS distribution over a growing plaque and ii) plaque composition. 
We induced atherosclerosis in ApoE-/- mice by placing a tapered cast around the 
right common carotid artery (RCCA). Five weeks after cast placement, Ivabradine 
was administered via drinking water (15 mg/kg/day) for 2 weeks, after which the 
RCCA was excised for histology analyses. Before and after Ivabradine treatment, 
animals were imaged with Doppler Ultrasound to measure blood velocity. Vessel 
geometry was obtained using contrast-enhanced micro-CT. Time-averaged WSS 
during systole, diastole and peak WSS was subsequently computed. 
Ivabradine significantly decreased heart rate (459 ± 28 bpm vs. 567 ± 32 bpm, 
p<0.001). Normalized peak flow significantly increased in the Ivabradine group 
(124.2% ± 40.5% vs. 87.3% ± 25.4%, p<0.05), reflected by an increased normalized 
WSS level during systole (110.7% ± 18.4% vs. 75.4% ± 24.6%, p<0.05). However, 
plaque size or composition including plaque area, relative necrotic core area and 
macrophage content were not altered in mice treated with Ivabradine compared 
to controls. 
We conclude that increased WSS in response to Ivabradine treatment did not 
affect plaque progression in a murine model. 
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1. Introduction 
Atherosclerosis is characterized by the accumulation of lipids, fibrous tissues and 
inflammatory cells in the arterial wall. The initiation of atherosclerosis is regulated 
by low wall shear stress (WSS), while high WSS is known to be athero-protective in 
the early phase of the disease22,25. When the disease progresses, the plaques can 
grow to the extent that they affect lumen diameter, resulting in changes in WSS 
over the plaque34,35,274. How these changes in WSS affect progression of the 
disease is still a topic under investigation34,35. 
Increased heart rate has been established as a risk factor for cardiovascular 
disease in a healthy population and in a population with a history of various heart 
diseases275–277. The heart rate lowering drug Ivabradine acts on the cardiac 
pacemaker If ion current which is highly expressed in the sinoatrial node. By 
inhibiting the If current, the diastolic depolarization phase is delayed, thus the 
heart rate is selectively reduced278. Several clinical studies showed that Ivabradine 
improved cardiac outcome in patients who had coronary artery disease with 
previous heart failure250,277,279. However, a recent study suggested no beneficial 
effect of Ivabradine on patients who had coronary artery disease without heart 
failure251. Since the reported results are event-based only, size and composition of 
these coronary artery plaques is unknown, and hence the effect of Ivabradine on 
plaque progression is not conclusive.  
Experimental evidence of lowering heart rate on reduced plaque burden was 
previously demonstrated by Beere et al246,247. Animal studies have shown that 
Ivabradine reduced heart rate and decreased oxidative stress, prevented 
endothelial dysfunction and thus reduced atherosclerosis252–254,280–282. These 
studies suggested that the effect of Ivabradine was exerted via alteration of the 
hemodynamic environment. However, the mechanism of the beneficial effect of 
Ivabradine on hemodynamics has not been established. We and others suggested 
that by increasing the duration of the diastolic phase and thus lowering the heart 
rate, Ivabradine indirectly alters the local hemodynamic environment254,283. In our 
previous study, using LDLR-/- mice, an increased WSS in the aortic arch was 
observed upon treatment with Ivabradine283. WSS was calculated using averaged 
flow measurement from multiple mice and using the geometry of one mouse. 
Also, the effect of Ivabradine on plaque progression and/or composition was not 
investigated. Most animal studies focused on the preventive effect of Ivabradine: 
the animals were treated with Ivabradine simultaneously with the onset of high 
fat diet. This does not reflect the clinical situation where patients with known 
cardiovascular disease showed improved secondary outcomes after Ivabradine 
treatment250,277,279. In other studies, endothelial dysfunction was first induced by 
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4-6 weeks of high fat diet and then Ivabradine was administered253,283. However, 
this duration of high fat diet was too short to induce formation of an advanced 
plaque. Therefore, a curative study design where Ivabradine treatment is 
administered after the formation of an advanced plaque is more clinically 
relevant. 
Therefore, in this study, we performed a detailed analysis of the effect of 
Ivabradine on WSS and atherosclerotic plaque progression and composition in a 
mouse model of atherosclerosis. We used the well-established cast mouse model 
on ApoE-/- mice, in which a plaque with characteristics of a vulnerable phenotype 
is induced upstream of the cast. After formation of this plaque, animals were 
treated with Ivabradine and its effect on blood flow parameters, WSS, and its 
potential effect on plaque composition was analyzed. 
2. Methods 
To study wall shear stress (WSS) in vivo, we need to acquire parameters including 
mouse-specific vessel geometry, blood flow velocity and vessel diameter. The 
vessel geometry can be obtained using high-resolution micro-CT imaging, while 
blood flow velocity and vessel diameter can be assessed using ultrasound imaging. 
This information can then be processed and used to compute WSS. 
2.1 Animals, cast placement and Ivabradine treatment 
Female ApoE-/- mice on a C57BL/6J genetic background (n = 18) were purchased 
from Charles River (Maastricht, The Netherlands). At 13 weeks of age, normal 
chow diet was replaced with an atherogenic high fat diet (Altromin Spezialfutter, 
Germany) and provided ad libitum. Cast surgery was performed two weeks later 
on the animals under isoflurane-induced anesthesia69,73,274. A constrictive cast 
with an internal diameter of 400 μm tapering to 200 μm over 1.5 mm was placed 
around the right common carotid artery (RCCA), leading to changes in local WSS 
environment and subsequent plaque development. Five weeks after the cast 
placement, mice (n = 9) were treated with Ivabradine in drinking water ad libitum 
for a duration of 2 weeks (162 mg/L, equivalent to 15 mg/kg/day) or with regular 
drinking water as control (n = 9). This optimal dose was determined in our 
previous publication283, where we demonstrated a biological effect of Ivabradine 
on the arterial wall and a reduction in heart rate by approximately 20%, 
proportional to that observed in Ivabradine-treated patients250. 
The amount of drinking water was monitored for mice and refreshed twice a 
week. A pre-study power analysis was performed based on our previous 
experience with this dose of Ivabradine283, where the smallest significant 
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biological effect of Ivabradine on the arterial wall was observed in the endothelial 
VCAM-1 expression in the outer curvature of the mouse aorta (reduction by 80% 
with a standard deviation of 45%). To reach a power of 80%, 5 experimental 
animals are required to obtain statistical significance (p<0.05). An estimated 40% 
loss of experimental animals due to the multiple anesthesia moments was 
incorporated and ethical approval for 9 experimental animals per group was 
obtained. All animal experiments were performed conform to the guidelines from 
Directive 2010/63/EU of the European Parliament on the protection of animals 
used for scientific purposes, and were approved by the ethical committee of 
Erasmus MC Rotterdam. 
2.2 Animal Imaging Experiments 
Doppler Ultrasound Imaging was performed using Vevo 2100 (VisualSonics). Blood 
velocity waveform upstream of the RCCA was measured with a 40-MHz 
transducer in the pulse-wave mode. The distinction between the systole and 
diastole of the cardiac cycle was determined by the dicrotic notch identified on 
the RCCA blood velocity waveforms284. RCCA diameter at systole or diastole was 
measured in the M-mode at the same location of the velocity measurement, 
allowing conversion of blood velocity (mm/s) to flow (mm3/s) assuming a 
parabolic velocity profile and a circular geometry of the vessel cross-section. The 
parameters were determined at 5 weeks after cast placement (t = 0, baseline) and 
3 days after the treatment of Ivabradine (t = 3) in both control and Ivabradine-
treated mice. Animals were anesthetized under isoflurane (1.5-3% with 1L/min 
oxygen) during the measurement while heart rate was measured by ECG during 
24-38 min after beginning anesthesia. The body temperature was maintained 
between 35.8 °C to 37.7 °C during the procedure by a heating pad and a heating 
lamp.  
At t = 3, contrast-enhanced micro-CT imaging was performed using a Quantum FX 
(PerkinElmer). The scanning parameters used were 90kvp, 160µA with 20mm field 
of view and a scan duration of 4.5 min. Contrast agent eXIA 160 (Binitio 
Biomedical, Canada) was used with an injection dose of 150 µl/25 grams of body 
weight. Micro-CT imaging was performed directly before the ultrasound imaging. 
Images in Hounsfield unit (HU) were reconstructed with an isotropic resolution of 
40 µm. However, 7 out of 18 mice died 1-2 days after the imaging point at t= 3. 
This premature death is probably due to the combination of repeated anesthesia 
and the use of imaging contrast agent. As a result, WSS simulation (n = 5 control 
and n = 5 Ivabradine-treated mice) and histology (n = 4 control and n = 5 
Ivabradine-treated mice) analyses were performed in a subset of animals. 
2.3 RCCA lumen surface reconstruction and CFD simulation 
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RCCA lumen geometry was segmented using previously established protocols in 
MeVisLab (MeVisLab 2.2.1) and Matlab (Matlab R2017a)232. RCCA lumen surface 
was reconstructed from its origin at the bifurcation of the brachiocephalic artery, 
to its bifurcation into the internal and external carotid artery. RCCA lumen surface 
was smoothed using the Vascular Modelling Tool Kit (VMTK 1.2). The superfluous 
ends at the proximal and distal side of the vessel surface were clipped and flow 
extensions were added. A volume mesh with prism layers was then generated 
using ICEM (ICEM-CFD 14.5, Ansys) and a mesh-independent solution with 
approximately 580,000 elements was obtained. The Surface area of the RCCA inlet 
was derived, enabling the calculation of location-specific blood flow velocity as an 
inlet boundary condition. 
The Navier-Stokes equations were solved by computational fluid dynamics (CFD) 
using Fluent (Fluent 17.1, Ansys). Blood was modeled to be incompressible. A 
constant viscosity of 3.5x10-3 kg·m-1·s-1 was used, and vessel wall was assumed to 
be rigid. A parabolic velocity profile was imposed as inlet boundary condition. The 
time-dependent blood flow wave form was derived from Doppler velocity 
measurements. For the outlet boundary condition, zero pressure was used. Time-
dependent flow simulations were performed for 2 cardiac cycles with 100 time 
steps per cycle. WSS was derived from the computed velocity field. Finally, post-
processing and analysis were performed in CFD-Post (CFD-Post 14.5, Ansys) and 
Matlab to quantify time-averaged WSS (TAWSS), TAWSS during systole and 
diastole, and peak WSS.  
2.4 Histological and immunohistochemical analyses 
RCCA vessel samples of Ivabradine-treated mice (n = 5) and control mice (n = 4) 
were harvested and embedded in paraffin for histological analysis. Serial sections 
of 5 µm thick were collected every 50 µm, from the brachiocephalic bifurcation 
proximally to the carotid bifurcation distally. The sections were stained with H&E 
for general plaque morphology, Resorcin-Fuchsin for collagen, CD31 for 
endothelium (1:20, Dianova, Germany) and CD68 for macrophages (1:100, Bio-
Rad, USA). Plaque area and macrophage area were quantified (BioPix iQ3.2). 
Necrotic core was defined as a-cellular, a-nuclear areas, free of H&E staining, 
essentially as described previously274. 
2.5 Statistical analysis 
Data analysis was performed in Matlab (Matlab R2017a) and RStudio (RStudio 
1.0.153). Data are presented as mean ± SD. The normality of the data was 
evaluated by Shapiro–Wilk test. If the data was normally distributed, the student 
t-test was used for further analyses. For data that was not normally distributed, a 
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non-parametric Wilcoxon signed-rank test was used. Differences between the 
Ivabradine-treated group and the control group were evaluated using an 
unpaired, two-tailed students’ t-test or Wilcoxon signed-rank test. Differences 
between the 2 time points (t = 0 vs. t = 3) within the same group were evaluated 
using a paired, two-tailed students’ t-test or non-parametric Wilcoxon signed-rank 
test. The results were considered significant if the p-value <0.05. 
2.6 Data availability statement 
All data generated or analyzed during this study are included in this published 
article. 
3. Results 
3.1 Ivabradine reduced heart rate 
Heart rate at baseline (t = 0 days) and after administration of Ivabradine (t = 3 
days) are shown in Figure 1A. At baseline, there was no difference in heart rate 
between the control and the treatment group (495 ± 64 bpm vs. 491 ± 83 bpm, 
p>0.05). After 3 days treatment, heart rate in mice treated with Ivabradine was 
459 ± 28 bpm, which was significantly lower compared to that of the control 
group (567 ± 32 bpm, p<0.001). Interestingly, heart rate in control mice increased 
significantly from baseline to 3 days treatment (p<0.05). The normalized values 
are listed in Table 1. Compared to the control mice, heart rate of the Ivabradine-
treated mice reduced 18.1%. The data for each individual mouse are presented in 
the supplemental figure 1. 
Table 1 Normalized Cardiac and Flow Parameters 
Parameter Control (n = 9) Ivabradine (n = 9) p-value 
Heart Rate 116.8% ± 22.1% 95.9% ± 17.2% 0.03* 
Systolic Duration 89.5% ± 14.4% 106.4% ± 29.1% 0.14 
Diastolic Duration 90.2% ± 22.5% 108.2% ± 31.0% 0.18 
Average Blood Flow 90.3% ± 35.9% 125.8% ± 48.5% 0.10 
Peak Blood Flow 87.3% ± 25.4% 124.2% ± 40.5% 0.03* 
 
3.2 Ivabradine prolonged the duration of the diastolic phase 
The reduction of heart rate after the administration of Ivabradine resulted in a 
prolonged cardiac cycle compare to control mice (p< 0.001, data not shown). The 
effect of Ivabradine was further investigated by dividing the cardiac cycle into the 
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systolic and the diastolic phase. As shown in Figure 1B, Ivabradine did not alter 
the duration of the systolic phase (0.028 ± 0.010 s vs. 0.029 ± 0.004 s). However, 
the diastolic phase was significantly longer in mice treated with Ivabradine 
compared to that of the control group (Fig. 1C, 0.072 ± 0.008 s vs. 0.096 ± 0.015 s, 
p<0.01). Table 1 shows the normalized cardiac duration of the systolic and the 
diastolic phase. The data for each individual mouse are presented in the 
supplemental figure 2. 
3.3 Ivabradine did not alter blood flow in the RCCA 
The effect of Ivabradine on the flow environment in the RCCA was studied. There 
were no differences in absolute time-averaged or peak blood flow between the 
Ivabradine-treated mice and the control mice. However, normalized peak flow 
was 124.2% ± 40.5% after the Ivabradine treatment, while it decreased to 87.3% ± 
25.4% in the control group (p < 0.05). The data for each individual mouse are 
presented in the supplemental figure 3. 
 
 
Figure 1 Differences of cardiac parameters between control mice (n = 9) and Ivabradine-
treated mice (n = 9). The graphs are shown as mean ± standard deviation. (A) Heart rate; 
(B) Duration of the systolic phase; (C) Duration of the diastolic phase. Note: *p<0.05, 
**p<0.01, ***p<0.001. 
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Figure 2 Ivabradine increased TAWSS during systole. (A) 3D distribution of TAWSS during 
systole in the RCCA before (t = 0) and after Ivabradine (t = 3) in a representative mouse; 
(B) Circumferentially-averaged WSS along the proximal RCCA; The proximal RCCA was 
divided into the healthy and the plaque segment, indicated by the vertical dashed line; (C) 
TAWSS during systole in both the healthy and the plaque segments were significantly 
increased after treatment with Ivabradine. Note: ***p<0.001. 
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3.4 Ivabradine affected wall shear stress in the RCCA during systole  
Different WSS parameters in the healthy segment and the plaque segment of the 
RCCA were investigated. After normalization, TAWSS during systole in the RCCA 
was significantly higher in animals treated with Ivabradine compared to the 
control mice (Table 2, p <0.05). Figure 2 illustrates the distribution of TAWSS 
during systole in the RCCA of a representative mouse. Treatment of Ivabradine 
significantly increased TAWSS during systole in both the healthy segment and the 
plaque segment (Fig.2C). Also, peak WSS increased significantly in the upstream 
RCCA after the treatment of Ivabradine (p<0.05, Table 2). However, there were no 
significant differences between the control and the Ivabradine-treated mice in 
terms of the other WSS parameters investigated, including TAWSS or TAWSS 
during diastole. Table 2 summarizes the normalized WSS parameters. The data for 
each individual mouse are presented in the supplemental figure 4 and 5. 
Table 2 Normalized WSS Parameters 
WSS Parameter Control (n = 5) Ivabradine (n = 5) p-value 
TAWSS Healthy Segment 77.9% ± 21.2% 99.7% ± 22.9% 0.16 
TAWSS Plaque Segment 77.4% ± 21.4% 99.4% ± 23.4% 0.16 
TAWSS Systole Healthy Segment 74.6% ± 21.5% 110.7% ± 18.2% 0.02* 
TAWSS Systole Plaque Segment 74.1% ± 21.5% 110.7% ± 18.4% 0.02* 
TAWSS Diastole Healthy Segment 80.3% ± 20.8% 95.6% ± 24.3% 0.32 
TAWSS Diastole Plaque Segment 80.0% ± 21.1% 95.0% ± 24.6% 0.33 
Peak WSS Healthy Segment 75.4% ± 22.9% 111.9% ± 22.1% 0.03* 
Peak WSS Plaque Segment 74.3% ± 23.1% 111.6% ± 22.9% 0.03* 
 
Table 3 Plaque Composition Parameters 
Plaque Composition Parameters Control (n=4) Ivabradine (n=5) p-value 
Plaque Area (mm2) 0.32 ± 0.15 0.32 ± 0.25 0.98 
Plaque Length (mm) 0.60 ± 0.28 0.72 ± 0.29 0.76 
Necrotic Core (%) 28.3 ± 10.20 24.3 ± 8.4 0.55 
Macrophages (%) 40.0 ± 4.5 34.6 ± 13.1 0.79 
 
3.5 Ivabradine did not change plaque composition 
After 2 weeks of Ivabradine treatment, RCCA vessel samples were harvested for 
histological analyses. Plaque compositional parameters including plaque area, 
plaque length, relative necrotic core area and relative macrophage area were 
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characterized. None of the parameters were significantly different between the 
control group and the Ivabradine-treated group (Table 3). 
4. Discussion 
Our study evaluated the effect of Ivabradine on heart rate and its subsequent 
effect on blood flow, WSS and plaque composition using a mouse model in which 
an advanced plaque was present. We demonstrated that Ivabradine significantly 
prolonged the duration of the diastolic phase, thus extending the entire cardiac 
cycle and reducing heart rate. Time averaged blood flow over the complete heart 
cycle did not change. Normalized peak blood flow was significantly higher in mice 
treated with Ivabradine, leading to a significant increase in normalized TAWSS 
during systole. These changes in WSS did not alter the plaque composition after 2 
weeks of Ivabradine treatment. 
Heart rate in mice treated with Ivabradine was 18.1% lower than the control mice, 
comparable to the values observed in other studies252–254,269,280–282. The control 
group showed an increase in heart rate. Such an increase was also reported by 
Drouin et al. in dyslipidaemic mice during aging252. This could be due to a 
combined effect of anesthesia and/or the use of contrast agent. To correct for 
this, we normalized the data to the baseline measurements. Ivabradine increased 
normalized peak blood flow in the RCCA to 124.2% ± 40.5% in our mice, which is 
comparable to the increase we measured in a single murine aorta previously283. In 
pigs of myocardial ischemia/reperfusion model, Heusch et al reported a 67.5% 
increase in myocardial blood flow after the administration of Ivabradine285. In 
patients diagnosed with stable coronary artery disease, Ivabradine also induced 
an increase in flow i.e. a 12.4% increase in time-averaged peak coronary flow 
velocity during hyperemia. In our study, the increase in systolic blood flow did 
result in an increase in TAWSS during systole to 110.7% ± 18.2%, comparable to 
the increase in TAWSS we found previously in the murine aorta283. However, the 
TAWSS over the entire cardiac cycle was not affected by Ivabradine. Based on our 
current findings and the existing literature, Ivabradine treatment, regardless of 
the concentration or duration used, appeared to induce an increase in blood flow, 
but only during systole. This increase might be due to an Ivabradine-induced 
increase in stroke volume, as a prolonged diastolic phase is likely to result in an 
increase in left ventricle volume and thus a larger amount of blood leaving the left 
ventricle during systole. Due to the prolonged duration of diastole, the time-
averaged blood flow during the complete cardiac cycle did not change in our 
study.  
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Ivabradine treatment for 6 weeks in LDLR-/- mice resulted in a reduction in 
endothelial inflammation283, suggesting that although the increase in TAWSS is of 
short duration, it is sufficient to affect vascular biology. Pre-treatment with 
Ivabradine has been shown to prevent plaque growth in animal models of 
atherosclerosis in some 253,254 but not all 282 studies. Custodis et al. and Baumhäkel 
et al. observed that treatment of mice with Ivabradine significantly reduced 
plaque size in the aortic root and/or the ascending aorta 253,254. However, it should 
be noted that both studies examined whether Ivabradine could prevent disease 
(i.e. they started Ivabradine treatment with the onset of high fat diet) but the 
potential effect of Ivabradine on plaque progression was not studied. We wished 
to know whether Ivabradine can be used to treat atherosclerosis and therefore 
analyzed whether Ivabradine treatment of an existing plaque would affect its 
composition. This hypothesis was supported by our previous report that changes 
in WSS over a developing plaque affects its phenotype274. However, we did not 
observe any changes in plaque composition in terms of plaque size, length, 
relative necrotic core area or relative macrophage accumulation in our current 
study. Our study design with 2 weeks of Ivabradine treatment did not show an 
effect on plaque size or composition. We set out, based on our power calculation, 
to analyse 5 control versus 5 Ivabradine-treated animals. However, due to the 
premature death of several animals, likely due to the combination of repeated 
anesthesia and the use of imaging contrast agent, we ended up with 4 control 
versus 5 Ivabradine-treated animals for histological analysis. Considering the P 
values we obtained (ranging from 0.55-0.98, see table 3) we conclude there is no 
significant effect of Ivabradine on the plaque parameters we studied in our model. 
If we do a power calculation in hindsight, using the lowest p-value found, i.e. 
p=0.55 for necrotic core 28.3 ± 10.20 versus 24.3 ± 8.4 (table 3), we find we would 
need more than 100 animals to reach statistical significance. Therefore, our 
findings point towards a lack of an effect of Ivabradine on plaque size and 
composition when it is administered after the initiation of disease. These data are 
in agreement with the clinical study by Fox et al, who did not observe a beneficial 
effect of Ivabradine on clinical outcome in patients who had coronary artery 
disease without heart failure251.  
In conclusion, Ivabradine led to a small but significant increase in flow and WSS 
during the systolic phase of the heart cycle. Due to the prolonged diastolic phase, 
time-averaged flow and TAWSS over the complete heart cycle did not change. 
However, increased WSS during the systolic phase only accounts for a short 
duration of the cardiac cycle. This increase did not affect plaque size or 
composition in our animal model. Previous clinical and animal studies showed 
inconclusive results upon treatment with Ivabradine, with no or a positive effect. 
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Discussion 
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WSS is responsible for the focal nature of atherosclerosis. Arterial wall locations 
that experience low WSS are susceptible to atherosclerosis, while high WSS is 
athero-protective in the early phase of the disease. In advanced atherosclerosis, 
when atherosclerotic plaques intrude into the vessel lumen, the plaque will 
experience changes in WSS. The aim of this thesis was to study the evolution of 
WSS during plaque progression and to determine its effect on plaque 
composition. We studied 1) the dynamics of WSS over a developing plaque and 2) 
the correlation between WSS and its alterations over time and plaque 
composition in mice. In Chapter 2, we discussed the use of different animal 
models that are used in WSS and atherosclerosis research. In Chapter 3, the 
protocol to compute WSS in the carotid arteries of our mouse model was 
established. In Chapter 4, the WSS environment during atherosclerotic plaque 
progression was monitored in the carotid artery using the cast model, and WSS 
was correlated to plaque composition. The possibility to manipulate WSS using 
the heart rate-lowering drug Ivabradine was investigated in Chapter 5 and 6. 
Finally, an ultrahigh-resolution imaging technique was used to obtain detailed 3D 
compositional information of murine atherosclerotic plaque. An image 
segmentation and plaque quantification protocol was established in Chapter 7. 
Below, we discuss the main findings of this thesis and their implications. 
8.1 Vascular imaging in mice 
WSS is a parameter that is highly sensitive to the input vessel geometry81. Given 
the small dimensions of the murine vasculature, it is crucial to select an imaging 
modality with high resolution. Throughout this thesis we used an ultra-fast micro-
CT scanner (Quantum FX, PerkinElmer), with an acquisition time of only 4.5 
minutes (Chapter 3, 4, and 6). The images obtained successfully captured the 
RCCA geometry in mice with a resolution of 40 µm. At the same time, since 
multiple imaging moments are needed to capture disease progression over time, 
the radiation dose resulting from the ionizing imaging experiments must be 
minimized to avoid irradiation side effects. Single-dose and fractionated 
irradiation was shown to aggravate atherosclerosis in ApoE-/- mice84,295. However, 
the lowest irradiation dose tested in these studies was 8 Gy, while a single CT scan 
with the Quantum FX results in a radiation dose of 1.7Gy. The animals in this 
thesis were scanned at most 3 times and sacrificed directly after the 3rd imaging 
time point. Therefore, the animals were not exposed to a dose that was shown to 
affect atherogenesis and we do not expect an effect of radiation exposure in our 
studies. Nevertheless, we included a non-imaged control group in which we found 
that plaque composition was not affected (Chapter 4).  
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High-resolution, low-radiation dose imaging is required 
to obtain detailed vessel geometry 
Due to the low attenuation rate of the vessel lumen, a contrast agent is needed to 
visualize lumen geometry. An introduction on contrast agents commercially 
available for small animal imaging was presented in Chapter 3. These contrast 
agents include Fenestra VC, Aurovist 15 nm, Exitron nano 6000, Exitron nano 
12000, eXIA 160 and eXIA 160XL. When selecting a contrast agent for a 
longitudinal imaging study, three aspects should be considered. First of all, the 
contrast agent should provide a strong signal. Second, it should be biocompatible 
with the murine system. Third, it should not affect disease pathophysiology. eXIA 
160, although providing lower equivalent iodine content than that of Exitron nano 
12000, provided a strong signal and allowed reconstruction of the murine 
vasculature209,213,296,297 (Chapter 3). Contrast agents like Exitron nano 6000 and 
Exitron nano 12000 accumulate in the liver and spleen where they affect organ 
functionality and remain detectable for months after injection211,212. On the 
contrary, eXIA 160 is cleared from the murine system within 24 hours211,212. 
Plaque-related uptake of contrast agent was observed with the gold-based 
contrast agent Aurovist 15 nm, which accumulates in macrophages in the 
plaques208. This can potentially interfere with disease progression, since 
macrophages play a crucial role in atherosclerotic pathophysiology, and can 
potentially lead to an overestimation of lumen diameter upon the second and 
third imaging time point, as the detected contrast signal can originate from both 
the lumen and the plaque-associated macrophages. Uptake by macrophages was 
never reported for eXIA 160. In our experiments, eXIA 160 did not accumulate in 
the plaque, as determined by a pre-scan before the 2nd and 3rd imaging moment. 
Choice of contrast agent depends on study design and research question 
The use of eXIA 160 for contrast-enhanced micro-CT in murine carotid arteries 
was tested in Chapter 3. A location-based segmentation protocol was established 
to reconstruct 3D vessel geometry of the RCCA. The lumen dimensions of the 
tapered cast sutured around the RCCA served as a landmark to verify the accuracy 
of the segmentation method. The dimension of the cast tapered from 400 µm to 
200 µm. The segmentation revealed a good agreement between the vessel 
geometry and the cast dimensions, with an offset of 9.6% which can be explained 
by the presence of the vessel wall. The segmentation method established in 
Chapter 3 allowed us to reconstruct 3D geometry of the RCCA for WSS 
computation and was used throughout this thesis. 
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The segmentation method should be tailor-made for the experimental model 
8.2 WSS distribution in mice 
The distribution of WSS in the RCCA with tapered cast was initially studied in 
Chapter 3. A time-dependent simulation was performed. WSS parameters 
including TAWSS and OSI were quantified in 3D maps. The upstream part of the 
RCCA was exposed to relatively low TAWSS while OSI was 0 since no flow reversal 
was present. Inside the cast region, TAWSS was high due to the narrowed lumen. 
Downstream of the cast region, due to the slight bending of the RCCA, a strong 
and asymmetrical jet was seen, resulting in high velocities in the center of the 
vessel immediately downstream of the cast. Further downstream of the RCCA, 
low TAWSS was observed with a small region that was exposed to an elevated 
OSI. This thesis focuses on the region upstream to the cast because of the 
presence of a plaque with characteristics of vulnerability. This relatively straight 
vessel segment was exposed to a homogeneously distributed WSS during the 
entire cardiac cycle. This justifies the use of a circumferentially, time-averaged 
analysis of WSS in the area proximal to the cast (Chapter 4). In Chapter 5 and 6, 
we opted for time-dependent WSS simulation, since the heart rate lowering drug 
Ivabradine was hypothesized to affect the cardiac duration and thus time-
dependent WSS levels. 
8.3 Dynamics of WSS in mice during disease progression 
In Chapter 4, the spatial dynamics of TAWSS and how they change during plaque 
progression were investigated. It is the first study to illustrate these changes of 
TAWSS during plaque progression in an animal model of atherosclerosis, and to 
correlated to high resolution plaque compositional information. As a lumen-
intruding plaque grew in size, we observed an increasing stenotic degree over 
time in the RCCA. On average, the maximum degree of stenosis increased from 41 
± 11% at the 1st imaging time point to 62 ± 16% at the final imaging time point. 
Intuitively, one would expect an increasing WSS level due to the narrowed vessel 
lumen. However, WSS is not just dependent on geometry, but also on blood flow. 
Make no assumptions on WSS based on geometry only 
In the ApoE-/- mouse cast model, blood flow through the diseased carotid artery 
decreased during plaque progression from 19.8 ± 9.2 mm3 s−1 at 5 weeks after the 
cast placement to 9.9 ± 11.3 mm3 s−1 at 9 weeks after the cast placement, a 
reduction of 50% on average. Regardless of the increasing degree of stenosis, 
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reduction in blood flow was so severe that as a result, absolute levels of TAWSS 
decreased during plaque progression.  
The severe reduction in flow in our murine cast model was a surprising finding. It 
can be potentially explained in two ways: 1) in addition to the RCCA, three other 
arteries supply blood to the brain i.e. the left common carotid artery (LCCA), and 
the left and right vertebral artery connected via the circle of Willis. Flow in these 
four arteries is balanced to maintain a good flow of oxygen to the brain. By placing 
the cast, we increased the resistance in the RCCA, whereby decreasing flow 
through the RCCA. As blood will flow where resistance is lowest, this might result 
in an increased flow in the other arteries. This is under the assumption that the 
resistance in arteries was not affected by possible plaque formation (not 
analyzed). However, in Chapter 6 we measured flow in the LCCA and found that it 
was not affected, therefore an increase in flow in the LCCA supplying to the brain 
is an unlikely cause for the severe reduction in flow in RCCA. 2) A more likely 
explanation is that the vascular bed distal to the RCCA is affected by the 
atherosclerotic disease (not analyzed), further increasing the resistance in the 
RCCA, whereby reducing flow. To investigate this, one should perform histological 
analysis of the distal vasculature. A similar mechanism was recently reported for 
the low WSS in the human coronary arteries, where an abnormal function of the 
microvascular bed was correlated to lower WSS in the upstream coronary 
arteries298. 
The evolution of WSS during plaque progression has been studied in other animal 
models and humans, at different vascular locations. In some of these studies WSS 
is assumed to increase or an increase was “calculated” with non-animal or non-
patient specific flow values or with estimated flow values. Based on our findings, 
these studies may need to be revisited.  
The evolution of WSS during plaque progression was never studied in mouse 
models of atherosclerosis, while three studies were performed in pigs. Both 
Chatzizisis et al53 and Koskinas et al37 studied WSS in the coronary arteries using a 
young Yorkshire swine model with induced diabetes on a high fat diet. WSS 
analysis in this model can be potentially challenging. As these animals were not 
full grown at the baseline measurement, plaque growth was accompanied by 
natural arterial development. Chatzizisis et al. found a significant decrease in WSS 
over time (two time points were studied) at minimally diseased vessel segments, 
while WSS was unchanged in advanced disease segments. Koskinas et al. studied 
WSS at five time points and found a heterogeneous WSS pattern, which, after an 
initial increase in WSS upon plaque formation, decreased at the 3rd imaging time 
point, only to increase from the 3rd to the 4th and the 4th to the 5th time 
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point37,299. As the flow and plaque size data were not reported in this study we 
cannot deduct the cause of these fluctuations in WSS. Pedrigi et al201 studied WSS 
in D374Y-PCSK9 hypercholesterolemic minipigs with an intracoronary shear-
modifying stent. They found that the average WSS downstream of the stent 
showed a decrease during plaque progression, but no statistical data was 
presented. Since there was an increased area stenosis in the stent, a stronger jet 
was found, leading to a more disturbed flow in the downstream region. As a 
consequence, there was a significant increase in the size of the vessel area 
exposed to increased WSS and decreased WSS. Only values averaged over the 
complete downstream segment were reported. Neither Chatzizisis et al. or Pedrigi 
et al. reported on the spatial heterogeneity in WSS over individual plaques but 
grouped plaque segments or plaque phenotypes of multiple plaques to assess 
correlations between WSS level and plaque phenotype (discussed below in 
section 8.5).  
In human atherosclerotic disease, few longitudinal studies on WSS over a plaque 
exist and they too mostly focus on correlations between WSS at baseline and 
plaque growth or regression at follow-up instead of the focal changes in WSS. In 
regard to these human studies, we need to distinguish between studies on carotid 
and coronary arteries. Studies on carotid arteries mainly found an increase in WSS 
over time44,300,301, due to an increasing stenotic degree and a relatively unaffected 
flow. Only in case of a stenotic degree >70% is a negative effect on flow expected. 
Studies on the role of WSS in human coronary plaque progression were 
performed by research groups of Stone302,303, Samady60 and Gijsen230, and focused 
on correlations between baseline WSS and plaque progression yet did not report 
temporal and spatial changes in WSS over disease progression. Taken together, 
the animal data are not conclusive and human data are lacking regarding how 
WSS changes over developing plaques. Our group is currently performing a 
longitudinal study on WSS evolution in pig and human coronary arteries, which 
will shed light on the local changes in WSS over a growing plaque. 
WSS decreased with plaque progression in our model  
 
revisit previous animal/patient studies 
8.4 Alteration of WSS using Ivabradine 
To study the effect of WSS on the composition of the proximal plaque in our 
mouse cast model, we wanted to test the effect of a drug-induced increase in 
WSS. Ivabradine, a drug that reduces heart rate, was suggested to induce an 
increase in WSS254. We tested the effect of Ivabradine treatment on 
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hemodynamics in atherosclerotic mice in Chapter 5 and 6. Ivabradine targets the 
pacemaker cells in the myocardium which control heart rate, resulting in a 
reduction of heart rate by 18.1%. Previous clinical studies established a 
correlation between increased heart rate and increased risk of cardiovascular 
diseases275–277. An Ivabradine-induced reduction in heart rate was shown to have 
beneficial effects on cardiac outcome in patients250,277,279 and reduced plaque 
burden in animals246,247. The mechanism behind this effect is unclear. It was shown 
that a higher heart rate was associated with expanded periods of low WSS in 
vascular regions where flow reversals was dominant. Thus, by slowing down the 
heart rate would suggest an increased level of WSS in the aorta304. 
Therefore, we set out to study the effect of Ivabradine on WSS, and its potential 
effect on atherosclerotic plaque development and progression in Chapter 5 and 6. 
Our results showed that the use of Ivabradine significantly prolonged the diastolic 
phase of the cardiac cycle, while leaving the duration of the systolic phase 
unchanged. This finding is in line with the fact that Ivabradine specifically targets 
and prolongs the diastolic depolarization, whereby reducing heart rate. An 
elevated level of peak blood flow was indeed observed in the aortic arch and the 
carotid artery of the atherosclerotic mice. In Chapter 5, WSS levels increased 
significantly during the entire cardiac cycle in the aortic arch, while significantly 
increased WSS was only observed during the systolic phase in the carotid artery as 
revealed in Chapter 6. We think these differences in the Ivabradine-induced effect 
on hemodynamics were due to the different routes of Ivabradine administration, 
resulting in different circulating concentrations and the time of measurement. The 
differences could also be attributed to the location of the measurement. In 
Chapter 5, blood flow was measured 15 minutes after an intravenous injection of 
Ivabradine in mouse aorta. On the other hand, Ivabradine was administrated via 
drinking water in studies performed in Chapter 6. Blood flow velocity was 
measured in the RCCA. In this case, we did not measure blood flow directly but 3 
days after the start of oral administration of Ivabradine, which represents a more 
realistic physiological response upon Ivabradine treatment. 
Ivabradine minimally altered WSS and did not affect plaque progression:  
mode of action remains unclear 
The observed increase in WSS in the RCCA was small and only lasted for 25% of 
the cardiac cycle. Slightly elevated WSS during such a small time window have not 
been shown to cause any physiological changes or affect plaque progression, 
while TAWSS was considered to influence endothelial function. In our study, the 
elevated levels of TAWSS observed during the systolic phase did not influence the 
TAWSS during the entire cardiac cycle and did not affect plaque size or 
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composition. We concluded that the use of Ivabradine minimally affected 
hemodynamics and did not affect atherosclerosis in the RCCA in our ApoE-/- 
mouse with cast placement. We suggest that the reported Ivabradine-induced 
beneficial effects on the cardiovasculature are not attributable to an effect on 
WSS. 
It is still unclear how Ivabradine or a reduction in heart rate affects WSS. We 
speculated that the extended diastolic phase potentially allowed more blood to fill 
into the left ventricle, and thus a larger volume of blood was ejected into the 
cardiovascular system during the systolic phase. However, we did not observe 
larger left ventricular volume during diastole or a higher cardiac output, ejection 
fraction, or stroke volume during systole. Nor did we see an increased blood flow 
over the entire cardiac cycle in the carotid arteries of mice treated with 
Ivabradine.  
8.5 Correlation between WSS and plaque composition in mice 
Cast placement induced the formation of a plaque with vulnerable phenotype 
upstream of the cast69. In Chapter 4, we found that this plaque was continuous 
along the axial direction, but plaque composition was heterogeneous. Proximally, 
a smaller and eccentric plaque was observed which was rich in macrophages yet 
less abundant in necrotic core area. The distal part of the plaque, a larger and 
concentric plaque area was present, with relatively less macrophages and higher 
necrotic core content. All animals showed this eccentric-concentric plaque 
morphology. After correlating the plaque composition to the WSS levels at 
different time points during disease progression, we observed a positive 
association between plaque area and absolute WSS level while the presence of 
macrophages was associated with lower absolute WSS in the majority of the mice. 
Our results revealed an inverse relationship between macrophages and WSS, 
corresponding to the pro-inflammatory role of low WSS in plaque progression 
reported before21,22,48. We thus speculate that the continuous exposure to 
reducing WSS in the proximal eccentric plaque promoted inflammation and thus 
induced further plaque growth in the cast mouse model. This is in line with 
previous correlations reported between low WSS and plaque progression in 
human coronary arteries302,303. Low WSS at a baseline measurement was 
correlated to an increase in plaque burden, larger necrotic cores and the presence 
of a vulnerable plaque phenotype at follow up60,302,303. Strikingly, an increase in 
necrotic core area was also correlated to high WSS. Although high WSS was 
correlated to plaque regression, it was also linked to a decrease in fibrous tissue, 
indicating a more vulnerable plaque phenotype51. 
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Reduced WSS level during disease progression was associated with 
the accumulation of macrophages in the eccentric segment of the plaque 
Overall, WSS decreased dramatically during disease progression in our mouse 
model. Therefore, the effect of low WSS on plaque composition could be studied. 
To study the effect of high WSS on plaque progression, it is necessary to use an in 
vivo model where high WSS can be induced during disease progression. We tried 
to achieve this by using the heart rate lowering drug Ivabradine. Nevertheless, it 
did not result in an increase in WSS over the entire cardiac cycle, and no 
correlations with plaque composition could be made.  
Studies using other animal models may provide insight of the role of high WSS in 
plaque progression. In the thesis by Simeone et al, an AV-fistula mouse model was 
used where an artery is connected directly to a neighboring vein. Flow 
measurements revealed a 10-fold increase while WSS was shown to be 7 times 
higher than baseline114,115. This increased level of WSS seemed to be maintained 
over the course of the entire study investigation. This would be an ideal model to 
test the effect of high WSS on plaque composition. Subsequent plaque regression 
where plaque size drastically decreased 50% with a smaller necrotic core and less 
inflammation was observed after 4 weeks of WSS elevation62. These data suggest 
a plaque stabilizing effect of high WSS. 
8.6 3D Plaque Imaging 
During the work of this thesis, we had two major challenges. First of all, it was 
difficult to perform rigid point-to-point registration between the 3D WSS map and 
the histological images, due to the unavoidable shrinkage of the artery upon 
fixation and excision. Secondly, it was difficult to define a fibrous cap in murine 
plaques. To resolve these two issues, we performed ex vivo 3D plaque imaging 
using a high-energy phase-contrast modality. This allowed us to acquire isotropic 
images with ultra-high resolution up to 6.5 µm. An imaging processing pipeline 
was established to reconstruct 3D plaque volume in any custom orientation, 
which aids in the quantification of plaque components on a 3D level, and provides 
a good registration between 3D WSS maps and histological sections. This 
technique can now be used to aid in registration and enables analysis of 3D 
plaque composition. 
8.7 Limitation of study 
Atherosclerotic mouse models are a fundamental tool in atherosclerosis research. 
Besides advantages including lack of genetic variability, fast induction of the 
disease and low costs, there are several disadvantages of using mice. The main 
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disadvantage is the difference in mouse versus human atherosclerosis. In humans, 
plaques are generally found in the coronary arteries, at carotid bifurcations, in the 
abdominal, and in the iliofemoral bifurcations, while mice present plaques in the 
aorta, carotid bifurcation and brachiocephalic artery305,306. Mice have a different 
LDL/HDL balance than humans307 and their plaques mainly consist of 
inflammatory components while these cover only a small area of the total plaque 
volume in humans308. Furthermore, intraplaque haemorrhage (a result of leaky 
neovessels), is rarely reported in mice, as is the presence of luminal thrombi after 
an event. This could be due to differences in the fibrinolytic system between mice 
and men305,306. Furthermore, inducing and accelerating the process of 
atherosclerosis in relatively young animals is far from the natural, usually slow, 
progression seen in, generally older, humans.  
Although the use of the cast model allows for the fast induction of an 
atherosclerotic plaque with characteristics of a vulnerable plaque, it does come 
with several limitations. In the work of our thesis, we noticed that even though 
the upstream part of the RCCA was exposed to distributed low levels of WSS 
homogeneously, plaque formation was only observed close to the cast. It 
suggested that low WSS induced by the cast placement alone is not enough to 
induce plaque initiation. We think that damage from the cast surgery combined 
with the low WSS induced the initial plaque growth. During plaque progression, 
the distribution of inflammatory cells or layout of fibrotic tissues from the existing 
plaque induced a non-homogeneous growth pattern in the upstream RCCA. Also, 
the cast is made of rigid material, restricting the pulsation of the arterial wall after 
its placement, thus influencing the compliance of the arterial region inside the 
cast and in the vicinity of the cast. This could potentially influence plaque 
initiation and development256,309. 
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Summary 
We have all seen it, perhaps not in real life, but definitely in movies or on TV 
screens: upon receiving some shocking news, our character of interest -in many 
cases a man- presses his hand on the chest, his upper body stiffens and what 
follows is a hard fall onto the ground, his face painted with agony. Media has 
never failed to depict a heart attack vividly. What we see less on the screens are 
incidents related to stroke. Perhaps because the image related to stroke is 
perceived less dramatic than that of a heart attack. However, strokes are as well 
common as heart attack. 
Both heart attack and stroke can be caused by a common disease called 
atherosclerosis. Atherosclerosis affects the arteries of our cardiovascular system. 
A healthy artery is soft and elastic. It compresses and relaxes as the heart beats, 
supplying blood rich in oxygen and nutrients from the heart to the rest of the 
body. In an artery affected by atherosclerosis, fatty lipids, inflammatory cells, 
calcium, fibrous tissue and other substances accumulate in the arterial wall. 
“Athero” means “gruel”, implying the plaque is a mixture of substances, while 
“sclerosis” means “hardening”, implying that the artery loses its elasticity when 
diseased. 
Atherosclerotic plaques progress into various forms. Depending on their 
composition, plaques are broadly divided into two categories: stable or 
vulnerable. Stable plaques are generally composed of fibrous tissue, with little or 
no fatty lipids. As suggested by its name, they are relatively stable. Vulnerable 
plaques are made of a more complex “gruel” mixture. They are rich in fatty lipids 
and inflammatory cells, with a thin layer of fibrous tissue overlying the top of a 
plaque. Vulnerable plaque is dangerous because the thin fibrous cap is prone to 
rupture. Upon rupture, the plaque “gruel” comes into contact with the blood. 
Subsequently, blood clots are formed which can obstruct blood supply to major 
organs, for example the brain and the heart, leading to a stroke or heart attack 
respectively. 
Risk factors for atherosclerosis include smoking, diabetes, high blood pressure, 
hyperlipidemia, genetics, etc. These risk factors are systemic in nature, meaning 
that the entire arterial system is exposed to these risk factors. However, 
atherosclerosis develops at specific sites of the arterial system, i.e. near curves 
and branches. This is because these sites are exposed to low or oscillating wall 
shear stress (WSS). 
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WSS is the frictional drag force that blood flow applies on the inner lining of the 
arterial wall. Low WSS is known to induce inflammation and plaque initiation, 
while high WSS is anti-inflammatory and protect against plaque formation. 
However, the relationship between WSS and the progression and composition of 
atherosclerotic plaque is not clear. This thesis aimed to study the evolution of 
WSS during plaque progression and determine its correlation to plaque 
composition. 
Confucius said, “the mechanic, who wishes to do his work well, must first sharpen 
his tools.” To investigate WSS and its relationship with plaque progression and 
composition, we first need to establish research methods and tools. Our 
interdisciplinary research required collaborations among experts in the field of 
cardiology, imaging, fluid mechanics, animal models and pathology. The 
background information is provided in Chapter 1. 
In Chapter 2, we reviewed different animal models that can be used to study the 
relations between WSS and atherosclerosis. Surgical manipulation of blood flow 
velocity, and concomitantly WSS were proven to induce plaque formation in 
animals. The animal models available include arteriovenous fistulas, vascular 
grafts, arterial ligation, and perivascular devices. We review these models from an 
engineering and biological perspective, focusing on the WSS profiles they induce 
and the vascular pathology that is observed. Throughout this thesis we make use 
of the cast model in Apolipoprotein E (ApoE) knockout mice, as cast placement 
quickly results in the formation of a vulnerable plaque. 
To determine WSS in vivo, detailed 3D geometry of the arterial network is 
required. However, a protocol to reconstruct the 3D murine vasculature using our 
animal model of choice is lacking. In Chapter 3, we evaluated the adequacy of 
eXIA 160, a small animal contrast agent, for assessing the murine vascular 
network on micro-CT. We determined that eXIA 160 allowed clear visualization of 
the murine vasculature. We established a novel threshold-based segmentation 
protocol to reconstruct the 3D artery geometry and developed a WSS 
computation pipeline. 
In Chapter 4, we used the protocol developed in Chapter 3 and studied the 
temporal and spatial changes in WSS over a growing atherosclerotic plaque in 
ApoE knockout mice. We found that over time, as the plaque progressed and 
further intruded into the lumen, absolute WSS significantly decreased. Lower WSS 
was significantly correlated to plaque area and the accumulation of macrophages 
in the plaque. 
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To determine the effect of an increase in WSS on atherosclerosis, we investigated 
the effect of the heart rate lowering drug Ivabradine on WSS, as it was previously 
suggested that Ivabradine increases WSS. In Chapter 5, the effect of Ivabradine on 
WSS and its effect on endothelial inflammation was evaluated particularly during 
the onset of atherosclerosis. Ivabradine increased WSS in the murine aorta, 
accompanied by an anti-inflammatory response in the arterial wall. Thus we 
concluded that Ivabradine protects arteries by altering local mechanical 
conditions which trigger an anti-inflammatory response. 
In Chapter 6, the effect of Ivabradine on WSS and its effect on plaque composition 
in advanced atherosclerosis was investigated. Ivabradine significantly decreased 
heart rate. An increase in the normalized WSS level was observed in mice treated 
with Ivabradine. However, the duration of this WSS increase occurred only during 
the systolic phase of the heartbeat and lasted minimal duration. Histology 
analyses showed that plaque size or composition including plaque area, relative 
necrotic core area and macrophage content were not altered in mice treated with 
Ivabradine. We concluded that instant increased WSS in response to Ivabradine 
treatment did not affect plaque progression in our murine model. 
The golden standard to evaluate plaque composition is histology analyses. 
However, histology can only provide compositional information on a 2D level, 
consequently, plaque components with a 3D nature, i.e. cap thickness, necrotic 
core volume or distribution are lost. In Chapter 7, we explored the possibility to 
use a new imaging modality and analysis pipeline to visualize and quantify 3D 
plaque composition in ultrahigh resolution of 6.5 µm. 
Finally, in Chapter 8, the implications of the findings of this thesis, the limitation 
and future prospects are discussed. 
 
S a m e n v a t t i n g  | P a g e  155 
 
Samenvatting 
We hebben het allemaal wel eens gezien. Dan wel niet in het echte leven, dan 
zeker wel in de film. Een persoon, normaal gesproken een oudere man, ontvangt 
schokkend nieuws en grijpt naar zijn borst. Zijn gezicht vertrokken van de pijn, zijn 
bovenlichaam verstijft. En dan, de onvermijdelijke val richting de grond. Dit 
dramatische beeld dat we zo vaak zien in films en op TV kennen we allemaal. 
Echter, wat we minder vaak zien op het grote scherm zijn beroertes. Misschien is 
dit wel omdat beroertes in het algemeen minder dramatisch weer te geven zijn 
dan een hartaanval. Echter, ze zijn net zo gewoon als hartaanvallen. 
Zowel hartaanvallen als beroertes kunnen veroorzaakt worden door de veel 
voorkomende ziekte genaamd atherosclerose. Deze ziekte treft de slagaders van 
ons cardiovasculair systeem. Een gezonde slagader is zacht en elastisch. Het perst 
en ontspant wanneer ons hart klopt om zo zuurstof- en voedingsstofrijk bloed 
naar andere delen van ons lichaam te sturen. Bij atherosclerose hopen vette 
lipiden, ontstoken cellen, calcium, vezelig weefsel en andere stoffen zich op aan 
de slagaderwand. Deze ophoping word ook wel “arthero” genoemd, hetgeen 
“gruel” betekent (oftewel een mengsel). De betekenis van “scelarosis” is 
verharding en refereert naar de vermindering in elasticiteit van de slagader. 
Atherosclerotische plaques ontwikkelen zich in verschillende vormen. Afhankelijk 
van hun samenstelling kunnen we deze plaques verdelen in twee categorieën: 
stabiel en kwetsbaar. Stabiele plaques zijn in het algemeen samengesteld uit 
vezelig weefsel, met weinig of geen vetachtige lipiden. Zoals de naam impliceert 
zijn ze relatief stabiel. Kwetsbare plaques bestaan uit een complexer “gruel” 
mengsel. Ze zijn rijk aan vette lipiden en ontstoken cellen, met een dunne laag 
vezelig weefsel die zich over de plaque heeft gevormd. Kwetsbare plaques zijn 
gevaarlijk aangezien deze dunne laag vezelig weefsel is geneigd om te scheuren. 
Zodra dit gebeurt komt de gruel in de bloedbaan terecht. Het gevolg is de vorming 
van bloedproppen die de bloedstromen naar organen kunnen verhinderen of zelfs 
blokkeren. Bij het hart of de hersenen kan dit leiden tot een hartaanval of 
beroerte. 
Risicofactoren voor atherosclerosis zijn o.a. roken, diabetes, hoge bloeddruk, 
hyperlipidemie, genen, enz. Deze risicofactoren zijn van nature systematisch. Dat 
betekend dat het hele slagader systeem getroffen kan worden door deze risico’s. 
Echter, atherosclerosis ontwikkeld zich in bepaalde delen van het slagader 
systeem, bijvoorbeeld bij bochten en vertakkingen. Deze onderdelen zijn namelijk 
vatbaar voor lage of oscillerende wandschuifspanning (WSS). 
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WSS is de wrijvingsweerstandskracht die de bloedstroom uitoefent op de 
binnenbekleding van de slagaderwand. Het is bekend dat een lage WSS 
ontstekingen en plaque-formaties veroorzaakt. Een hoge WSS voorkomt deze. 
Echter, de relatie tussen WSS en de progressie en samenstelling van 
atherosclerotische plaque is onduidelijk. Dit proefschrift was gericht op het 
bestuderen van de evolutie van WSS tijdens plaque-progressie en het bepalen 
van de correlatie ervan met de samenstelling van plaques. 
Confucius zei ooit: “de monteur die zijn werk goed wilt doen moet eerst zijn 
gereedschap slijpen”. Om de relatie tussen WSS en de progressie en samenstelling 
van atherosclerotische plaques te onderzoeken moeten we eerst 
onderzoekmethodes en gereedschappen opzetten. Ons multidisciplinair 
onderzoek vereiste een samenwerking tussen experts op het gebied van 
cardiologie, imaging, vloeistofmechanica, diermodellen en pathologie. De 
achtergrondinformatie wordt gegeven in Hoofdstuk 1. 
In Hoofdstuk 2 hebben we verscheidene diermodellen bekeken die kunnen 
worden gebruikt om de relaties tussen WSS en atherosclerose te bestuderen. We 
ontdekten dat chirurgische manipulatie van de bloedstroomsnelheid en gelijktijdig 
WSS plaquevorming bij dieren bleek te induceren. De beschikbare diermodellen 
omvatten arterioveneuze fistels, vasculaire grafts, arteriële ligatie en 
perivasculaire inrichtingen. We bekijken deze modellen vanuit technisch en 
biologisch perspectief. Hierbij focussen we op de WSS-profielen die deze 
induceren en de vasculaire pathologie die wordt waargenomen. In dit proefschrift 
maken we gebruik van het cast-model in Apolipoproteïne E (ApoE) knockout-
muizen, omdat een gegoten plaatsing snel resulteert in de vorming van een 
kwetsbare plaque. 
Om WSS in vivo te bepalen is een gedetailleerde 3D-geometrie van het arteriële 
netwerk benodigd. Echter er bestond nog geen protocol om het 3D 
muizenvaatstelsel te reconstrueren met behulp van het door ons gekozen 
diermodel. In Hoofdstuk 3 hebben we de adequaatheid van eXIA 160, een klein 
contrastmiddel voor dieren, geëvalueerd voor het beoordelen van het muriene 
vasculaire netwerk op micro-CT. We hebben vastgesteld dat eXIA 160 
gedetailleerde visualisatie van het muizenvaatstelsel mogelijk maakte. We hebben 
een nieuw drempel gebaseerd segmentatie protocol opgesteld om de 3D-arteriële 
geometrie te reconstrueren en een WSS-berekeningspijplijn te ontwikkelen. 
In Hoofdstuk 4 gebruikten we het protocol dat werd ontwikkeld in Hoofdstuk 3 en 
bestudeerden de temporele en spatiale veranderingen in WSS bij een groeiende 
atherosclerotische plaque in ApoE knock-out muizen. We ontdekten dat naarmate 
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de plaque zich ontwikkelde en verder in het lumen binnendrong de absolute WSS 
significant afnam. Lagere WSS was significant gecorreleerd aan plaque gebied en 
de accumulatie van macrofagen in de plaque. 
Om het effect van een toename in WSS op atherosclerose te bepalen, 
onderzochten we het effect van het hartslagverlagende medicijn Ivabradine op 
WSS. We kozen hiervoor omdat er eerder was gesuggereerd dat Ivabradine de 
WSS verhoogt. In Hoofdstuk 5 werd het effect van Ivabradine op WSS en het 
effect op endotheliale inflammatie geëvalueerd, vooral tijdens het ontstaan van 
atherosclerose. Ivabradine verhoogde WSS in de murine aorta en had een 
ontstekingsremmende werking in de slagaderwand. We concludeerden dat 
Ivabradine de slagaders beschermt door lokale mechanische condities te 
veranderen die een ontstekingsremmende reactie teweegbrengen. 
In Hoofdstuk 6 werd het effect van Ivabradine op WSS en het effect ervan op de 
samenstelling van de plaque in geavanceerde atherosclerose onderzocht. 
Ivabradine verminderde de hartslag drastisch. Een verhoging van het 
genormaliseerde WSS- niveau werd waargenomen bij muizen die werden 
behandeld met Ivabradine. De duur van deze WSS-verhoging trad echter alleen op 
tijdens de systolische fase van de hartslag en duurde zeer kort. Een histologische 
analyse liet zien dat de plaquegrootte of -samenstelling (inclusief plaque-
oppervlak, relatief necrotisch kerngebied en het gehalte aan macrofagen) niet 
veranderde in muizen de waren behandeld met Ivabradine. We concludeerden 
dat verhoogde WSS als reactie op de behandeling met Ivabradine geen invloed 
had op de plaque-ontwikkeling in ons muizenmodel. 
De gouden standaard om de samenstelling van de plaque te evalueren is via een 
histologische analyse. De histologie kan echter alleen compositiegegevens op 2D- 
niveau verschaffen. Dit betekent dat gegevens over plaquecomponenten met een 
3D- aard, d.w.z. kapdikte, necrotisch kernvolume of verdeling verloren gaan. In 
Hoofdstuk 7 hebben we de mogelijkheid onderzocht om een nieuwe 
beeldvormingsmodaliteit en analysepijplijn te gebruiken om 3D-
plaquensamenstelling in ultra-hoge resolutie te visualiseren en kwantificeren. Dit 
deden we met behulp van Phase contrast X-ray tomographic microscopy. 
Tot slot worden in Hoofdstuk 8 de implicaties van de bevindingen van dit 
proefschrift, de beperking en toekomstperspectieven besproken. 
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6th Cardio Vasculaire Conferentie, Amersfoort, NL 2015 0.3 ECTS 
10th Biomechanics in Vascular Biology and Cardiovascular Disease, Rotterdam, NL 2015 0.3 ECTS 
North American Vascular Biology Organization, Hyannis, MA, USA 2015 0.3 ECTS 
12th Biomechanics in Vascular Biology and Cardiovascular Disease, Rotterdam, NL 2017 0.3 ECTS 
North American Vascular Biology Organization, Monterey, CA, USA 2017 0.3 ECTS 
   
Teaching and Training Activities   
Supervised Gayle McCann, master student from Glasgow University, Scotland, UK 2014 1.0 ECTS 
Performed mouse micro-surgery training at Department of Infection, 
Immunity & Cardiovascular Disease, University of Sheffield, UK 
2015 1.5 ECTS 
Performed mouse micro-surgery training at College of Pharmacy,  
University New Mexico, Albuquerque, NM, USA 
2016 0.9 ECTS 
Supervised Daniel Rodrigues, master student from University of Porto, Portugal 2017 0.8 ECTS 
   
   
   
   
   
   
   
   
Total  32.8 ECTS 
 
